| | Molcan Corporation |
Country: Canada 70 East Beaver Creek Road #39, Richmond Hill, Ontario, Canada L4B 3B2 | http://www.molcan.com | | Molcan Corporation Page: Home | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | | |
Product List | DICLOFENAC 4-BROMO ANALOG ; DICLOFENAC 4-BROMO 6-DESCHLORO IMPURITY ; DCF44 : 2-[2-[(4-Bromo-2-chlorophenyl)amino]phenyl]acetic acid ; | DICLOFENAC CARBAZOLE IMPURITY ; CAS:131023-44-4 DCF51 : 2-(8-Chloro-9H-carbazol-1-yl)acetic acid ; | DICLOFENAC CARBOXYLIC ACID (METABOLITE) ; CAS:13625-57-5 DCF31 : 2-[(2,6-Dichlorophenyl)amino]benzoic acid ; N-(2,6-Dichlorophenyl) anthranilic acid ; | DICLOFENAC CHLOROACETYL IMPURITY ; CAS:15308-01-7 DCF45 : N-Chloroacetyl-N-phenyl-2,6-dichloroaniline ; | DICLOFENAC DESACETATE IMPURITY ; CAS:15307-93-4 DCF46 : N-(2,6-Dichlorophenyl)aniline ; | DICLOFENAC DIMER ;; CAS:1609187-30-5 DCF55 : | DICLOFENAC EP IMPURITY A (= USP RC A) ; ACECLOFENAC EP IMPURITY I ; CAS:15362-40-0 DCF01 : 1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Diclofenac Amide ; | DICLOFENAC EP IMPURITY B (= USP RC B) ; CAS:22121-58-0 DCF02 : 2-[(2,6-Dichlorophenyl)amino]benzaldehyde ; | DICLOFENAC EP IMPURITY C (= USP RC C) ; CAS:27204-57-5 DCF03 : [2-[(2,6-Dichlorophenyl)amino]phenyl]methanol ; | DICLOFENAC EP IMPURITY D (= USP RC D) ; DICLOFENAC SODIUM 2-BROMO ANALOG ; CAS:127792-23-8 DCF04N : 2-[2-[(2-Bromo-6-chlorophenyl)amino]phenyl]acetic acid sodium salt ; | DICLOFENAC EP IMPURITY E (= USP RC E) ; CAS:59-48-3 DCF05 : 1,3-Dihydro-2H-indol-2-one ; | DICLOFENAC EP IMPURITY F (= USP RC F) ; CAS:560075-65-2 DCF06 : N-(4-Chlorophenyl)-2-(2,6-dichlorophenyl)acetamide ; | DICLOFENAC ETHYL ESTER ; ACECLOFENAC EP IMPURITY C ; CAS:15307-77-4 DCF33 : Ethyl [2-[(2,6-dichlorophenyl)amino]phenyl]acetate ; | DICLOFENAC KETO SODIUM ; CAS:70757-34-5 DCF50N : 2-[(2,6-Dichlorophenyl)amino]-a-oxo-benzeneacetic acid sodium salt ; | DICLOFENAC METHYL ESTER ; ACECLOFENAC EP IMPURITY B ; CAS:15307-78-5 DCF32: Methyl [2-[(2,6-dichlorophenyl)amino]phenyl]acetate ; | DICLOFENAC POTASSIUM ; CAS:15307-81-0 DCF00K : Potassium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate ; | DICLOFENAC SODIUM ; ACECLOFENAC EP IMPURITY A ; CAS:15307-79-6 DCF00N : Sodium [2-[(2,6-dichlorophenyl)amino]phenyl]acetate ; | DICLOXACILLIN EP IMPURITY A ; PENICILLOIC ACIDS OF DICLOXACILLIN ; CAS:42947-69-3 DCX01 : (4S)-2-[Carboxy[[[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl] amino]methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ; | DICLOXACILLIN EP IMPURITY B ; PENILLOIC ACIDS OF DICLOXACILLIN ; CAS:89353-77-5 DCX02 : (2RS,4S)-2-[[[[3-(2,6-Dichlorophenyl)-5-methylisoxazol-4-yl]carbonyl]amino] methyl]-5,5-dimethylthiazolidine-4-carboxylic acid ; | DICLOXACILLIN EP IMPURITY C ; CLOXACILLIN EP IMPURITY C ; SULBACTAM EP IMPURITY B ; AMPICILLIN EP IMPURITY A ; AMOXICILLIN EP IMPURITY A ; 6-AMINOPENICILLANIC ACID ; 6-APA ; CAS:551-16-6 DCX03 : (2S,5R,6R)-6-Amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid ; | DICLOXACILLIN EP IMPURITY D ; DICLOXACILLIN USP RC D ; CAS:3919-76-4 DCX04 : 3-(2,6-Dichlorophenyl)-5-methylisoxazole-4-carboxylic acid ; | DICLOXACILLIN SODIUM ; CAS:13412-64-1 DCX00N : Sodium (2S,5R,6R)-6-[[[3-(2,6-dichlorophenyl)-5-methylisoxazol-4-yl] carbonyl] amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate monohydrate ; | DICLOXACILLIN SODIUM 6-APA AMIDE ; 6-APA DICLOXACILLIN SODIUM AMIDE ; DCX65N : (2S,5R,6R)-6-[[[(2S,5R,6R)-6-[[[3-(2,6-Dichlorophenyl)-5-methylisoxazol-4-yl] carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl] carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid sodium salt ; | DICYCLOVERINE DICYCLOHEXYL IMPURITY ; CAS:92-51-3 DCV52 : Cyclohexylcyclohexane ; | DICYCLOVERINE EP IMPURITY A ; CAS:60263-54-9 DCV01 : Bicyclohexyl-1-carboxylic acid ; | DICYCLOVERINE HCL ; DICYCLOMINE HCL ; CAS:67-92-5 DCV00H : 2-(Diethylamino)ethyl bicyclohexyl-1-carboxylate hydrochloride ; | DIDANOSINE ; 2',3'-DIDEOXYINOSINE ; CAS:69655-05-6 DDN00 : 9-(2,3-Dideoxy-ß-D-glycero-pentofuranosyl)-1,9-dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY A ; DIDANOSINE USP RC A ; HYPOXANTHINE ; AZATHIOPRINE EP IMPURITY F ; AZATHIOPRINE BP IMPURITY F ; CAS:68-94-0 DDN01 : 1,7-Dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY B ; INOSINE (USP) ; CAS:58-63-9 DDN02 : 9-ß-D-Ribofuranosyl-1,9-dihydro-6H-purin6-one ; | DIDANOSINE EP IMPURITY C ; 2'-DEOXYINOSINE (USP) ; CAS:890-38-0 DDN03 : 9-(2-Deoxy-ß-D-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY D ; 3'-DEOXYINOSINE (USP) ; CAS:13146-72-0 DDN04 : 9-(3-Deoxy-ß-D-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY E ; 2',3'-ANHYDROINOSINE (USP) ; CAS:31766-13-9 DDN05 : 9-(2,3-Anhydro-ß-D-ribofuranosyl)-1,9-dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY F ; 2',3'-DIDEOXY-2',3'-DIDEHYDROINOSINE (USP) ; CAS:42867-68-5 DDN06 : 9-(2,3-Dideoxy-ß-D-glycero-pent-2-enofuranosyl)-1,9-dihydro-6H-purin-6-one ; | DIDANOSINE EP IMPURITY G ; DIDANOSINE USP RC B ; 2',3'-DIDEOXYADENOSINE (USP) ; CAS:4097-22-7 DDN07 : 9-(2,3-Dideoxy-ß-D-glycero-pentofuranosyl)-9H-purin-6-amine ; | DIDANOSINE EP IMPURITY H ; 2',3',5'-TRIDEOXYADENOSINE ; 5'-DEOXYDIDEOXYADENOSINE (USP) ; CAS:6612-70-0 DDN08 : 9-(2,3,5-trideoxy-ß-D-glycero-pentofuranosyl)-9H-purin-6-amine; | DIDANOSINE EP IMPURITY I ; 2',3'-DIDEOXY-2',3'-DIDEHYDROADENOSINE ; CAS:7057-48-9 DDN09 : 9-(2,3-Dideoxy-ß-D-glycero-pent-2-enofuranosyl)-9H-purin-6-amine ; | DIENOGEST ; CAS:65928-58-7 DEG00 : 17a-Cyanomethyl-17ß-hydroxyestra-4, 9-dien-3-one ; | DIENOGEST 11SS-HYDROPEROXY IMPURITY ; CAS:106111-43-7 DEG61 : (11ß,17a)-11-Hydroperoxy-17-hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile ; | DIENOGEST 17-EPI DIMETHOXY IMPURITY ; DEG51 : 2-((8S,13S,14S,17S)-17-Hydroxy-3,3-dimethoxy-13-methyl-2,3,4,6,7,8,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetonitrile ; | DIENOGEST 17-EPI IMPURITY ; DEG50 : (17ß)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile ; | DIENOGEST DIMETHOXY IMPURITY ; CAS:102193-41-9 DEG52 : (17a)-17-Hydroxy-3,3-dimethoxy-19-norpregna-5(10),9(11)-diene-21-nitrile ; | DIENOGEST EP IMPURITY A ; 11-HYDROXY DIENOGEST ; CAS:86153-39-1 DEG01 : (11,17-Dihydroxy-3-oxoestra-4,9-dien-17a-yl)acetonitrile ; | DIENOGEST EP IMPURITY B ; DIENEDIONE ; DEG02 : Estra-4,9-diene-3,17-dione ; | DIENOGEST EP IMPURITY C ; CAS:106111-42-6 DEG03 : [17-Hydroxy-3-oxoestra-5(10),9(11)-dien-17a-yl]-acetonitrile ; | DIENOGEST EP IMPURITY D ; CAS:190662-30-7 DEG04 : [17'-Hydroxyspiro[1,3-dioxolan-2,3'-estra-5'(10'),9'(11')-dien]-17'a-yl]acetonitrile ; | DIENOGEST EP IMPURITY E ; CAS:102193-41-9 DEG05 : [17-Hydroxy-3,3-dimethoxyestra-5(10),9(11)-dien-17a-yl]-acetonitrile ; | DIENOGEST EP IMPURITY F ; CAS:67473-36-3 DEG06 : (17-Hydroxy-3-oxoestr-4-en-17a-yl)acetonitrile ; | DIENOGEST EP IMPURITY G ; ?9,11-DEHYDRO-17A-CYANOMETHYL ESTRADIOL ; CAS:86153-38-0 DEG07 : [3,17-Dihydroxyestra-1,3,5(10),9(11)-tetraen-17a-yl]-acetonitrile ; | DIENOGEST SS-D-GLUCURONIDE ; DEG53 : (17a)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile ß-D-Glucuronide ; | DIETHYLCARBAMAZINE CITRATE ; CAS:1642-54-2 DCM00C : N,N-Diethyl-4-methylpiperazine-1-carboxamide dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate ; | DIETHYLCARBAMAZINE EP IMPURITY A ; IMATINIB EP IMPURITY G ; CYCLIZINE EP IMPURITY A ; CAS:109-01-3 DCM01H : 1-Methylpiperazine Dihydrochloride ; | DIETHYLCARBAMAZINE EP IMPURITY B ; CAS:106-58-1 DCM02 : 1,4-Dimethylpiperazine ; | DIETHYLCARBAMAZINE N-OXIDE ; CAS:34812-73-2 DCM50 : N,N-Diethyl-4-methylpiperazine-1-carboxamide N-oxide ; | DIFLORASONE ; CAS:2557-49-5 DRS60 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLORASONE 11,21-O-DIPROPIONYL ; DRS62 ; Diflorasone 11,21-O-dipropionyl ; | DIFLORASONE 11-O-PROPIONYL ; DRS61 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-17-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-11-yl propionate ; | DIFLORASONE 17-O-ACETYL ; CAS:50630-19-8 DRS63 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl acetate ; | DIFLORASONE 17-PROPIONATE ; HALOBETASOL PROPIONATE 21-HYDROXY ANALOG ; CAS:924726-89-6 DRS53 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ; | DIFLORASONE 17-PROPIONATE 6-CHLORO ; HALOBETASOL PROPIONATE 6-CHLORO 21-HYDROXY ANALOG ; DRS58 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Chloro-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-Dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ; 6a-Desfluoro-6a-chloro-21-hydroxy halobetasol propiona | DIFLORASONE 17-PROPIONATE 9-CHLORO ; HALOBETASOL PROPIONATE 9-CHLORO 21-HYDROXY ANALOG ; CAS:84509-91-1 DRS55 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-9-Chloro-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ; | DIFLORASONE 17-PROPRIONATE 21-MESYLATE ; HALOBETASOL PROPIONATE 21-MESYLATE ; CAS:84509-92-2 DRS54 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-17-(2-(methylsulfonyloxy)acetyl)-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate ; | DIFLORASONE 21-ACETATE 17-PROPIONATE ; HALOBETASOL PROPIONATE 21-ACETATE ; CAS:79861-38-4 DRS52 ; 6a,9-Difluoro-11b,17,21-trihydroxy-16b-methylpregna-1,4-diene-3,20-dione 21-acetate 17-propionate ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Acetoxyacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyc | DIFLORASONE 21-CHLORO ; HALOBETASOL ; CAS:98651-66-2 DRS50 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLORASONE 21-DEHYDRO ; DRS51 ; 2-((6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetaldehyde ; | DIFLORASONE 6-CHLORO ; HALOBETASOL 6-CHLORO 21-HYDROXY ANALOG ; DRS57 ; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-6-Chloro-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLORASONE ACETYLOXY ; CAS:3826-17-3 DRS56 ; 2-((6S,8S,9R,10S,11S,13S,14S,16S,17R)-6,9-Difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate ; | DIFLORASONE DIACETATE ; CAS:33564-31-7 DRS00 ; (6a,11ß,16ß)-17,21-Bis(acetyloxy)-6,9-difluoro-11-hydroxy-16-methyl-pregna-1,4-diene-3,20-dione ; | DIFLOXACIN EP IMPURITY A ; DXN01 : 6-Fluoro-7-(4-methylpiperazin-1-yl)-1-[4-(4-methylpiperazin-1-yl)phenyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | DIFLOXACIN EP IMPURITY B ; SARAFLOXACIN HCL ; CAS:91296-87-6 DXN02H : 6-Fluoro-1-(4-fluorophenyl)-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid HCl ; | DIFLOXACIN EP IMPURITY C ; DXN03 : 1-(4-Chlorophenyl)-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | DIFLOXACIN EP IMPURITY D ; DXN04 : 6-Chloro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | DIFLOXACIN EP IMPURITY E ; DXN05 : 7-Chloro-1-(4-fluorophenyl)-6-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | DIFLOXACIN EP IMPURITY F ; DXN06 : 6-Fluoro-N,1-bis(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxamide ; | DIFLOXACIN EP IMPURITY G ; CAS:98105-79-4 DXN07 : 7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | DIFLOXACIN HYDROCHLORIDE ; CAS:91296-86-5 DXN00H : 6-Fluoro-1-(4-fluorophenyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride ; | DIFLUNISAL ; CAS:22494-42-4 DFS00 : 2',4'-Difluoro-4-hydroxybiphenyl-3-carboxylic acid ; | DIFLUNISAL EP IMPURITY A ; CAS:92-69-3 DFS01 : Biphenyl-4-ol ; | DIFLUNISAL EP IMPURITY B ; CAS:59089-68-8 DFS02 : 2 ',4'-Difluorobiphenyl-4-ol ; | DIFLUNISAL EP IMPURITY C ; CAS:59089-67-7 DFS03 : 2 ',4'-Difluorobiphenyl-4-yl acetate ; | DIFLUOCORTOLONE ; CAS:6/9/2607 DFC00 : (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLUOCORTOLONE 17-CARBOXYLIC ACID ; DFC57 : (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carboxylic acid ; | DIFLUOCORTOLONE 21-ACETATE ; DFC51 : 2-((6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate ; | DIFLUOCORTOLONE 21-VALERATE ; DFC61 : 2-((6S,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-Difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl pentanoate ; | DIFLUOCORTOLONE 6R-FLUORO IMPURITY ; DFC56 : (6R,8S,9R,10S,11S,13S,14S,16R,17S)-6,9-Difluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLUOCORTOLONE 6S-CHLORO IMPURITY ; DFC66 : (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6-Chloro-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-7,8,11,12,13,15,16,17-octahydro-6H-cyclopenta[a]phenanthren-3(9H,10H,14H)-one ; | DIFLUPREDNATE ; CAS:23674-86-4 DFN00 : (6a,11ß)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione ; | DIFLUPREDNATE 21-DESACETYL 21-DEHYDRO IMPURITY ; DFN51 : (6a,11ß)-6,9-Difluoro-11-hydroxy-3,20-dioxo-17-(1-oxobutoxy)pregna-1,4-dien-21-al ; | DIFLUPREDNATE 21-DESACETYL IMPURITY ; CAS:23640-96-2 DFN50 : (6a,11ß)-6,9-Difluoro-11,21-dihydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione ; | DILTIAZEM 2-EPIMER O-DESACETYL IMPURITY ; CAS:91926-66-8 DTZ41 : (2R,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol ; | DILTIAZEM 2-EPIMER O-DESACETYL N-DESDIMETHYLAMINOETHYL IMPURITY ; DTZ51 : (2R,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol ; | DILTIAZEM EP IMPURITY A ; DILTIAZEM USP RC A ; TRANS-(2R)-DILTIAZEM ; DILTIAZEM 2-EPIMER ; CAS:103532-27-0 DTZ01 : (2R,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate ; | DILTIAZEM EP IMPURITY B ; DILTIAZEM USP RC B ; CAS:87447-47-0 DTZ02 : (2S,3S)-2-(4-Methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate ; Des[5-(2-dimethylamino)ethyl] Diltiazem ; | DILTIAZEM EP IMPURITY C ; DILTIAZEM USP RC C ; O-DESMETHYL DILTIAZEM HCL ; CAS:142926-07-6 DTZ03H : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-hydroxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate HCl ; | DILTIAZEM EP IMPURITY D ; DILTIAZEM USP RC D ; N-DESMETHYL DILTIAZEM HCL ; CAS:130606-60-9 DTZ04H : (2S,3S)-5-[2-(Methylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate HCl ; | DILTIAZEM EP IMPURITY E ; DILTIAZEM USP RC E ; DES[3-ACETYL-5-(2-DIMETHYLAMINO)ETHYL] DILTIAZEM ; CAS:42399-49-5 DTZ05 : (2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one ; | DILTIAZEM EP IMPURITY F ; DILTIAZEM USP RC F ; O-DESACETYL DILTIAZEM HCL ; CAS:42399-40-6 DTZ06H : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol HCl ; | DILTIAZEM EP IMPURITY G ; DILTIAZEM USP RC G ; N-DESMETHYL O-DESACETYL DILTIAZEM HCL ; CAS:81353-09-5 DTZ07H : (2S,3S)-5-[2-(Methylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol HCl ; | DILTIAZEM EP IMPURITY H ; DILTIAZEM USP RC H ; N,N,O-TRI-DESMETHYL DESACETYL DILTIAZEM ; CAS:115992-91-1 DTZ08 : (2S,3S)-5-[2-(Amino)ethyl]-2-(4-hydroxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol ; | DILTIAZEM HYDROCHLORIDE ; CAS:33286-22-5 DTZ00H : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride ; | DILTIAZEM N,N-DIDESMETHYL HCL ; CAS:116050-35-2 DTZ34H : (2S,3S)-5-[2-Aminoethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate HCl ; | DILTIAZEM N-OXIDE ; CAS:142843-04-7 DTZ37 : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate N-Oxide ; | DILTIAZEM N-OXIDE O-DESACETYL IMPURITY ; CAS:122619-90-3 DTZ47 : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-ol N-Oxide ; | DILTIAZEM O-DESACETYL-O-DESMETHYL HCL ; CAS:96252-32-3 DTZ36H : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(4-hydroxyphenyl)-1,5-benzothiazepin-4(5H)-one hydrochloride ; | DILTIAZEM SULFONE ; DTZ39 : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,1-dioxido-1,5-benzothiazepin-3-yl acetate ; | DILTIAZEM SULFONE N-OXIDE ; DTZ50 : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,1-dioxido-1,5-benzothiazepin-3-yl acetate N-Oxide ; | DILTIAZEM SULFOXIDE ; CAS:370094-12-5 DTZ38 : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1-oxido-1,5-benzothiazepin-3-yl acetate ; | DILTIAZEM SULFOXIDE N-OXIDE (FORMATE) ; DTZ40F : (2S,3S)-5-[2-(Dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1-oxido-1,5-benzothiazepin-3-yl acetate N-Oxide formate ; | DIMENHYDRINATE ; CAS:523-87-5 DMH00 : 8-Chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIMENHYDRINATE EP IMPURITY A ; PENTOXIFYLLINE EP IMPURITY C ; THEOPHYLLINE ; CAS:58-55-9 DMH01 : 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIMENHYDRINATE EP IMPURITY C ; PENTOXIFYLLINE EP IMPURITY F ; THEOPHYLLINE EP IMPURITY A ; CAFFEINE ; CAS:58-08-2 DMH03 : 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIMENHYDRINATE EP IMPURITY D ; CAS:2718-46-9 DMH04M : N-[2-(Diphenylmethoxy)ethyl]-N,N',N'-trimethylethane-1,2-diamine dimaleate ; | DIMENHYDRINATE EP IMPURITY E ; DIMENHYDRINATE USP RC E ; 8-CHLOROCAFFEINE ; CAS:4921-49-7 DMH05 : 8-Chloro-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIMENHYDRINATE EP IMPURITY F ; DIMENHYDRINATE USP RC A ; DIPHENHYDRAMINE EP IMPURITY A ; CAS:17471-10-2 DMH06H : 2-(Diphenylmethoxy)-N-methylethanamine HCl ; | DIMENHYDRINATE EP IMPURITY G ; DIPHENHYDRAMINE EP IMPURITY B ; 4-METHYLDIPHENHYDRAMINE ; ORPHENADRINE EP IMPURITY F ; ORPHENADRINE USP RC F ; ORPHENADRINE PARA-METHYL ANALOG ; TOLADRYL ; CAS:19804-27-4 DMH07 : N,N-Dimethyl-2-[(RS)-(4-methylphenyl)(phenyl)-methoxy]ethanamine ; | DIMENHYDRINATE EP IMPURITY H ; DIPHENHYDRAMINE EP IMPURITY C ; 4-BROMODIPHENHYDRAMINE HCL ; BROMAZINE HCL ; CAS:1808-12-4 DMH08H : 2-[(RS)-(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine hydrochloride ; | DIMENHYDRINATE EP IMPURITY I ; EBASTINE EP IMPURITY A ; DIPHENHYDRAMINE EP IMPURITY D ; BENZHYDROL ; CAS:91-01-0 DMH09 : Diphenylmethanol ; | DIMENHYDRINATE EP IMPURITY J ; DIPHENHYDRAMINE EP IMPURITY E ; PHENYTOIN EP IMPURITY A ; PHENYTOIN BP IMPURITY A ; BENZOPHENONE ; CAS:119-61-9 DMH10 : Diphenylmethanone ; | DIMENHYDRINATE EP IMPURITY K ; CAS:574-42-5 DMH11 : [Oxybis(methanetriyl)]tetrabenzene ; | DIMETINDENE EP IMPURITY A ; DIMETHINDENE EP IMPURITY A ; CAS:100-71-0 DTD01 : 2-Ethylpyridine ; | DIMETINDENE EP IMPURITY B ; DIMETHINDENE EP IMPURITY B ; CAS:92039-35-5 DTD02H : 2-(1H-Inden-2-yl)-N,N-dimethylethanamine hydrochloride ; | DIMETINDENE EP IMPURITY C ; DIMETHINDENE EP IMPURITY C ; CAS:92726-29-9 DTD03 : Ethyl (2RS)-2-benzyl-4-(dimethylamino)butanoate ; | DIMETINDENE EP IMPURITY D ; DIMETHINDENE EP IMPURITY D ; CAS:1613-23-6 DTD04H : (2RS)-2-Benzyl-4-(dimethylamino)butanoic acid hydrochloride ; | DIMETINDENE EP IMPURITY E ; DIMETHINDENE EP IMPURITY E ; CAS:5143-99-7 DTD05H : (2RS)-2-[2-(Dimethylamino)ethyl]indan-1-one hydrochloride ; | DIMETINDENE EP IMPURITY F ; DIMETHINDENE EP IMPURITY F ; CAS:1346746-53-9 DTD06H : 2-(3-Butyl-1H-inden-2-yl)-N,N-dimethylethanamine hydrochloride ; | DIMETINDENE EP IMPURITY G ; DIMETHINDENE EP IMPURITY G ; CAS:803617-18-7 DTD07H : N,N-Dimethyl-2-(3-phenyl-1H-inden-2-yl)ethanamine hydrochloride ; | DIMETINDENE EP IMPURITY H ; DIMETHINDENE EP IMPURITY H ; CAS:1346597-95-2 DTD08 : 2-[(1RS)-1-(2-Ethenyl-1H-inden-3-yl)ethyl]pyridine ; | DIMETINDENE EP IMPURITY I ; DIMETHINDENE EP IMPURITY I ; RAC-N-DESMETHYL DIMETINDENE MALEATE ; CAS:135784-57-5 DTD09M : N-Methyl-2-[3-[(1RS)-1-(pyridin-2-yl)ethyl]-1H-inden-2-yl]ethanamine maleate ; | DIMETINDENE MALEATE ; DIMETHINDENE MALEATE ; CAS:3614-69-5 DTD00M : 2-[1-[2-(2-Dimethylaminoethyl)inden-3-yl]ethyl]pyridine maleate ; | DIMETINDENE N-OXIDE MALEATE ; DIMETHINDENE-N-OXIDE MALEATE ; CAS:188295-03-6 DTD50M : 2-[1-[2-(2-Dimethylaminoethyl)inden-3-yl]ethyl]pyridine N-oxide maleate ; | DIOSMIN ; CAS:520-27-4 DSM00 : 7-[[6-O-(6-Deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN DESHYDROXY DIHYDRO (2S)-ISOMER ; DIDYMIN ; NEOPONCIRIN ; CAS:14259-47-3 DSM50 : (2S)-7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN DESHYDROXY DIHYDRO RACEMATE ; DSM51 : 7-[[6-O-(6-deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY A ; DIOSMIN BP IMPURITY A ; ACETOISOVANILLONE ; ISOACETOVANILLONE ; CAS:6100-74-9 DSM01 : 1-(3-Hydroxy-4-methoxyphenyl)ethanone ; | DIOSMIN EP IMPURITY B ; DIOSMIN BP IMPURITY B ; DIHYDRO DIOSMIN ; HESPERIDIN ; CAS:520-26-3 DSM02 : (2S)-7-[[6-O-(6-Deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY C ; DIOSMIN BP IMPURITY C ; ISORHOIFOLIN ; CAS:552-57-8 DSM03 : 7-[[6-O-(6-Deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY D ; DIOSMIN BP IMPURITY D ; 6-IODO DIOSMIN ; CAS:1431536-92-3 DSM04 : 7-[[6-O-(6-Deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6-iodo-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY E ; DIOSMIN BP IMPURITY E ; LINARIN ; CAS:480-36-4 DSM05 : 7-[[6-O-(6-Deoxy-a-L-mannopyranosyl)-ß-D-glucopyranosyl]oxy]-5-hydroxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY F ; DIOSMIN BP IMPURITY F ; DIOSMIN AGLYCONE ; DIOSMETIN ; CAS:520-34-3 DSM06 : 5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one ; | DIOSMIN EP IMPURITY G ; DIOSMIN BP IMPURITY G ; (S)-HESPERETIN ; CAS:520-33-2 DSM07 : (2S)-5,7-Dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one ; 3’,5,7-Trihydroxy-4’-methoxy-flavanone ; | DIPHENHYDRAMINE EP IMPURITY A ; DIPHENHYDRAMINE USP RC A ; DIMENHYDRINATE EP IMPURITY F ; CAS:17471-10-2 DPH01H : 2-(Diphenylmethoxy)-N-methylethanamine HCl ; | DIPHENHYDRAMINE EP IMPURITY B ; ORPHENADRINE EP IMPURITY F ; ORPHENADRINE USP RC F ; ORPHENADRINE PARA-METHYL ANALOG ; CAS:19804-27-4 DPH02 : 2-[(RS)-(4-Methylphenyl)phenylmethoxy]-N,N-dimethylethanamine ; | DIPHENHYDRAMINE EP IMPURITY C ; DIMENHYDRINATE EP IMPURITY H ; 4-BROMODIPHENHYDRAMINE HCL ; BROMAZINE HCL ; CAS:1808-12-4 DPH03H : 2-[(RS)-(4-Bromophenyl)phenylmethoxy]-N,N-dimethylethanamine hydrochloride ; | DIPHENHYDRAMINE EP IMPURITY D ; EBASTINE EP IMPURITY A ; BENZHYDROL ; CAS:91-01-0 DPH04 : Diphenylmethanol ; | DIPHENHYDRAMINE EP IMPURITY E ; PHENYTOIN EP IMPURITY A ; BENZOPHENONE ; CAS:119-61-9 DPH05 : Diphenylmethanone ; | DIPHENHYDRAMINE HYDROCHLORIDE ; ORPHENADRINE EP IMPURITY D ; CAS:147-24-0 DPH00H : 2-(Diphenylmethoxy)-N,N-dimethylethanamine hydrochloride ; | DIPHENHYDRAMINE N-OXIDE HYDROCHLORIDE ; CAS:13168-00-8 DPH50H : 2-(Diphenylmethoxy)-N,N-dimethylethanamine N-oxide hydrochloride ; | DIPHENHYDRAMINE USP RC B ; CAS:19574-66-4 DPH22 : 3-(Benzhydryloxy)propane-1,2-diol ; | DIPIVEFRINE EP IMPURITY A ; RAC-EPINEPHRINE ; RACEPINEPHRINE ; CAS:329-65-7 DPV01 : 4-(1-Hydroxy-2-(methylamino)ethyl)benzene-1,2-diol ; | DIPIVEFRINE EP IMPURITY B ; ADRENALONE ; CAS:99-45-6 DPV02 : 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone ; | DIPIVEFRINE EP IMPURITY C ; CAS:144750-97-0 DPV03 : 2-Hydroxy-5-(1-hydroxy-2-(methylamino)ethyl)phenyl pivalate ; | DIPIVEFRINE EP IMPURITY D ; DPV04 : 2-Hydroxy-4-(1-hydroxy-2-(methylamino)ethyl)phenyl pivalate ; | DIPIVEFRINE EP IMPURITY E ; ADRENALONE DIPAVALATE ESTER ; CAS:52245-00-8 DPV05 : 4-[(Methylamino)acetyl]-1,2-phenylene bis(2,2-dimethylpropanoate) ; | DIPIVEFRINE EP IMPURITY F ; DPV06 : 4-[(1RS)-2-(Ethylmethylamino)-1-hydroxyethyl]-1,2-phenylene bis(2,2-dimethylpropanoate) ; | DIPIVEFRINE HYDROCHLORIDE ; CAS:64019-93-8 DPV00H : 4-[(1RS)-1-Hydroxy-2-(methylamino)ethyl]-1,2-phenylene bis(2,2-dimethylpropanoate) hydrochloride ; | DIPROPHYLLINE ; DYPHYLLINE ; CAS:479-18-5 DPP00 : 7-[(2RS)-2,3-Dihydroxypropyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIPROPHYLLINE EP IMPURITY A ; THEOPHYLLIDINE HCL ; CAS:116131-08-9 DPP01H : N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide HCl ; | DIPROPHYLLINE EP IMPURITY B ; PENTOXIFYLLINE EP IMPURITY C ; THEOPHYLLINE ; CAS:58-55-9 DPP02 : 1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIPROPHYLLINE EP IMPURITY C ; ETOFYLLINE ; CAS:519-37-9 DPP03 : 7-(2-Hydroxyethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIPROPHYLLINE EP IMPURITY D ; PROXYPHYLLINE ; CAS:603-00-9 DPP04 : 7-[(2RS)-2-Hydroxypropyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione ; | DIPYRIDAMOLE ; CAS:58-32-2 DPR00 : Dipyridamole ; | DIPYRIDAMOLE DICHLORO DIHYDROXYETHYL IMPURITY ; DIPYRIDAMOLE DICHLORO IMPURITY, CAS:1449029-15-5 DPR11 : 2,6-Dichloro-4-di(2-hydroxyethyl)amino-8-(piperidin-1-yl)-pyrimido[5,4-d] pyrimidine ; | DIPYRIDAMOLE DICHLORO MONOHYDROXYETHYL IMPURITY ; DPR12 : 2,6-Dichloro-4-(2-hydroxyethyl)amino-8-(piperidin-1-yl)-pyrimido[5,4-d] pyrimidine ; | DIPYRIDAMOLE DITARTARIC ACID DIESTER DIAMMONIUM SALT ; CAS:1316276-51-3 DPR52N : Ammonium (2S,3R)-5-(2-((6-((2-(((2S,3S)-3-Carboxylato-2,3-dihydroxypropanoyl) oxy)ethyl)(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl)(2-hydroxyethyl)amino)ethoxy)-2,3-dihydroxy-5-oxopentanoate ; | DIPYRIDAMOLE EP IMPURITY A ; DIPYRIDAMOLE USP RC A ; CAS:16982-40-4 DPR01 : 2,2'-[[4,6,8-Tri(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]nitrilo] diethanol ; | DIPYRIDAMOLE EP IMPURITY B ; DIPYRIDAMOLE USP RC B ; CAS:16908-47-7 DPR02 : 2,2',2",2''',2'''',2'''''-[[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]trinitrilo]hexaethanol ; | DIPYRIDAMOLE EP IMPURITY C ; DIPYRIDAMOLE USP RC C ; CAS:54093-92-4 DPR03 : 2,2'-[[2-Chloro-4,8-di(piperidin-1-yl) pyrimido [5,4-d] pyrimidin-6-yl] nitrilo] diethanol ; | DIPYRIDAMOLE EP IMPURITY D ; DIPYRIDAMOLE USP RC D ; CAS:1176886-12-6 DPR04 : 2,2'-[[2-(2-Hydroxyethyl)amino-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyri midin-6-yl]nitrilo]diethanol ; Desethanol Dipyridamole ; | DIPYRIDAMOLE EP IMPURITY E ; DIPYRIDAMOLE USP RC E ; DPR05 : 2,4-Di[di(2-hydroxyethyl)amino]-6,8-di(piperidin-1-yl)-pyrimido[5,4-d] pyrimidine ; | DIPYRIDAMOLE EP IMPURITY F ; DIPYRIDAMOLE USP RC F ; CAS:60286-30-8 DPR06 : 4,6-Di[di(2-hydroxyethyl)amino]-2-(2-hydroxyethyl)amino-8-(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine ; | DIPYRIDAMOLE EP IMPURITY G ; CAS:7139-02-8 DPR07 : 2,6-Dichloro-4,8-di(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine ; | DIPYRIDAMOLE TARTARIC ACID ESTER AMMONIUM SALT ; CAS:1246816-97-6 DPR51N : Ammonium (2S,3S)-4-(2-((6-(Bis(2-Hydroxyethyl)amino)-4,8-di(piperidin-1-yl) pyrimido[5,4-d]pyrimidin-2-yl)(2-hydroxyethyl)amino)ethoxy)-2,3-dihydroxy-4-oxobutanoate ; | DIPYRIDAMOLE TETRACHLORO IMPURITY ; CAS:32980-71-5 DPR09 : 2,4,6,8-Tetrachloro-pyrimido[5,4-d]pyrimidine ; | DIPYRIDAMOLE TRICHLORO IMPURITY ; CAS:1449029-14-4 DPR10 : 2,4,6-Trichloro-8-(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine ; | DISOPYRAMIDE EP IMPURITY A ; DIISOPYRONITRILE ; CAS:5005-46-9 DPY01 : (2RS)-4-[Bis(1-methylethyl)amino]-2-phenyl-2-(pyridin-2-yl)butanenitrile ; | DISOPYRAMIDE EP IMPURITY B ; DPY02 : (3RS)-N,N-Bis(1-methylethyl)-3-phenyl-3-(pyridin-2-yl)propan-1-amine ; | DISOPYRAMIDE EP IMPURITY C ; CAS:1216619-15-6 DPY03X : (2RS)-4-[(1-Methylethyl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide oxalate ; | DISOPYRAMIDE EP IMPURITY D ; PYRONITRILE ; CAS:5005-36-7 DPY04 : (RS)-Phenyl(pyridin-2-yl)acetonitrile ; | DISOPYRAMIDE PHOSPHATE ; CAS:22059-60-5 DPY00P : (2RS)-4-[Bis(1-methylethyl)amino]-2-phenyl-2-(pyridin-2-yl)butanamide phosphate ; | DISULFIRAM ; CAS:97-77-8 DSF00 : Tetraethyldisulfanedicarbothioamide ; | DISULFIRAM EP IMPURITY A ; SULFIRAM ; CAS:95-05-6 DSF01 : Diethylthiocarbamic thioanhydride ; | DISULFIRAM EP IMPURITY B ; CAS:20624-25-3 DSF02N : Sodium Diethyldithiocarbamate Trihydrate ; | DITHRANOL ; ANTHRALIN ; CAS:1143-38-0 DTR00 : 1,8-Dihydroxyanthracen-9(10H)-one ; | DITHRANOL EP IMPURITY A ; ANTHRONE ; CAS:90-44-8 DTR01 : Anthracen-9(10H)-one ; | DITHRANOL EP IMPURITY B ; DANTRON ; CAS:117-10-2 DTR02 : 1,8-Dihydroxyanthracene-9,10-dione ; | DITHRANOL EP IMPURITY C ; DITHRANOL DIMER ; CAS:31991-54-5 DTR03 : 4,4'-5,5'-Tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9H)-dione ; | DITHRANOL EP IMPURITY D ; CAS:1715-81-7 DTR04 : 1-Hydroxyanthracen-9(10H)-one ; | DOBUTAMINE EP IMPURITY A ; CAS:62-31-7 DBM01H : 4-(2-Aminoethyl)benzene-1,2-diol hydrochloride ; | DOBUTAMINE EP IMPURITY B ; CAS:5471-51-2 DBM02 : 4-(4-Hydroxyphenyl)butan-2-one ; | DOBUTAMINE EP IMPURITY C ; DOBUTAMINE USP RC C ; TRIMETHOXY DOBUTAMINE HCL ; CAS:51062-14-7 DBM03H : (2RS)-N-[2-(3,4-Dimethoxyphenyl)ethyl]-4-(4-methoxyphenyl)butan-2-amine hydrochloride; | DOBUTAMINE HCL ; CAS:49745-95-1 DBM00H : 4-[2-[[(2RS)-4-(4-Hydroxyphenyl)-butan-2-yl]amino]ethyl]-benzene-1,2-diol hydrochloride ; | DOCETAXEL ; CAS:114977-28-5 DTX00 : 5ß,20-Epoxy-1,7ß,10ß-trihydroxy-9-oxotax-11-ene-2a,4,13a-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] ; | DOCETAXEL 2-DEBENZOYL 2-PENTENOYL ; CAS:1412898-66-8 DTX52 : (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one 12b-acetate, 12-[(E)-2-methylbut-2-enoate], 9-ester with (2R,3S)-N-ter | DOCETAXEL 7-EPI-DAB-IMPURITY ; 7-EPI-10-DEACETYL BACCATIN III ; CAS:71629-92-0 DTX55 : 5ß,20-Epoxy-4-(acetyloxy)-1,7a,10ß,13a-tetrahydroxy-9-oxotax-11-en-2a-yl benzoate ; | DOCETAXEL CROTONALDEHYDE ANALOG ; DTX51 : (1S,2S,3R,9S,E)-3-((S,E)-2-Acetoxy-1-hydroxy-5-oxopent-3-en-2-yl)-9-((2R,3S)-3-(tert-butoxycarbonyl)-2-hydroxy-3-phenylpropanoyloxy)-1,5-dihydroxy-4,8,11,11-tetramethyl-6-oxobicyclo[5.3.1]undeca-4,7-dien-2-yl benzoate ; | DOCETAXEL EP IMPURITY A ; 2-O-DESBENZOYL-2-O-TIGLYL DOCETAXEL ; CAS:1887057-05-7 DTX01 : 5ß,20-Epoxy-1,7ß,10ß-trihydroxy-9-oxotax-11-ene-2a,4,13a-triyl 4-acetate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenyl propanoate] 2-[(2E)-2-methylbut-2-enoate] ; | DOCETAXEL EP IMPURITY B ; 10-DEOXY-10-OXO DOCETAXEL ; 6-OXO DOCETAXEL (USP) ; CAS:167074-97-7 DTX02 : 5ß,20-Epoxy-1,7ß-dihydroxy-9,10-dioxotax-11-ene-2a,4,13a-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-henylpropanoate] ; | DOCETAXEL EP IMPURITY C ; 7-EPI-DOCETAXEL ; 7-EPI-TAXOTERE; 4-EPI-DOCETAXEL (USP) ; CAS:153381-68-1 DTX03 : 5ß,20-Epoxy-1,7a,10ß-trihydroxy-9-oxotax-11-ene-2a,4,13a-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-henylpropanoate] ; | DOCETAXEL EP IMPURITY D ; 10-DEOXY-10-OXO-7-EPI-DOCETAXEL ; 4-EPI-6-OXO DOCETAXEL (USP) ; CAS:162784-72-7 DTX04 : 5ß,20-Epoxy-1,7a-dihydroxy-9,10-dioxotax-11-ene-2a,4,13a-triyl 4-acetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-phenylpropanoate] ; | DOCETAXEL EP IMPURITY E ; 10-DESACETYL BACCATIN III ; DOCETAXEL DAB-IMPURITY ; CAS:32981-86-5 DTX05 : 5ß,20-Epoxy-4-(acetyloxy)-1,7ß,10ß,13a-tetrahydroxy-9-oxotax-11-en-2a-yl benzoate ; | DOCETAXEL EP IMPURITY F ; PACLITAXEL ; CAS:33069-62-4 DTX06 : 5ß,20-Epoxy-1,7ß-dihydroxy-9-oxotax-11-ene-2a,4,10ß,13a-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenyl propanoate] ; | DOCETAXEL EP IMPURITY G ; 10-ACETYL DOCETAXEL ; CAS:125354-16-7 DTX07 : 5ß,20-Epoxy-1,7ß-dihydroxy-9-oxotax-11-ene-2a,4,10ß,13a-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-[[(1,1-dimethylethoxy)carbonyl]amino]-2-hydroxy-3-henylpropanoate] ; | DOCUSATE ETHYL ESTER ANALOG ; DCS52N : Sodium 4-ethoxy-1-(2-ethylhexyloxy)-1,4-dioxobutane-2-sulfonate ; | DOCUSATE SODIUM ; CAS:577-11-7 DCS00N : Sodium 1,4-bis(2-ethylhexyloxy)-1,4-dioxobutane-2-sulfonate ; | DOCUSATE USP RC B ; CAS:86878-53-7 DCS22N : Disodium 4-(2-ethylhexyloxy)-4-oxo-3-sulfonatobutanoate ; | DOFETILIDE ; CAS:115256-11-6 DFT00 : N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-methanesulfonamide ; | DOFETILIDE DIAMINE IMPURITY ; CAS:115256-13-8 DFT52 : 4-(2-((4-Aminophenethyl)(methyl)amino)ethoxy)benzenamine ; | DOFETILIDE DIMETHYLSULFONYL IMPURITY ; CAS:937194-91-7 DFT44 : N-[4-[2-[[2-[4-[Bis(Methylsulfonyl)amino]phenyl]ethyl]methylamino]ethoxy]phenyl]-N-(methylsulfonyl)-methanesulfonamide ; | DOFETILIDE N'-DESMETHYLSULFONYL IMPURITY ; CAS:115256-12-7 DFT55 : N-(4-(2-((4-Aminophenethyl)(methyl)amino)ethoxy)phenyl)methanesulfonamide ; | DOFETILIDE N'-DESMETHYLSULFONYL N-METHYLSULFONYL IMPURITY ; CAS:937195-06-7 DFT56 : N-[4-[2-[[2-(4-Aminophenyl)ethyl]methylamino]ethoxy]phenyl]-N-(methylsulfonyl)-methanesulfonamide ; | DOFETILIDE N'-METHYLSULFONYL IMPURITY ; CAS:312315-47-2 DFT58 : N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-N-(methylsulfonyl)-methanesulfonamide ; | DOFETILIDE N'-NITRYL IMPURITY ; CAS:115256-44-5 DFT60 : N-(4-(2-((4-Nitrophenethyl)(methyl)amino)ethoxy)phenyl)methanesulfonamide ; | DOFETILIDE N-DESMETHYLSULFONYL IMPURITY ; CAS:115256-46-7 DFT53H : N-(4-(2-((2-(4-Aminophenoxy)ethyl)(methyl)amino)ethyl)phenyl)methanesulfonamide dihydrochloride ; | DOFETILIDE N-DESMETHYLSULFONYL N'-METHYLSULFONYL IMPURITY ; CAS:937194-99-5 DFT54 : N-[4-[2-[[2-(4-Aminophenoxy)ethyl]methylamino]ethyl]phenyl]-N-(methylsulfonyl)-methanesulfonamide ; | DOFETILIDE N-METHYLSULFONYL IMPURITY ; CAS:937195-03-4 DFT57 : N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenyl]ethyl]amino]ethoxy]phenyl]-N-(methylsulfonyl)-methanesulfonamide ; | DOFETILIDE N-NITRYL IMPURITY ; CAS:115256-45-6 DFT59 : N-(4-(2-(Methyl(2-(4-nitrophenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide ; | DOFETILIDE N-OXIDE ; CAS:144449-71-8 DFT50 : N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]oxidoamino]ethyl]phenyl]-methanesulfonamide ; | DOFETILIDE USP RC A ; N-DESMETHYL DOFETILIDE ; CAS:176447-94-2 DFT21 : N-[4-[2-[[2-[4-[(Methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methane sulfonamide ; | DOLASETRON (BASE) ; CAS:115956-12-2 DLS00B : (2a,6a,8a,9aß)-1H-Indole-3-carboxylic acid octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester ; | DOLASETRON HYDROXY IMPURITY ; CAS:127951-99-9 DLS50 : (2a,6a,8a,9aß)-1H-Indole-3-carboxylic Acid Octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester ; | DOLASETRON MESYLATE ; CAS:115956-13-3 DLS00M : (2a,6a,8a,9aß)-1H-Indole-3-carboxylic acid octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester monomethanesulfonate ; | DOLASETRON USP RC A ; CAS:115956-07-5 DLS21H : Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3 (4H)-one HCl ; | DOLUTEGRAVIR (R,R)-ISOMER ; CAS:1357289-29-2 DGV61 : (4R,12aR)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR (S,R)-ISOMER ; DOLUTEGRAVIR ENANTIOMER ; CAS:1309560-49-3 DGV63 : (4S,12aR)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR (S,S)-ISOMER ; DGV64 : (4S,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR ; (R,S)-DOLUTEGRAVIR ; CAS:1051375-16-6 DGV00 : (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR 2,4-DIDESFLUORO IMPURITY ; DGV70 : (4R,12aS)-N-Benzyl-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR 2-DESFLUORO IMPURITY ; CAS:1863916-88-4 DGV72 : (4R,12aS)-N-(4-Fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR 4-DESFLUORO 6-FLUORO IMPURITY ; DOLUTEGRAVIR 2,6-DIFLUORO ANALOG ; DOLUTEGRAVIR IMPURITY C ; DGV73 : (4R,12aS)-N-(2,6-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR 4-DESFLUORO IMPURITY ; CAS:1863916-87-3 DGV74 : (4R,12aS)-N-(2-Fluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR 4-EPIMER ; 4-EPI-DOLUTEGRAVIR ; CAS:1357289-37-2 DGV44 : (4S,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR AMIDE ; N-DES-2,4-DIFLUOROBENZYL DOLUTEGRAVIR ; CAS:1485081-26-2 DGV55 : (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR CARBOXYLIC ACID ; DOLUTEGRAVIR DESDIFLUOROPHENYL CARBOXYLIC ACID ; CAS:1246616-73-8 DGV54 : (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid ; | DOLUTEGRAVIR CARBOXYLIC ACID ETHYL ESTER ; CAS:1246616-78-3 DGV56 : (4R,12aS)-3,4,6,8,12,12a-Hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid ethyl ester ; | DOLUTEGRAVIR DIBENZYL DIHYDRO IMPURITY ; DOLUTEGRAVIR IMPURITY F ; DGV58 : (R)-3-(7-((2,4-Difluorobenzyl)carbamoyl)-9-hydroxy-1,8-dioxo-3,4-dihydro-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 2,4-difluorobenzylcarbamate ; | DOLUTEGRAVIR DIBENZYL IMPURITY ; DOLUTEGRAVIR IMPURITY 7 ; DGV57 : (R)-3-(7-((2,4-Difluorobenzyl)carbamoyl)-9-hydroxy-1,8-dioxo-1H-pyrido[1,2-a]pyrazin-2(8H)-yl)butyl 2,4-difluorobenzylcarbamate ; | DOLUTEGRAVIR IMPURITY A ; DGV71 : (R)-N-(2,4-Difluorobenzyl)-9-ethoxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-2,8-dihydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide ; | DOLUTEGRAVIR IMPURITY E ; DGV75 : (R)-N-(2,4-Difluorobenzyl)-9-hydroxy-2-(4-hydroxybutan-2-yl)-1,8-dioxo-2,3,4,8-tetrahydro-1H-pyrido[1,2-a]pyrazine-7-carboxamide ; | DOLUTEGRAVIR O-BENZYL IMPURITY ; CAS:1206102-11-5 DGV65 : (4R,12aS)-N-(2,4-Difluorobenzyl)-7-benzyloxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR O-ETHYL IMPURITY ; DGV62 : (4R,12aS)-N-(2,4-Difluorobenzyl)-7-ethoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR O-METHYL 12A-EPIMER ; DGV52 : (4R,12aR)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR O-METHYL ENANTIOMER ; DGV53 : (4S,12aR)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR O-METHYL IMPURITY ; CAS:1335210-35-9 DGV60 : (4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-methoxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide ; | DOLUTEGRAVIR O-SS-D-GLUCOSIDE ; CAS:1822365-49-0 DGV50 : N-?[(2,?4-?difluorophenyl)?methyl]?-?7-?(ß-?D-?glucopyranosyloxy)?-?3,?4,?6,?8,?12,?12a-?hexahydro-?4-?methyl-?6,?8-?dioxo2H-?Pyrido[1’,?2’:4,?5]?pyrazino[2,?1-?b]?[1,?3]?oxazine-?9-?carboxamide ; | DOLUTEGRAVIR O-SS-D-GLUCURONIDE ; CAS:1485692-21-4 DGV51 : (4R,12aS)-9-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-3,4,6,8,12,12a-hexahydro-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazin-7-yl ß-D-glucopyranosiduronic acid ; | DOLUTEGRAVIR SODIUM SALT ; CAS:1051375-19-9 DGV00N : N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1’,2’:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide sodium salt ; | DOMPERIDONE ; CAS:57808-66-9 DPD00 : 5-Chloro-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one ; | DOMPERIDONE EP IMPURITY A ; CAS:53786-28-0 DPD01 : 5-Chloro-1-(piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one ; | DOMPERIDONE EP IMPURITY B ; CAS:1346598-11-5 DPD02 : 4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-formylpiperidine ; | DOMPERIDONE EP IMPURITY C ; DOMPERIDONE N-OXIDE ; CAS:118435-03-3 DPD03 : cis-4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)-1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidine 1-oxide ; | DOMPERIDONE EP IMPURITY D ; CAS:1614255-34-3 DPD04 : 5-Chloro-3-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]-1-[1-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one ; | DOMPERIDONE EP IMPURITY E ; CAS:1346602-50-3 DPD05 : 1-[3-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl] propyl]-3-[3-(2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one ; | DOMPERIDONE EP IMPURITY F ; CAS:1391053-55-6 DPD06 : 1,3-bis[3-[4-(5-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]propyl]-1,3-dihydro-2H-benzimidazol-2-one ; | DONEPEZIL 3-HYDROXY IMPURITY ; 3-HYDROXY DONEPEZIL (USP) ; CAS:2097683-67-3 DNP53H : 2-((1-Benzylpiperidin-4-yl)methyl)-3-hydroxy-5,6-dimethoxy-2,3-dihydroinden-1-one HCl ; | DONEPEZIL 4-HYDROXY IMPURITY ; CAS:197010-22-3 DNP54 : 2,3-Dihydro-2-[[4-hydroxy-1-(phenylmethyl)-4-piperidinyl]methyl]-5,6-dimethoxy-1H-inden-1-one ; | DONEPEZIL 5-O-DESMETHYL IMPURITY ; CAS:120013-57-2 DNP55 : (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5-hydroxy-6-methoxy-1-indanone ; | DONEPEZIL 6-O-DESMETHYL IMPURITY ; CAS:120013-56-1 DNP56 : (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-6-hydroxy-5-methoxy-1-indanone ; | DONEPEZIL ALDEHYDE IMPURITY ; CAS:22065-85-6 DNP42 : (RS)-(1-Benzyl-piperidin-4-yl)formaldehyde ; | DONEPEZIL ALKENE PYRIDINE N-OXIDE (USP) ; DONEPEZIL PYRIDINE DEHYDRO N-OXIDE ; CAS:896134-06-8 DNP48 : 4-[(5,6-Dimethoxy-1-oxo-1H-inden-2-yl)methyl]pyridine 1-oxide ; 5,6-Dimethoxy-2-(1-oxido-pyridin-4-ylmethylene)indan-1-one ; | DONEPEZIL BENZYL BROMIDE ; DONEPEZIL QUATERNARY SALT (USP) ; CAS:844694-85-5 DNP31 : 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl) methyl]piperidinium bromide ; | DONEPEZIL DEHYDRO DEOXY IMPURITY (USP) ; DONEPEZIL INDENE IMPURITY (USP) ; CAS:120013-45-8 DNP32 : 1-Benzyl-4-[(5,6-dimethoxyinden-2-yl)methyl] piperidine ; | DONEPEZIL DEOXY IMPURITY ; CAS:844694-84-4 DNP33 : 1-Benzyl-4-[(5,6-dimethoxyindan-2-yl)methyl] piperidine ; | DONEPEZIL DESBENZYL DEOXY IMPURITY ; DEOXY DESBENZYL DONEPEZIL HCL ; CAS:1034439-43-4 DNP44H : 4-[(5,6-Dimethoxyindan-2-yl)methyl] piperidine HCl ; | DONEPEZIL DESBENZYL IMPURITY ; DESBENZYL DONEPEZIL HYDROCHLORIDE (USP) ; CAS:120013-39-0 DNP34H : 5,6-Dimethoxy-2-(piperidin-4-ylmethyl) indan-1-one hydrochloride ; | DONEPEZIL DIDESMETHYL IMPURITY ; CAS:220170-71-8 DNP57H : (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dihydroxy-1-indanone HBr ; | DONEPEZIL DIHYDRO IMPURITY ; CAS:120012-04-6 DNP35 : 2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-ol ; | DONEPEZIL HYDROCHLORIDE ; CAS:120011-70-3 DNP00H : (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone hydrochloride ; | DONEPEZIL HYDROXY KETO IMPURITY ; HYDROXY DONEPEZIL (USP) ; CAS:197010-20-1 DNP36 : 2-[(1-Benzylpiperidin-4-yl)(hydroxy)methyl]-5,6-dimethoxyindan-1-one ; | DONEPEZIL INDANONE IMPURITY ; CAS:2107-69-9 DNP41 : 5,6-Dimethoxy-1-indanone ; | DONEPEZIL N-OXIDE ; CAS:120013-84-5 DNP50 : (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone N-Oxide ; | DONEPEZIL OPEN-RING HYDROXY ACID ; DONEPEZIL HYDROXY ACID IMPURITY ; DNP39N : 2-[3-(1-Benzylpiperidin-4-yl)-2-hydroxypropyl)-4,5-dimethoxybenzoic acid sodium salt ; | DONEPEZIL OPEN-RING KETO ACID (SODIUM SALT) ; DONEPEZIL KETO ACID SODIUM SALT ; CAS:197010-25-6 DNP40N : 2-[3-(1-Benzylpiperidin-4-yl)-2-oxopropyl)-4,5-dimethoxybenzoic acid sodium salt ; | DONEPEZIL PYRIDINE ANALOG (USP) ; DPMI ; CAS:4803-57-0 DNP37 : 5,6-Dimethoxy-2-(pyridin-4-ylmethyl)indan-1-one ; | DONEPEZIL PYRIDINE DEHYDRO IMPURITY ; CAS:4803-74-1 DNP38 : 5,6-Dimethoxy-2-(pyridin-4-ylmethylene)indan-1-one ; | DONEPEZIL PYRIDINE N-OXIDE ; CAS:896134-07-9 DNP47 : 5,6-Dimethoxy-2-(1-oxido-pyridin-4-ylmethyl)indan-1-one ; | DONEPEZIL USP RC A ; DONEPEZIL DEHYDRO IMPURITY ; (E)-DEHYDRO DONEPEZIL ; CAS:145546-80-1 DNP21 : (E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one ; | DOPEXAMINE DIHYDROCHLORIDE ; CAS:86484-91-5 DPX00H : 4-[2-[[6-[(2-Phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol dihydrochloride ; | DOPEXAMINE EP IMPURITY A ; DPX01 : 4,4'-[Hexane-1,6-diylbis(iminoethylene)]dibenzene-1,2-diol ; | DOPEXAMINE EP IMPURITY B ; DPX02 : 2-Methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol ; | DOPEXAMINE EP IMPURITY C ; DPX03 : 2-Methoxy-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol ; | DOPEXAMINE EP IMPURITY D ; DPX04 : 4,4'-Methylenebis[5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol] ; | DOPEXAMINE EP IMPURITY E ; DPX05 : 3-[4,5-Dihydroxy-2-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzyl]-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol ; | DOPEXAMINE EP IMPURITY F ; DPX06 : 4-Chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benzene-1,2-diol ; | DOPEXAMINE EP IMPURITY G ; DPX07 : Bis(2-phenylethyl) hexanedioate ; | DOPEXAMINE EP IMPURITY H ; CAS:86480-27-5 DPX08 : N-[2-(3,4-Dimethoxyphenyl)ethyl]-N'-(2-phenylethyl)hexane-1,6-diamine ; | DOPEXAMINE EP IMPURITY I ; DPX09 : 1-[6-[(2-Phenylethyl)amino]hexyl]-2,3-dihydro-1H-indole-5,6-dione ; | DOPEXAMINE EP IMPURITY J ; DPX10 : N,N'-Bis(2-phenylethyl)hexane-1,6-diamine ; | DOPEXAMINE EP IMPURITY K ; DPX11 : 1-[6-[(2-Phenylethyl)amino]hexyl]-1H-indole-5,6-diol ; | DORIPENEM MONOHYDRATE ; CAS:364622-82-2 DRP00 : (4R,5S,6S)-6-(1-Hydroxyethyl)-4-methyl-7-oxo-3-[(3S,5S)-5-[(sulfamoyl amino) methyl]pyrrolidin-3-yl]sulfanyl-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monohydrate | DORZOLAMIDE 3-SULFONAMIDE ANALOG ; DZL43 : (4S-trans)-4-(N-Ethylamine)-5,6-dihydro-(6S)-methyl-4H-thieno-[2,3]thiopyran-3-sulfonamide-7,7-dioxide ; | DORZOLAMIDE DESAMINOSULFONYL HCL ; CAS:897657-77-1 DZL44H : (4S,6S)-N-Ethyl-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-4-amine 7,7-dioxide hydrochloride ; | DORZOLAMIDE EP IMPURITY A ; DORZOLAMIDE USP RC A ; ENT-DORZOLAMIDE HCL ; CAS:120279-95-0 DZL01H : (4R,6R)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2, 3-b]thiopyran-2-sulfonamide 7,7-dioxide HCl ; | DORZOLAMIDE EP IMPURITY B ; DORZOLAMIDE USP RC B ; RAC-CIS DORZOLAMIDE HCL ; CAS:120279-37-0 DZL02H : (4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2, 3-b]thiopyran-2-sulfonamide 7,7-dioxide HCl ; | DORZOLAMIDE EP IMPURITY C ; N-DESETHYL-N-(2-BORONOETHYL) DORZOLAMIDE HCL ; DZL03H : [2-[[(4S,6S)-6-Methyl-7,7-dioxo-2sulfamoyl-4,5,6,7-tetrahydro-7?6 -thieno[2,3-b]thiopyran-4yl]amino]ethyl]boronic acid HCl ; | DORZOLAMIDE EP IMPURITY D ; DORZOLAMIDE USP RC D ; N-DESETHYL DORZOLAMIDE HCL ; CAS:154154-90-2 DZL04H : (4S,6S)-4-Amino-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide HCl ; | DORZOLAMIDE HCL ; CAS:130693-82-2 DZL00 : (4S,6S)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride ; | DORZOLAMIDE N-ACETYL IMPURITY ; N-ACETYL DORZOLAMIDE ; CAS:403848-09-9 DZL45 : N-[(4S,6S)-2-(Aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b]thiopyran-4-yl]-N-ethyl-acetamide ; | DORZOLAMIDE N-DESETHYL N-ACETYL ANALOG ; CAS:147200-03-1 DZL40 : (4S,6S)-4-(Acetylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide ; | DOSULEPIN DESMETHYL IMPURITY ; NORDOSULEPIN ; CAS:1154-09-2 DSL50 : (E)-3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N-methylpropan-1-amine ; | DOSULEPIN EP IMPURITY A ; DOSULEPIN SULFOXIDE ; CAS:1447-71-8 DSL01 : (E)-3-(5-Oxo-5.4-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine ; | DOSULEPIN EP IMPURITY B ; CAS:1531-77-7 DSL02 : Dibenzo[b,e]thiepin-11(6H)-one ; | DOSULEPIN EP IMPURITY C ; CAS:1531-85-7 DSL03 : (11RS)-11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]thiepin-11-ol ; | DOSULEPIN EP IMPURITY D ; DOSULEPIN (S,S)-DIOXIDE ; CAS:25846-81-5 DSL04 : (E)-3-(5,5-Dioxo-5.6-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine ; | DOSULEPIN EP IMPURITY E ; (Z)-DOSULEPIN ; CAS:25627-38-7 DSL05 : (Z)-3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine ; | DOSULEPIN HCL ; DOTHIEPIN HCL ; CAS:897-15-4 DSL00H : (E)-3-(Dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine hydrochloride ; | DOSULEPIN N-OXIDE SULFOXIDE ; DSL51H : (E)-3-(5-Oxo-5.4-dibenzo[b,e]thiepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine n-oxide hydrochloride ; | DOVITINIB LACTATE ; CAS:692737-80-7 DVT00L : 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate ; | DOVITINIB N-DESMETHYL ANALOG ; CAS:668432-44-8 DVT51 : 4-Amino-5-fluoro-3-[6-(1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone ; | DOXAPRAM EP IMPURITY A ; CAS:3192-64-1 DXM01 : (4RS)-4-(2-Chloroethyl)-1-ethyl-3,3-diphenylpyrrolidin-2-one ; | DOXAPRAM EP IMPURITY B ; CAS:100106-91-0 DXM02 : (4RS)-1-Ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrrolidin-2-one ; | DOXAPRAM HYDROCHLORIDE ; CAS:113-07-5 DXM00H : (4RS)-1-Ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one hydrochloride ; | DOXAZOSIN EP IMPURITY A (= USP RC D) ; CAS:3663-80-7 DXZ01 : 1,4-Benzodioxan-2-carboxylic acid ; | DOXAZOSIN EP IMPURITY B (= USP RC A) ; CAS:70918-74-0 DXZ02H : N-(1,4-Benzodioxane-2-carbonyl)piperazine hydrochloride ; | DOXAZOSIN EP IMPURITY C (= USP RC F) ; CAS:617677-53-9 DXZ03 : N,N'-bis(1,4-Benzodioxane-2-carbonyl)piperazine ; | DOXAZOSIN EP IMPURITY D (= USP RC B) ; CAS:28888-44-0 DXZ04 : 6,7-Dimethoxy-2,4-quinazolinedione ; | DOXAZOSIN EP IMPURITY E (= USP RC E) ; CAS:27631-29-4 DXZ05 : 2,4-Dichloro-6,7-dimethoxyquinazoline ; | DOXAZOSIN EP IMPURITY F (= USP RC C) ; ALFUZOSIN EP IMPURITY B ; CAS:23680-84-4 DXZ06 : 4-Amino-2-chloro-6,7-dimethoxyquinazoline ; | DOXAZOSIN EP IMPURITY G ; TERAZOSIN EP IMPURITY C ; TERAZOSIN USP RC A ; PRAZOSIN EP IMPURITY C ; CAS:60547-97-9 DXZ07 : 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine ; | DOXAZOSIN EP IMPURITY H ; PRAZOSIN EP IMPURITY E ; TERAZOSIN EP IMPURITY E ; CAS:102839-00-9 DXZ08 : 2,2'-(1,4-Piperazinediyl)bis[6,7-dimethoxy-4-quinazolinamine] ; | DOXAZOSIN MESYLATE ; CAS:77883-43-3 DXZ00M : 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[(2RS)-2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl]piperazine methanesulphonate ; | DOXEPIN EP IMPURITY A ; DOXEPIN USP RC A ; DOXEPINONE ; CAS:4504-87-4 DXP01 : Dibenzo[b,e]oxepin-11(6H)-one ; 6,11-Dihydrodibenz[b,e]oxepin-11-one ; | DOXEPIN EP IMPURITY B ; DOXEPIN USP RC B ; DOXEPINOL ; CAS:4504-88-5 DXP02 : (11RS)-11-[3-(Dimethylamino)propyl]-6,11-dihydrodibenzo[b,e]oxepin-11-ol ; | DOXEPIN EP IMPURITY C ; DOXEPIN USP RC C ; N-DESMETHYL (E)-DOXEPIN HCL ; CAS:4504-96-5 DXP03H : (E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl ; | DOXEPIN EP IMPURITY D ; DOXEPIN HCL (Z)-ISOMER ; CAS:25127-31-5 DXP04H : (Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine HCl ; | DOXEPIN HCL ; CAS:1229-29-4 DXP00H : (E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine hydrochloride ; | DOXEPIN HCL N-DESMETHYL (Z)-ISOMER ; CAS:124694-02-6 DXP50H : (3Z)-3-Dibenz[b,e]oxepin-11(6H)-ylidene-N-methyl-1-propanamine HCl ; | DOXEPIN HCL N-DESMETHYL (Z/E)-MIXTURE ; CAS:2887-91-4 DXP53H : 3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine HCl ; | DOXEPIN N-DESMETHYL N-ACETYL IMPURITY ; CAS:250331-54-5 DXP51 : N-[(3E)-3-Dibenz[b,e]oxepin-11(6H)-ylidenepropyl]-N-methylacetamide ; | DOXEPIN-N-OXIDE ; CAS:22684-91-9 DXP52 : 3-Dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-1-propanamine N-Oxide ; N,N-Diethyldibenz[b,d]oxepin-11(6H),a-propylamine N-Oxide ; | DOXIFLURIDINE ; CAPECITABINE EP IMPURITY B ; CAPECITABINE USP RC B ; DEOXY-5-FLUOROURIDINE ; CAS:9/5/3094 DFL00 : Deoxy-5-Fluorouridine ; | DOXIFLURIDINE 5-FLUOROCYTOSINE IMPURITY ; CAPECITABINE EP IMPURITY A ; CAPECITABINE USP RC A ; CAS:66335-38-4 DFL50 : 5'-Deoxy-5-fluorocytidine ; | DOXOFYLLINE ; CAS:69975-86-6 DXF00 : 7-(1,3-Dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione ; | DOXOFYLLINE CARBOXYLIC ACID IMPURITY ; DXF51 : 1-((1,3-Dioxolan-2-yl)methyl)-4-(1,3-dimethylureido)-1H-imidazole-5-carboxylic acid ; | DOXOFYLLINE DIHYDROXYETHYL ANALOG ; DXF53 : 7-(2,2-Dihydroxyethyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione ; | DOXOFYLLINE N9-ISOMER ; CAS:1174289-18-9 DXF59 : 9-((1,3-Dioxolan-2-yl)methyl)-1,3-dimethyl-1H-purine-2,6(3H,9H)-dione ; | DOXOFYLLINE USP RC B ; DESCARBONYL DOXOFYLLINE ; CAS:1429636-74-7 DXF22 : 1-((1,3-Dioxolan-2-yl)methyl)-N-methyl-4-(methylamino)-1H-imidazole-5-carboxamide ; | DOXYCYCLINE EP IMPURITY A (BASE) ; DOXYCYCLINE USP RC A (BASE) ; 6-EPI DOXYCYCLINE ; CAS:3219-99-6 DXC01B : (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ; | DOXYCYCLINE EP IMPURITY A (HCL) ; DOXYCYCLINE USP RC A (HCL) ; 6-EPI DOXYCYCLINE HCL ; CAS:41411-66-9 DXC01H : (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ; | DOXYCYCLINE EP IMPURITY B ; METHACYCLINE HCL ; CAS:914-00-1 DXC02H : (4S,4aR,5S,5aR,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide HCl ; | DOXYCYCLINE EP IMPURITY C ; 4-EPI DOXYCYCLINE ; CAS:6543-77-7 DXC03 : (4R,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ; | DOXYCYCLINE EP IMPURITY D ; 4-EPI 6-EPI DOXYCYCLINE ; CAS:97583-08-9 DXC04 : (4R,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide ; | DOXYCYCLINE EP IMPURITY E ; OXYTETRACYCLINE ; CAS:79-57-2 DXC05 : (4S,4aR,5S,5aR,6S,12aS) -4-(dimethylamino)-3,5,6,10,11,12a-hexahydroxy -6-methyl-1,12-dioxo-1,4,4a,5,5a,6,12,12a-octahydrotetracene -2-carboxamide ; | DOXYCYCLINE EP IMPURITY F ; 2-ACETYL 2-DECARBAMOYL DOXYCYCLINE ; DOXYCYCLINE 2-ACETYL ANALOG ; CAS:122861-53-4 DXC06 : (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-4a,5a,6,12a-tetrahydrotetracene-1,11(4H,5H)-dione ; | DOXYCYCLINE HYCLATE ; DOXYCYCLINE HYDROCHLORIDE HEMIETHANOL HEMIHYDRATE ; CAS:24390-14-5 DXC00H : (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride hemiethanol hemihydrate ; | DOXYCYCLINE MONOHYDRATE ; CAS:17086-28-1 DXC00B : (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide monohydrate ; | DOXYLAMINE EP IMPURITY A ; DOXYLAMINE 4-PYRIDINYL ISOMER ; CAS:873407-01-3 DXA01 : N,N-Dimethyl-2-[(1RS)-1-phenyl-1-(pyridin-4-yl)ethoxy]ethanamine ; | DOXYLAMINE EP IMPURITY B ; CAS:19490-92-7 DXA02 : a-Methyl-a-phenyl-2-pyridinemethanol ; | DOXYLAMINE EP IMPURITY C ; C-DESMETHYL DOXYLAMINE ; CAS:1221-70-1 DXA03 : N,N-Dimethyl-2-[(1RS)-1-phenyl-1-(pyridin-2-yl)methoxy]ethanamine ; | DOXYLAMINE EP IMPURITY D ; 2-BENZOYLPYRIDINE ; CAS:91-02-1 DXA04 : Phenyl(pyridin-2-yl)methanone ; | DOXYLAMINE ETHYLAMINE N-OXIDE ; CAS:97143-65-2 DXA50 : N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]ethanamine N-Oxide ; | DOXYLAMINE N,N-DIDESMETHYL IMPURITY ; CAS:78868-04-9 DXA52 : 2-?[1-Phenyl-?1-?(2-?pyridinyl)?ethoxy]?ethanamine ; | DOXYLAMINE N,N-DIOXIDE ; CAS:105176-70-3 DXA62 : N,N-Dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-ethanamine N,N’-dioxide ; | DOXYLAMINE N-DESMETHYL IMPURITY ; CAS:78868-03-8 DXA51 : N-?Methyl-?2-?[1-?phenyl-?1-?(2-?pyridinyl)?ethoxy]?ethanamine ; | DOXYLAMINE PYRIDINE N-OXIDE ; CAS:99430-77-0 DXA61 : N,?N-Dimethyl-?2-?[1-?(1-?oxido-?2-?pyridinyl)?-?1-?phenylethoxy]?-ethanamine ; | DOXYLAMINE SUCCINATE ; CAS:562-10-7 DXA00S : N,N-Dimethyl-2-[(1RS)-1-phenyl-1-(pyridin-2-yl)ethoxy]ethanamine butanedioate ; | DRONEDARONE HYDROCHLORIDE ; CAS:141625-93-6 DND00H : N-[2-Butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methane sulfonamide hydrochloride ; | DRONEDARONE N,N-DIDESBUTYL IMPURITY ; DND41H : N-[2-Butyl-3-[4-[3-aminopropoxy]benzoyl]-5-benzofuranyl]methane sulfonamide hydrochloride ; | DRONEDARONE N-FORMYL IMPURITY ; CAS:1309381-32-5 DND43H : N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl) formamide hydrochloride ; | DRONEDARONE N-OXIDE ; CAS:1638586-56-7 DND44 : N-Butyl-N-(3-(4-(2-butyl-5-(methylsulfonamido)benzofuran-3-carbonyl) phenoxy)propyl)butan-1-amine oxide ; | DRONEDARONE USP RC A ; DRONEDARONE N-DESBUTYL IMPURITY ; CAS:197431-02-0 DND21H : N-[2-Butyl-3-[4-[3-(butylamino)propoxy]benzoyl]-5-benzofuranyl]methane sulfonamide hydrochloride ; | DRONEDARONE USP RC B ; DES(METHYLSULFONYL) DRONEDARONE DIOXALATE ; CAS:500791-70-8 DND22X : (5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino) propoxy)phenyl) methanone dioxalate ; | DRONEDARONE USP RC C ; DND23 : (5-Amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl) methanone ; | DRONEDARONE USP RC D ; CAS:141645-16-1 DND24 : (2-Butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl) methanone ; | DROPERIDOL ; CAS:548-73-2 DPL00 : 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; | DROPERIDOL EP IMPURITY A ; CAS:2147-83-3 DPL01 : 1-(1,2,3,6-Tetrahydropyridin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one ; | DROPERIDOL EP IMPURITY B ; 4-DESFLUORO 2-FLUORO DROPERIDOL ; CAS:1026015-45-1 DPL02 : 1-(1-(4-(2-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one ; | DROPERIDOL EP IMPURITY C ; CAS:60373-77-5 DPL03 : 4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium bromide ; | DROPERIDOL EP IMPURITY D ; DROPERIDOL N-OXIDE ; CAS:466118-75-2 DPL04 : 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydropyridin-4-yl)-1H-benzo[d]imidazol-2(3H)-one N-oxide ; | DROPERIDOL EP IMPURITY E ; CAS:1346604-17-8 DPL05 : 1-[1-[4-[4-[4-(2-Oxo-2,3-dihydro-1H-benzimidazol-1-yl)-3,6-dihydropyridin-1(2H)-yl]-1-oxobutyl]phenyl]-1,2,3,6-tetrahydro-4-pyridinyl]-1,3-dihydro-2H-benzimidazol-2-one ; | DROSPIRENONE ; CAS:67392-87-4 DSN00 : 3-Oxo-6a,7a,15a,16a-tetrahydro-3'H,3?H-dicyclopropa[6,7:15,16]-17a-pregn-4-en-21,17-carbolactone ; | DROSPIRENONE 5SS-HYDROXY IMPURITY ; CAS:197721-70-3 DSN52 : 6ß,7ß:15ß,16ß-Dimethylene-5ß-hydroxy-3-oxo-17a-pregnane-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY A ; DROSPIRENONE BP IMPURITY A ; DROSPIRENONE USP IMP G ; 6,7-DESMETHYLENE DROSPIRENONE ; CAS:67372-68-3 DSN01 : 3-Oxo-15a,16a-dihydro-3'H-cyclopropa[15,16]-17a-pregn4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY B ; DROSPIRENONE BP IMPURITY B ; 7SS-HYDROXYMETHYL DROSPIRENONE ; DSN02 : 7ß-(Hydroxymethyl)-3-oxo-15a,16a-dihydro-3'H-cyclopropa[15,16]-17a-pregn-4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY C ; DROSPIRENONE BP IMPURITY C ; 17-KETO DROSPIRENONE ; CAS:116298-21-6 DSN03 : 6a,7a,15a,16a-Tetrahydro-3'H,3?H-dicyclopropa[6,7:15,16]androst-4-ene-3,17-dione ; | DROSPIRENONE EP IMPURITY D ;DROSPIRENONE BP IMPURITY D ; ?6-DROSPIRENONE ; 6,7-DEMETHYLENE-6,7-DEHYDRO DROSPIRENONE ; CAS:67372-69-4 DSN04 : 3-Oxo-15a,16a-dihydro-3'H-cyclopropa[15,16]-17apregna-4,6-diene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY E ; DROSPIRENONE BP IMPURITY E ; DROSPIRENONE USP RC A ; 17-EPIDROSPIRENONE ; (17R)-DROSPIRENONE ; CAS:90457-65-1 DSN05 : 3-Oxo-6a,7a,15a,16a-tetrahydro-3'H,3?H-dicyclopropa[6,7:15,16]pregn-4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY F ; DROSPIRENONE BP IMPURITY F ; 3?-16-SECODROSPIRENONE ; 15SS-METHYL DROSPIRENONE ; DSN06 : 15ß-Methyl-3-oxo-6a,7a-dihydro-3'H-cyclopropa[6,7]17a-pregn-4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY G ; DROSPIRENONE BP IMPURITY G ; 3'-CHLORO-3',6-SECODROSPIRENONE ; 7-CHLOROMETHYL DROSPIRENONE ; CAS:932388-90-4 DSN07 : 7ß-(Chloromethyl)-3-oxo-15a,16a-dihydro-3'H-cyclopropa[15,16]-17a-pregn-4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY H ; DROSPIRENONE BP IMPURITY H ; 3'-CHLORO-3',6-SECO-17-EPIDROSPIRENONE ; 7-CHLOROMETHYL 17R-DROSPIRENONE ; CAS:932388-89-1 DSN08 : 7ß-(Chloromethyl)-3-oxo-15a,16a-dihydro-3'Hcyclopropa[15,16]pregn-4-ene-21,17-carbolactone ; | DROSPIRENONE EP IMPURITY I ; DROSPIRENONE BP IMPURITY I ; 7SS-HYDROXYMETHYLDIENE DROSPIRENONE ; DSN09 : 7ß-(Hydroxymethyl)-15a,16a-dihydro-3'H-cyclopropa[15,16]-17a-pregna-3,5-diene-21,17carbolactone ; | DROSPIRENONE EP IMPURITY J ; 3-DEOXO-4,5-DIHYDRO-5SS-HYDROXY DROSPIRENONE ; DSN10 : 6ß,7ß:15ß,16ß-Dimethylene-5ß-hydroxy-17a-pregnane-21,17-carbolactone ; (2’S,5R,6R,7R,8R,9S,10R,13S,14S,15S,16S)-Octadecahydro-5-hydroxy-10,13-dimethylspiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2’(5’H)-furan]-5’(2H)-one ; | DROSPIRENONE EP IMPURITY K ; DROSPIRENONE BP IMPURITY K ; 6A,7A-DROSPIRENONE ; CAS:889652-31-7 DSN11 : 3-Oxo-6ß,7ß,15a,16a-tetrahydro-3'H,3?H-dicyclopropa[6,7:15,16]-17a-pregn-4-ene-21,17-carbolactone ; | DROXIDOPA ; L-THREO 3,4-DIHYDROXYPHENYLSERINE ; CAS:23651-95-8 DXD00 : (2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)3-hydroxypropanoic acid ; | DROXIDOPA DL-THREO IMPURITY ; DL-THREO 3,4-DIHYDROXYPHENYLSERINE ; CAS:3916-18-5 DXD50 : (2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)3-hydroxypropanoic acid and enantiomer ; | DULOXETINE 2-NAPHTHALENOL IMPURITY ; CAS:1346599-09-4 DLX35 : 1-[3-(Methylamino)-1-(2-thienyl)propyl]-2-naphthalenol ; | DULOXETINE DIMETHYLAMINOPROPANOL IMPURITY ; DULOXETINE HYDROXY IMPURITY ; CAS:132335-44-5 DLX34: (S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl) propanamine ; | DULOXETINE EP IMPURITY A ; DULOXETINE USP RC A ; DULOXETINE (R)-ISOMER ; CAS:910138-96-4 DLX01H : (3R)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine HCl ; | DULOXETINE EP IMPURITY B ; CAS:116539-55-0 DLX02 : (1S)-3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol ; | DULOXETINE EP IMPURITY C ; CAS:949096-01-9 DLX03H : 4-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl]naphthalen-1-ol HCl ; | DULOXETINE EP IMPURITY D ; CAS:90-15-3 DLX04 : Naphthalen-1-ol ; | DULOXETINE EP IMPURITY E ; CAS:1033803-59-6 DLX05 : 2-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl]naphthalen-1-ol ; | DULOXETINE EP IMPURITY F ; DULOXETINE USP RC F ; DULOXETINE OXALATE 3-THIOPHENE ISOMER ; CAS:959392-22-4 DLX06X : (3S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine oxalate ; | DULOXETINE EP IMPURITY G ; CAS:321-38-0 DLX07 : 1-Fluoronaphthalene ; | DULOXETINE HCL ; CAS:136434-34-9 DLX00H : (?S)-N-Methyl-?-(1-naphthalenyloxy)-2-thiophenepropanamine Hydrochloride ; | DULOXETINE METHYLAMINOPROPANOL RACEMATE ; CAS:116539-56-1 DLX52 : 3-(Methylamino)-1-(thiophen-2-yl)propan-1-ol ; | DULOXETINE N-DESMETHYL (R)-ISOMER OXALATE ; N-DESMETHYL R-DULOXETINE OXALATE ; CAS:1193213-97-6 DLX43X : (R)-(+)-3-(1-Naphthoxy)-3-(2-thienyl)-1-propylamine oxalate ; | DULOXETINE N-DESMETHYL (S)-ISOMER OXALATE ; DULOXETINE N-DESMETHYL METABOLITE (OXALATE) ; N-DESMETHYL S- DULOXETINE OXALATE ; N-DESMETHYL DULOXETINE OXALATE ; CAS:178273-35-3 DLX33X : (S)-(+)-3-(1-Naphthoxy)-3-(2-thienyl)-1-propylamine oxalate ; | DULOXETINE N-METHYL (R)-ISOMER OXALATE ; N-METHYL R-DULOXETINE OXALATE ; CAS:932013-45-1 DLX42X : (R)-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate ; | DULOXETINE N-METHYL (S)-ISOMER OXALATE ; N-METHYL (S)-DULOXETINE OXALATE ; CAS:132335-47-8 DLX32X : (S)-(+)-N,N-Dimethyl-3-(1-naphthoxy)-3-(2-thienyl)-1-propylamine oxalate ; | DULOXETINE N-METHYL 3-THIOPHENE ISOMER OXALATE ; CAS:1384080-34-5 DLX46X : (3S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine oxalate ; | DULOXETINE RACEMATE 3-THIOPHENE ISOMER ; CAS:116817-27-7 DLX36B : N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine ; | DULOXETINE USP RC H ; (S)-DULOXETINE SUCCINAMIDE ; CAS:199191-66-7 DLX28 : (S)-4-(Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino)-4-oxobutanoic acid ; | DUTASTERIDE ; CAS:164656-23-9 DTS00 : N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5a-androst-1-ene-17ß-carboxamide ; | DUTASTERIDE DIHYDRO IMPURITY ; CAS:164656-22-8 DTS52 : (5a,17ß)-N-[2,5-Bis (trifluoromethyl)phenyl]-3-oxo-4-azaandrostane-17-carboxamide ; | DUTASTERIDE EP IMPURITY A ; FINASTERIDE CARBOXYLIC ACID ; DUTASTERIDE CARBOXYLIC ACID ; CAS:104239-97-6 DTS01 : 3-Oxo-4-aza-5a-androst-1-ene-17ß-carboxylic acid ; | DUTASTERIDE EP IMPURITY B ; DUTASTERIDE DIMETHYLAMIDE ; DTS02 : N,N-Dimethyl-3-oxo-4-aza-5a-androst-1-ene-17ß-carboxamide ; | DUTASTERIDE EP IMPURITY C ; DUTASTERIDE ETHYL ESTER ; CAS:157307-36-3 DTS03 : Ethyl 3-oxo-4-aza-5a-androst-1-ene-17ß-carboxylate ; | DUTASTERIDE EP IMPURITY D ; 5,6-DEHYDRO-17A-DUTASTERIDE ; DTS04 : N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1,5-diene-17a-carboxamide ; | DUTASTERIDE EP IMPURITY E ; 17A-DUTASTERIDE ; DUTASTERIDE 17-EPIMER ; CAS:1796930-46-5 DTS05 : N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5a-androst-1-ene-17a-carboxamide ; | DUTASTERIDE EP IMPURITY F ; CHLORO DUTASTERIDE ; 1-CHLORO DIHYDRO DUTASTERIDE ; CAS:1365545-42-1 DTS06 : N-[2,5-Bis(trifluoromethyl)phenyl]-1a-chloro-3-oxo-4-aza-5a-androstane-17ß-carboxamide ; | DUTASTERIDE EP IMPURITY G ; 5,6-DEHYDRO-17SS-DUTASTERIDE ; DUTASTERIDE 5-ENE ; CAS:1430804-85-5 DTS07 : N-[2,5-Bis(trifluoromethyl)phenyl]-3-oxo-4-azaandrost-1,5-diene-17ß-carboxamide ; | DUTASTERIDE EP IMPURITY H ; DUTASTERIDE DIMER 1 ; DUTASTERIDE A-DIMER ; DTS08 : N-[2,5-Bis(Tri?uoromethyl)phenyl]-3-oxo-4-[3-oxo-4-aza-5a-androst-1-ene-17a-carbonyl]-4-aza-5a-androst-1-ene-17ß-carboxamide ; | DUTASTERIDE EP IMPURITY I ; DUTASTERIDE DIMER 2 ; DUTASTERIDE SS-DIMER ; CAS:1648593-70-7 DTS09 : N-[2,5-Bis(Tri?uoromethyl)phenyl]-3-oxo-4-[3-oxo-4-aza-5a-androst-1-ene-17ß-carbonyl]-4-aza-5a-androst-1-ene-17ß-carboxamide ; | DUTASTERIDE METHYL ESTER ANALOG ; FINASTERIDE EP IMPURITY B ; CAS:103335-41-7 DTS53 : Methyl 3-oxo-4-aza-5a-androst-1-ene-17ß-carboxylate ; | DYDROGESTERONE ; CAS:152-62-5 DYD00 : 9ß,10a-Pregna-4,6-diene-3,20-dione ; (8S,9R,10S,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,10,11,12,13,15,16,17-octahydro-2H-cyclopenta[a]phenanthren-3(8H,9H,14H)-one ; | DYDROGESTERONE BIS(ETHYLENE ACETAL) ; CAS:5488-51-7 DYD52 : (9ß,10a)-Pregna-5,7-diene-3,20-dione cyclic 3,20-bis(1,2-ethanediyl acetal) ; | DYDROGESTERONE EP IMPURITY A ; CAS:23035-53-2 DYD01 : 9ß,10a-Pregna-4,6,8(14)-triene-3,20-dione ; (9S,10S,13R,17S)-17-Acetyl-10,13-dimethyl-1,10,11,12,13,15,16,17-octahydro-2H-cyclopenta[a]phenanthren-3(9H)-one ; | DYDROGESTERONE EP IMPURITY B ; PROGESTERONE EP IMPURITY H ; PROGESTERONE BP IMPURITY H ; ?6-PROGESTERONE ; CAS:1162-56-7 DYD02 : Pregna-4,6-diene-3,20-dione ; (8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,10,11,12,13,15,16,17-octahydro-2H-cyclopenta[a]phenanthren-3(8H,9H,14H)-one ; | DYDROGESTERONE EP IMPURITY C ; 17A-DYDROGESTERONE ; CAS:246038-13-1 DYD03 : 9ß,10a,17a-Pregna-4,6-diene-3,20-dione ; (8S,9R,10S,13S,14S,17R)-17-Acetyl-10,13-dimethyl-1,10,11,12,13,15,16,17-octahydro-2H-cyclopenta[a]phenanthren-3(8H,9H,14H)-one ; | DYDROGESTERONE IMPURITY 1 ; CAS:1819-14-3 DYD51 : 1-((3S,9R,10S,13S,14R,17S)-3-Hydroxy-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)ethanone ; | EBASTINE ; CAS:90729-43-4 EBN00 : 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-piperidin-1-yl]butan-1-one ; | EBASTINE EP IMPURITY A ; BENZHYDROL ; DIPHENHYDRAMINE EP IMPURITY D ; CYCLIZINE EP IMPURITY B ; CAS:91-01-0 EBN01 : Diphenylmethanol ; | EBASTINE EP IMPURITY B ; CAS:943-27-1 EBN02 : 4-tert-Butylacetophenone ; | EBASTINE EP IMPURITY C ; DESALKYL EBASTINE ; CAS:58258-01-8 EBN03 : 4-(Diphenylmethoxy)piperidine ; | EBASTINE EP IMPURITY D ; CAS:97928-18-2 EBN04 : 1-[4-(1,1-Dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one ; | EBASTINE EP IMPURITY E ; TERT-AMYL EBASTINE ; CAS:1312211-93-0 EBN05 : 1-[4-(1,1-Dimethylpropyl)phenyl]-4-[4-(diphenylmethoxy)piperidin-1-yl]butan-1-one ; | EBASTINE EP IMPURITY F ; EBASTINE CIS-N-OXIDE ; CAS:1256285-71-8 EBN06 : 1-[4-(1,1-Dimethylethyl)phenyl]-4-[cis-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one ; | EBASTINE EP IMPURITY G ; EBASTINE TRANS-N-OXIDE ; CAS:1256285-71-8 EBN07 : 1-[4-(1,1-Dimethylethyl)phenyl]-4-[trans-4-(diphenylmethoxy)-1-oxidopiperidin-1-yl]butan-1-one ; | EBASTINE HYDROXY IMPURITY ; CAS:210686-41-2 EBN50 : 4-[4-(Diphenylmethoxy)-1-piperidinyl]-1-[4-(2-hydroxy-1,1-dimethylethyl)phenyl]-1-butanone ; | EBERCONAZOLE NITRATE ; CAS:130104-32-4 EBC00N : 1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole nitrate ; | EBERCONAZOLE NITRATE 2-DESCHLORO IMPURITY ; EBC52N : 1-(4-Chloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole nitrate ; | EBERCONAZOLE NITRATE 2-METHYL ANALOG ; EBC62N : 1-(4-Chloro-2-methyl-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole nitrate ; | EBERCONAZOLE NITRATE 4-DESCHLORO IMPURITY ; EBC54N : 1-(2-Chloro-10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole nitrate ; | EBERCONAZOLE NITRATE DIDESCHLORO IMPURITY ; EBC72N : 1-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-yl)-1H-imidazole nitrate ; | ECABET DEHYDROABIETIC ACID IMPURITY ; CAS:1740-19-8 EBS02 : Dehydroabietic Acid ; | ECABET SODIUM ; CAS:86408-72-2 EBS00N : Ecabet Sodium ; | ECONAZOLE ; CAS:27220-47-9 ECZ00B : 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole ; | ECONAZOLE EP IMPURITY A ; ECONAZOLE USP RC A ; TIOCONAZOLE EP IMPURITY D ; CAS:24155-42-8 ECZ01 : (1RS)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol ; | ECONAZOLE EP IMPURITY B ; ECONAZOLE USP RC B ; CAS:2334059-11-7 ECZ02 : (2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine ; | ECONAZOLE EP IMPURITY C ; ECONAZOLE USP RC C ; ECZ03 : 1-(4-Chlorobenzyl)-3-[(2RS)-2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl] imidazolium chloride ; | ECONAZOLE NITRATE ; CAS:24169-02-6 ECZ00N : 1-[(2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole nitrate ; | EDARAVONE ; CAS:89-25-8 ERV00 : 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one ; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one ; | EDARAVONE IMPURITY 1 ; ERV51N : Sodium 1-Hydroxy-2-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)propane-2-sulfonate ; | EDARAVONE IMPURITY 2 ; CAS:1357477-99-6 ERV52 : 2-(3-Methyl-5-oxo-1-phenyl-4,5-dihydro-1H-pyrazol-4-yl)-2-sulfopropanoic acid ; | EDARAVONE IMPURITY 3 ; ERV53N : Sodium 2-(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)propane-2-sulfonate ; | EDARAVONE IMPURITY 4 ; BISPYRAZOLONE ; CAS:7477-67-0 ERV54 : 4-(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-pyrazol-5-ol ; | EDARAVONE IMPURITY 5 ; CAS:124009-63-8 ERV55 : 4,4-bis(5-Hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-3-methyl-1-phenyl-1H-pyrazol-5(4H)-one ; | EDARAVONE IMPURITY 6 ; ERV56 : 3-Methyl-1-phenyl-4,5-dihydro-1H-pyrazole-4,5-diol ; | EDARAVONE IMPURITY 7 ; ERV57 : (Z)-3-Methyl-4-(3-methyl-5-oxo-1-phenyl-1H-pyrazol-4(5H)-ylidene)-1-phenyl-1H-pyrazol-5(4H)-one N-Oxide ; | EDARAVONE IMPURITY 8 ; CAS:27349-35-5 ERV58 : 5-Methoxy-3-methyl-1-phenyl-1H-pyrazole ; | EDARAVONE N-OXIDE ; ERV70 : 3-?Methyl-?1-?phenyl-?2-?pyrazolin-?5-?one ; 2,4-Dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one N-Oxide ; | EDOXABAN (BASE) ; (S,R,S)-EDOXABAN ; CAS:480449-70-5 EDX00B : N-(5-Chloro-2-pyridinyl)-N’-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-ethanediamide ; | EDOXABAN (RRR)-ISOMER ; CAS:1255529-24-8 EDX51 : N1-(5-Chloropyridin-2-yl)-N2-((1R,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl- 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN (RRS)-ISOMER ; 1-EPI-EDOXABAN ; CAS:500572-10-1 EDX52 : N1-(5-Chloropyridin-2-yl)-N2-((1R,2R,4S)-4-(dimethylcarbamoyl)-2-(5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN (RSR)-ISOMER ; ENT-EDOXABAN ; EDOXABAN IMPURITY I ; CAS:1255529-23-7 EDX53 : N1-(5-Chloropyridin-2- yl)-N2-((1R,2S,4R)-4-(dimethylcarbamoyl)-2-(5- methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine- 2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN (RSS)-ISOMER ; CAS:1255529-25-9 EDX54 : N1-(5-Chloropyridin-2-yl)-N2-((1R,2S,4S)-4-(dimethylcarbamoyl)-2-(5-methyl- 4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN AMINO T-BOC IMPURITY ; EDX55 : t-Butyl ((1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl)carbamate ; | EDOXABAN AZIDO T-BOC IMPURITY ; CAS:480450-69-9 EDX56 : t-Butyl N-[(1R,2S,5S)-2-azido-5-(dimethylcarbamoyl)cyclohexyl]carbamate ; | EDOXABAN CYCLOHEXANE ETHYL ESTER (R,R,R)-ISOMER ; CAS:1392745-70-8 EDX57 : (1R,3R,4R)-3-Amino-4-hydroxy-cyclohexanecarboxylic acid ethyl ester ; | EDOXABAN CYCLOHEXANE ETHYL ESTER (S,S,S)-ISOMER ; EDX58 : (1S,3S,4S)-3-Amino-4-hydroxy-cyclohexanecarboxylic acid ethyl ester ; | EDOXABAN EP IMPURITY C ; EDOXABAN (SSS)-ISOMER ; CAS:1255529-27-1 EDX03 : N1-(5-Chloropyridin-2-yl)-N2-((1S,2S,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN EP IMPURITY G ; EDOXABAN (SRR)-ISOMER ; CAS:1255529-26-0 EDX07 : N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4R)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN EP IMPURITY H ; EDOXABAN (SSR)-ISOMER ; CAS:1255529-28-2 EDX08 : N-(5-Chloropyridin-2-yl)-N’-[(1S,2S,4R)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide ; | EDOXABAN HYDROXY T-BOC IMPURITY ; CAS:929693-30-1 EDX59 : t-Butyl N-[(1R,2R,5S)-5-(dimethylcarbamoyl)-2-hydroxycyclohexyl]carbamate ; | EDOXABAN M1 (LITHIUM SALT) ; CAS:767625-11-6 EDX61L : 2-(((1S,2R,4S)-4-(Dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)amino)-2-oxoacetic acid lithium salt ; | EDOXABAN M2 ; CAS:480450-71-3 EDX62 : N-((1R,2S,5S)-2-Amino-5-(dimethylcarbamoyl)cyclohexyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide ; | EDOXABAN M4 ; EDOXABAN 4-CARBOXYLIC ACID ; CAS:834919-19-6 EDX64 : (1S,3R,4S)-4-[[2-[(5-Chloro-2-pyridinyl)amino]-2-oxoacetyl]amino]-3-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexanecarboxylic acid ; | EDOXABAN M5 ; EDOXABAN N-OXIDE ; EDX65 : 2-(((1R,2S,5S)-2-(2-((5-Chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl) cyclohexyl)carbamoyl)-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine 5-oxide ; | EDOXABAN M6 ; EDOXABAN N-DESMETHYL HCL ; CAS:480449-52-3 EDX66H : N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide hydrochloride ; | EDOXABAN M7 ; EDX67 : N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-((hydroxymethyl)(methyl)carbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide ; | EDOXABAN M8 ; CAS:740794-83-6 EDX68 : N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)-4-(methylcarbamoyl)cyclohexyl)oxalamide ; | EDOXABAN PYRIDINE ETHYL ESTER IMPURITY ; CAS:1243308-37-3 EDX69H : 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride ; | EDOXABAN TOSYLATE MONOHYDRATE ; CAS:1229194-11-9 EDX00T : N-(5-Chloropyridin-2-yl)-N’-((1S,2R,4S)-4-[(dimethyl amino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl)ethanediamide p-toluenesulfonate monohydrate ; | EFAVIRENZ ; (S)-EFAVIRENZ ; CAS:154598-52-4 EFV00 : (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ AMINO ALCOHOL ETHYL CARBAMATE (USP) ; EFAVIRENZ USP IMPURITY L ; CAS:211563-41-6 EFV49 : (S)-Ethyl 4-chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl)phenylcarbamate ; | EFAVIRENZ BENZOYL AMINO ALCOHOL (RACEMATE) ; EFAVIRENZ N-METHOXYBENZOYL AMINO ALCOHOL (RACEMATE) ; CAS:1189491-03-9 EFV50 : N-(4-Chloro-2-(4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl) phenyl)-4-methoxybenzamide ; | EFAVIRENZ BIS-ETHOXYCARBONYL IMPURITY ; EFAVIRENZ AMINO ALCOHOL BIS-ETHOXYCARBONYL IMPURITY ; EFAVIRENZ USP IMPURITY N ; EFV48 : (S)-Ethyl 4-chloro-2-[4-cyclopropyl-2-(ethoxycarbonyloxy)-1,1,1-trifluorobut-3-yn-2-yl]phenylcarbamate ; | EFAVIRENZ CYCLOBUTENYLINDOLE ANALOG ; EFAVIRENZ USP IMPURITY P ; CAS:2177283-35-9 EFV69 : Ethyl 5-chloro-2-cyclobutenyl-3-(trifluoromethyl)-1H-indole-1-carboxylate ; | EFAVIRENZ ENANTIOMER ; (R)-EFAVIRENZ ; CAS:154801-74-8 EFV70 : (R)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ IP IMPURITY A ; EFAVIRENZ USP IMPURITY J ; EFAVIRENZ BENZOYL AMINO ALCOHOL (USP) ; EFAVIRENZ N-METHOXYBENZOYL AMINO ALCOHOL S-ISOMER ; CAS:353270-77-6 EFV51 : N-(4-Chloro-2-((2S)-4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-2-yl) phenyl)-4-methoxybenzamide ; | EFAVIRENZ IP IMPURITY B ; EFAVIRENZ USP RC B ; EFAVIRENZ USP IMPURITY B ; EFAVIRENZ ETHENE ANALOG (USP) ; (E)-DIHYDRO EFAVIRENZ ; CAS:440124-96-9 EFV52 : (S,E)-6-Chloro-4-(2-cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ IP IMPURITY C ; EFV53: (4S)-6-Chloro-4-(pent-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ IP IMPURITY D ; EFV54: (4S)-6-Chloro-4-(2-cyclopropyleth-1-yn-1-yl)-1-[(4-methoxyphenyl)methyl]-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ IP IMPURITY E ; EFAVIRENZ USP RC A ; EFAVIRENZ USP IMPURITY A ; EFAVIRENZ AMINO ALCOHOL (USP) ; CAS:209414-27-7 EFV55 : (S)-2-(2-Amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol ; | EFAVIRENZ IP IMPURITY F ; EFAVIRENZ USP RC C ; EFAVIRENZ QUINOLINE ANALOG (USP) ; EFAVIRENZ USP IMPURITY K ; CAS:391860-73-4 EFV56 : 6-Chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline ; | EFAVIRENZ IP IMPURITY G ; EFV57: (S)-6-Chloro-4-[2-(2-methylcyclopropyl)eth-1-yn-1-yl]-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ IP IMPURITY H ; EFAVIRENZ AMINO ALCOHOL METHYL CARBAMATE (USP) ; CAS:211563-40-5 EFV58: Methyl {4-chloro-2-[(2S)-4-cyclopropyl-1,1,1-trifluoro-2-hydroxybut-3-yn-1-yl]phenyl}carbamate ; | EFAVIRENZ IP IMPURITY I ; CAS:173676-60-3 EFV59: (2S)-2-(5-Chloro-2-{[(4-methoxyphenyl)methyl]amino}phenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol ; | EFAVIRENZ IP IMPURITY J ; CAS:209414-26-6 EFV60: (2RS,4S)-6-Chloro-4-(2-cyclopropyleth-1-yn-1-yl)-2-(4-methoxyphenyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazine ; | EFAVIRENZ METHYL IMPURITY ; METHYL EFAVIRENZ (RACEMATE) ; EFAVIRENZ USP IMPURITY G (RACEMATE) ; CAS:353270-76-5 EFV47 : 6-Chloro-4-{[2-methylcyclopropyl]ethynyl}-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ N-METHOXYBENZYL IMPURITY (USP) ; N-BENZYL EFAVIRENZ (USP) ; CAS:174819-21-7 EFV79 : (S)-6-Chloro-4-(cyclopropylethynyl)-1-(4-methoxybenzyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ PENT-3-ENE-1-YNE IMPURITY (USP) ; EFV43 : (S)-6-Chloro-4-(pent-3-en-1-ynyl)-4-(trifluoromethyl)-1H-benzo[d][1,3]oxazin-2(4H)-one ; | EFAVIRENZ PENTENEYNE IMPURITY (USP) ; EFAVIRENZ USP IMPURITY E ; EFV45 : (S)-6-Chloro-4-(3-methylbut-3-en-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ PENTYNE ANALOG (RACEMATE) ; EFAVIRENZ USP IMPURITY F (RACEMATE) ; CAS:205755-86-8 EFV46 : 6-Chloro-4-(pent-1-ynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFAVIRENZ RACEMATE ; RAC-EFAVIRENZ ; CAS:177530-93-7 EFV80 : (RS)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one ; | EFINACONAZOLE (2R,3R)-DIOL IMPURITY ; (2R,3R)-EFINACONAZOLE DIOL ; CAS:133775-25-4 EFC71 : (2R,3R)- 2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol ; | EFINACONAZOLE (2R,3S)-DIOL IMPURITY ; CAS:135270-11-0 EFC72 : (2R,3S)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE (2R,3S)-ISOMER ; EFC51X : (2R,3S)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol oxalate ; | EFINACONAZOLE (2S,3R)-DIOL IMPURITY ; CAS:135272-36-5 EFC73 : (2S,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE (2S,3R)-ISOMER ; CAS:2055038-61-2 EFC52X : (2S,3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol oxalate ; | EFINACONAZOLE (2S,3S)-DIOL IMPURITY ; CAS:135270-05-2 EFC74 : (2S,3S)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl) butane-2,3-diol ; | EFINACONAZOLE (2S,3S)-ISOMER ; EFINACONAZOLE ENANTIOMER ; CAS:164650-45-7 EFC53 : (2S,3S)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ; | EFINACONAZOLE ; (R,R)-EFINACONAZOLE ; CAS:164650-44-6 EFC00 : (aR,ßR)-a-(2,4-Difluorophenyl)-ß-methyl-4-methylene-a-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol ; | EFINACONAZOLE 2,3-DIFLUORO IMPURITY ; EFC54 : (2R,3R)-2-(2,3-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol ; | EFINACONAZOLE 2,4-DIDESFLUORO IMPURITY ; EFC80 : (2R,3R)-3-(4-Methylidenepiperidin-1-yl)-2-phenyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ; | EFINACONAZOLE 2,5-DIFLUORO IMPURITY ; EFC55 : (2R,3R)-2-(2,5-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol ; | EFINACONAZOLE 2,6-DIFLUORO IMPURITY ; EFC56 : (2R,3R)-2-(2,6-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol ; | EFINACONAZOLE 2-DESFLUORO IMPURITY ; EFC82 : (2R,3R)-2-(4-Fluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ; | EFINACONAZOLE 3,4-DIFLUORO IMPURITY ; EFC57 : (2R,3R)-2-(3,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(4H-1,2,4-triazol-4-yl)butan-2-ol ; | EFINACONAZOLE 4-DESFLUORO IMPURITY ; EFC84 : (2R,3R)-2-(2-Fluorophenyl)-3-(4-methylidenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ; | EFINACONAZOLE 4-METHYLPIPERIDINE IMPURITY ; CAS:144230-50-2 EFC40H : 4-Methylenepiperidine hydrochloride ; | EFINACONAZOLE DIOL 2,3-DIFLUORO IMPURITY ; (2R,3R)-EFINACONAZOLE DIOL 2,3-DIFLOURO ANALOG ; EFC58 : (2R,3R)-2-(2,3-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE DIOL 2,5-DIFLUORO IMPURITY ; (2R,3R)-EFINACONAZOLE DIOL 2,5-DIFLOURO ANALOG ; EFC59 : (2R,3R)-2-(2,5-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE DIOL 2,6-DIFLUORO IMPURITY ; (2R,3R)-EFINACONAZOLE DIOL 2,6-DIFLOURO ANALOG ; EFC60 : (2R,3R)-2-(2,6-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE DIOL 3,4-DIFLUORO IMPURITY ; (2R,3R)-EFINACONAZOLE DIOL 3,4-DIFLOURO ANALOG ; EFC61 : (2R,3R)-2-(3,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol ; | EFINACONAZOLE ENANTIOMER ; (S,S)-EFINACONAZOLE ; CAS:164650-45-7 EFC50 : (aS,ßS)-a-(2,4-Difluorophenyl)-ß-methyl-4-methylene-a-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol ; | EFINACONAZOLE EPOXY IMPURITY ; (R,R)-EFINACONAZOLE EPOXIDE ; CAS:135270-13-2 EFC75 : (2R,3R)-2-(2,4-Difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)methyl]oxirane ; | EFINACONAZOLE KETO IMPURITY ; FLUCONAZOLE EP IMPURITY E ; VORICONAZOLE EP IMPURITY A ; VORICONAZOLE USP RC C ; FLUCONAZOLE KETO IMPURITY ; CAS:86404-63-9 EFC62 : 1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone ; | EICOSAPENTAENOIC ACID ; CAS:10417-94-4 EPC00 : (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid ; | EICOSAPENTAENOIC ACID ETHYL ESTER ; CAS:86227-47-6 EPC52 : (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaenoic acid ethyl ester ; | ELETRIPTAN (S)-ISOMER ; ELETRIPTAN ENANTIOMER ; CAS:1252673-29-2 ETT50 : 3-[[(2S)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole ; | ELETRIPTAN ; CAS:143322-58-1 ETT00 : 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole ; | ELETRIPTAN DEHYDRO N-ACETYL IMPURITY ; CAS:188113-71-5 ETT52 : 1-Acetyl-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethenyl]- 1H-indole ; | ELETRIPTAN IMPURITY A ; CAS:143322-55-8 ETT61 : (R)-3-((1-Methylpyrrolidin-2-yl)methyl)-1H-indole ; | ELETRIPTAN IMPURITY B ; ELETRIPTAN USP RC B ; CAS:143322-57-0 ETT62 : (R)-5-Bromo-3-((1-methylpyrrolidin-2-yl)methyl)-1H-indole ; | ELETRIPTAN IMPURITY C ; ELETRIPTAN DEHYDRO IMPURITY ; CAS:188113-72-6 ETT63 : 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[(1E)-2-(phenylsulfonyl)ethenyl]-1H-indole ; | ELETRIPTAN IMPURITY D ; ELETRIPTAN DES-DIMETHYLPYRROLIDINE ; CAS:1225327-16-1 ETT64 : 5-[2-(Phenylsulfonyl)ethyl]-1H-indole ; | ELETRIPTAN IMPURITY E ; ETT65 : Benzyl 2-(5-Ethyl-1H-indole-3-carbonyl)pyrrolidine-1-carboxylate ; | ELETRIPTAN IMPURITY F ; CAS:209682-64-4 ETT66 : 5-Ethyl-3-[[(2R)-1-methyl-2-pyrrolidinyl]methyl]-1H-indole ; | ELETRIPTAN IMPURITY G ; ETT67 : (R)-3-((1-Methylpyrrolidin-2-yl)methyl)-1,5-bis(2-(phenylsulfonyl)ethyl)-1H-indole ; | ELETRIPTAN IMPURITY H ; ELETRIPTAN DIMER (S)-ISOMER ; ETT68 : 3-(((R)-1-Methylpyrrolidin-2-yl)methyl)-1-((S)-1-(3-(((R)-1-methylpyrrolidin-2-yl)methyl)-1H-indol-5-yl)-2-(phenylsulfonyl)ethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole ; | ELETRIPTAN IMPURITY I ; ELETRIPTAN DIMER (R)-ISOMER ; ETT69 : 3-(((R)-1-Methylpyrrolidin-2-yl)methyl)-1-((R)-1-(3-(((R)-1-methylpyrrolidin-2-yl)methyl)-1H-indol-5-yl)-2-(phenylsulfonyl)ethyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole ; | ELETRIPTAN IMPURITY J ; CAS:6163-58-2 ETT70 : Tris(2-methylphenyl)phosphine ; trio-Tolylphosphine ; | ELETRIPTAN IMPURITY K ; CAS:6163-63-9 ETT71 : Tris(2-methylphenyl)phosphine oxide ; trio-Tolylphosphine oxide ; | ELETRIPTAN N-OXIDE ; ELETRIPTAN IMPURITY L ; CAS:1217641-89-8 ETT72 : 3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole N-Oxide ; | ELETRIPTAN PSEUDO DIMER ; ETT55 : 4-(1-(3-(((R)-1-Methylpyrrolidin-2-yl)methyl)-1H-indol-5-yl)-2-(phenylsulfonyl) ethyl)-3-(((S)-1-methylpyrrolidin-3-yl)methyl)-5-(2-(phenylsulfonyl)ethyl)-1H-indole ; | ELTROMBOPAG ; CAS:496775-61-2 EBP00 : 3’-[2-[(2Z)-1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic acid ; | ELTROMBOPAG AMIDE ; CAS:1246929-02-1 EBP50 : 3’-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2’-hydroxy-[1,1’-Biphenyl]-3-carboxamide ; | ELTROMBOPAG ETHYL ESTER ; EBP52 : 3’-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2’-hydroxy-[1,1’-Biphenyl]-3-carboxylic Acid Ethyl Ester ; | ELTROMBOPAG GLUCURONIDE ; EBP53 : 1-[3’-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene-3-14C]hydrazinyl]-2’-hydroxy[1,1’-biphenyl]-3-carboxylate]-ß-D-glucopyranuronic Acid ; | ELTROMBOPAG IMPURITY 1 ; CAS:277299-70-4 EBP56 : 1-(3,4-Dimethylphenyl)-3-methyl-1H-pyrazol-5(4H)-one ; | ELTROMBOPAG METHYL ESTER ; CAS:1246929-01-0 EBP51 : 3’-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2’-hydroxy-[1,1’-Biphenyl]-3-carboxylic Acid Methyl Ester ; | ELTROMBOPAG N-HYDROXY IMPURITY ; EBP54 : (Z)-3’-(2-(1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)-1-hydroxyhydrazinyl)-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic Acid ; | ELTROMBOPAG OLAMINE ; CAS:496775-62-3 EBP55 : 3’-[(2Z)-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2’-hydroxy-[1,1’-biphenyl]-3-carboxylic acid compoundedd with 2-aminoethanol ; | ELVITEGRAVIR ; CAS:697761-98-1 EGV00 : 6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid ; | ELVITEGRAVIR 2-CHLORO 3-FLUORO ISOMER ; EGV50 : 6-[(2-Chloro-3-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic Acid ; | ELVITEGRAVIR 7-FLUORO ANALOG ; ELVITEGRAVIR 7-DESMETHOXY-7-FLUORO IMPURITY ; CAS:869893-92-5 EGV51 : 6-(3-Chloro-2-fluorobenzyl)-7-fluoro-1-[(S)-1-hydroxymethyl-2-methylpropyl]-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid ; | ELVITEGRAVIR ACYL GLUCURONIDE ; CAS:870649-25-5 EGV52 : ß-D-Glucopyranuronic acid 1-[6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylate] ; | EMEDASTINE DIFUMARATE ; CAS:87233-62-3 EDS00F : 1-(2-Ethoxyethyl)-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole bis[hydrogen (2E)-butenedioate] ; | EMEDASTINE EP IMPURITY A ; CAS:101953-61-1 EDS01 : 1-(2-Ethoxyethyl)-1,3-dihydro-2H-benzimidazol-2-one ; | EMEDASTINE EP IMPURITY B ; CAS:87233-54-3 EDS02 : 2-Chloro-1-(2-ethoxyethyl)-1H-benzimidazole ; | EMEDASTINE EP IMPURITY C ; EDS03 : 2-[2-(4-Methylhexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazol-1-yl]ethanol ; | EMEDASTINE EP IMPURITY D ; EDS04 : 1-Ethenyl-2-(4-methylhexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole ; | EMEDASTINE EP IMPURITY E ; CAS:101954-20-5 EDS05 : 1-(2-Ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1-yl)-1H-benzimidazole ; | EMEDASTINE EP IMPURITY F ; EDS06 : N-[1-(2-Ethoxyethyl)-1H-benzimidazol-2-yl]-N'-methylpropane-1,3-diamine ; | EMODIN ; DIACEREIN EP IMPURITY A ; CAS:518-82-1 EMX00 : 1,3,8-Trihydroxy-6-methylanthracene-9,10-dione ; | EMODIN 1-OBD 6-O-MALONYLGLUCOSIDE ; CAS:928262-58-2 EMX56 : 8-[[6-O-(2-Carboxyacetyl)-ß-D-glucopyranosyl]oxy]-1,6-dihydroxy-3-methyl-9,10-anthracenedione ; | EMODIN GLUCOSIDE ; EMODIN 8-SS-D-GLUCOSIDE ; CAS:23313-21-5 EMX58 : 1-(ß-D-Glucopyranosyloxy)-3,8-dihydroxy-6-methyl-9,10-anthracenedione ; | EMODIN TRIACETATE ; CAS:6030-60-0 EMX53 : 1,3,8-Trihydroxy-6-methylanthraquinone triacetate ; | EMPAGLIFLOZIN ; CAS:864070-44-0 EGF00 : (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy] phenyl]methyl]phenyl]-D-glucitol ; | EMPAGLIFLOZIN 1,4-ANHYDRO-1,5-DIHYDROXY 3-EPIMER ; EGF50 : (2S,3S,4S,5R)-2-(3-((R)-4-((R)-Tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-5-((R)-1,2-dihydroxyethyl)-tetrahydrofuran-3,4-diol ; | EMPAGLIFLOZIN 1,4-ANHYDRO-1,5-DIHYDROXY IMPURITY ; EGF51 : (2S,3R,4S,5R)-2-(3-((S)-4-((S)-Tetrahydrofuran-3-yloxy)benzyl)-4-chlorophenyl)-5-((R)-1,2-dihydroxyethyl)-tetrahydrofuran-3,4-diol ; | EMPAGLIFLOZIN 1,5-DIHYDROXY 3-EPIMER ; EGF73 : (1R)?-1-?C-?[4-Chloro-?3-?[[4-?[[(3R)?-?tetrahydro-?3-?furanyl]?oxy]?phenyl]?methyl]?phenyl]?-?D-?glucitol ; | EMPAGLIFLOZIN 1,5-DIHYDROXY IMPURITY ; CAS:1620758-34-0 EGF70 : (1R)?-1-?C-?[4-Chloro-?3-?[[4-?[[(3S)?-?tetrahydro-?3-?furanyl]?oxy]?phenyl]?methyl]?phenyl]?-?D-?glucitol ; | EMPAGLIFLOZIN 1-HYDROXY IMPURITY ; CAS:1279691-35-8 EGF61 : (2S,3R,4S,5S,6R)-2-(4-Chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol ; | EMPAGLIFLOZIN 3-EPIMER ; EMPAGLIFLOZIN IMPURITY C ; CAS:864070-43-9 EGF53 : (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3R)-tetrahydro-3-furanyl]oxy]phenyl] methyl]phenyl]-D-glucitol ; | EMPAGLIFLOZIN ALPHA-ANOMER ; CAS:1620758-33-9 EGF60 : (1R)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy] phenyl]methyl]phenyl]-D-glucitol ; | EMPAGLIFLOZIN ALPHA-ANOMER 3-EPIMER ; (R,R)-EMPAGLIFLOZIN ; EGF63 : (1R)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3R)-tetrahydro-3-furanyl]oxy] phenyl]methyl]phenyl]-D-glucitol ; | EMPAGLIFLOZIN BENZOIC ACID IMPURITY ; EMPAGLIFLOZIN DESGLUCUORONIDE ; EGF52 : (S)-3-(4-(Tetrahydrofuran-3-yloxy)benzyl)-4-chlorobenzoic acid ; | EMPAGLIFLOZIN BROMO IMPURITY ; CAS:915095-89-5 EGF54 : (R)-3-(4-(5-Bromo-2-chlorobenzyl)phenoxy)-tetrahydrofuran ; | EMPAGLIFLOZIN FURANOSE ; EMPAGLIFLOZIN R/S FURANOSE ; CAS:1620758-31-7for EGF57 : Mixture of (1R)-1,4-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol and (1S)-1,4-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol ; | EMPAGLIFLOZIN HYDROXYMETHYLPHENYL ; EGF55 : (2S,3S,4R,5S)-2-(4-Chloro-3-(hydroxy(4-((S)-tetrahydrofuran-3-yloxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol ; | EMPAGLIFLOZIN PHENYLKETONE IMPURITY ; EGF56 : (2-Chloro-5-((2S,3S,4R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl)phenyl)(4-((S)-tetrahydrofuran-3-yloxy)phenyl)methanone ; | EMTRICITABINE ; CAS:143491-57-0 EMT00 : 4-Amino-5-fluoro-1-[(2R,5S)-2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone ; | EMTRICITABINE 5-EPIMER ; EMTRICITABINE (2R,5R)-ISOMER ; CAS:145986-26-1 EMT85 : 4-Amino-5-fluoro-1-[(2R,5R)-2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone ; | EMTRICITABINE 5-FLUOROURACIL ANALOG (USP) ; EMTRICITABINE 4-HYDROXY ANALOG ; EMTRICITABINE 2,4-DIONE IMPURITY ; CAS:145986-11-4 EMT74 : 5-Fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolane-5-yl]uracil ; cis 5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione ; | EMTRICITABINE 5-O-SULFATE ; EMT75 : 4-Amino-5-fluoro-1-[(2R,5S)-2-hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H-pyrimidinone 5-O-Sulfate ; | EMTRICITABINE AMADORI REARRANGEMENT PRODUCT ; EMT 70 : 5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-4-((3S,4R)-3,5,6-trihydroxy-2-oxo-4-((2S,3R,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)hexylamino)pyrimidin-2(1H)-one ; | EMTRICITABINE FT1 ; CAS:1962114-95-9 EMT61 : ((2R,5S)-5-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl hydrogen ((R)-1-(6-amino-7H-purin-7-yl)propan-2-yloxy)methylphosphonate ; | EMTRICITABINE FT2 ; CAS:1962115-01-0 EMT62 : ((R)-1-(6-((5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-ylamino)methylamino)-9H-purin-8-yl)propan-2-yloxy)methylphosphonic acid ; | EMTRICITABINE FT3 ; EMT63 : 4-Amino-5-fluoro-1-(2-(((5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-ylamino)methoxy)methyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one ; | EMTRICITABINE FT4 ; EMT64 : ? | EMTRICITABINE FT6 ; EMT65 : ? | EMTRICITABINE FTU IMPURITY ; CAS:145281-92-1 EMT66 : 5-Fluoro-1-[(2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione ; (2S-cis)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2,4(1H,3H)-pyrimidinedione ; | EMTRICITABINE GLYCOSAMINE ; EMT67 : 4-((2R,3R,4R,5S)-3,4-Dihydroxy-6-(hydroxymethyl)-5-((2S,3R,4S,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-tetrahydro-2H-pyran-2-ylamino)-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one ; | EMTRICITABINE IMINE ; EMT68 : 5-Fluoro-1-((2S,5R)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-4-(methyleneamino)pyrimidin-2(1H)-one ; | EMTRICITABINE IP IMPURITY A ; EMTRICITABINE CARBOXYLIC ACID ; CAS:1238210-10-0 EMT51 : (2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid ; | EMTRICITABINE IP IMPURITY B ; TRANS-EMTRICITABINE RACEMATE ; EMTRICITABINE 5-EPIMER & ENANTIOMER ; EMT52 : 4-Amino-5-fluoro-1-[(2RS,5RS)-2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone ; | EMTRICITABINE IP IMPURITY C ; LAMIVUDINE ; DESFLUORO EMTRICITABINE ; CAS:134678-17-4 EMT53 : 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl] pyrimidin-2(1H)-one ; | EMTRICITABINE IP IMPURITY D ; EMTRICITABINE ENANTIOMER ; EMTRICITABINE (2S,5R)-ISOMER ; CAS:137530-41-7 EMT54 : 4-Amino-5-fluoro-1-[(2S,5R)-2- (hydroxymethyl)-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone ; | EMTRICITABINE IP IMPURITY E ; 5-FLUORO CYTOSINE ; CAS:2022-85-7 EMT55 : 4-Amino-5-fluoropyrimidin-2(1H)-one ; | EMTRICITABINE IP IMPURITY F ; 5-FLUORO URACIL ; CAS:51-21-8 EMT56 : 5-Fluoropyrimidin-2,4(1H,3H)-dione ; | EMTRICITABINE IP IMPURITY G ; EMTRICITABINE SULFOXIDE (S)-ISOMER ; EMT57 : 4-Amino-5-fluoro-1-[(2R,3S,5S)-2-(hydroxymethyl)-3-oxo-1,3-oxa-?4-thiolan-5-yl]pyrimidin-2(1H)-one ; | EMTRICITABINE IP IMPURITY H ; EMTRICITABINE SULFOXIDE (R)-ISOMER ; EMT58 : 4-Amino-5-fluoro-1-[(2R,3R,5S)-2-(hydroxymethyl)-3-oxo-1,3-oxa-?4-thiolan-5-yl]pyrimidin-2(1H)-one ; | EMTRICITABINE IP IMPURITY I ; EMTRICITABINE 6'-DISULFIDE ; CAS:1246819-86-2 EMT59 : 1,1'-[Disulfanediylbis(methylene-(2R,5S)-1,3-oxathiolane-2,5-diyl)]bis(4-amino-5-fluoropyrimidin-2(1H)-one) ; | EMTRICITABINE IP IMPURITY J ; 2-EPI-EMTRICITABINE ; CAS:145416-34-8 EMT60 : 4-Amino-5-fluoro-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]pyrimidin-2(1H)-one ; | EMTRICITABINE ISOPROPYL CARBAMATE ; EMT76 : Isopropyl (5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate ; | EMTRICITABINE MENTHYL ESTER ; CAS:764659-72-5 EMT78 : (2R,5S)-5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexyl ester ; | EMTRICITABINE N,N-METHYLENE DIMER ; EMT44 : (R,S)-4,4’-(Methylenebis(azanediyl)bis(5-fluoro-1-((2R,5S)-2-(hyroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one ; | EMTRICITABINE N,O-METHYLENE DIMER ; EMT69 : 4-Amino-5-fluoro-1-(2-((((5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methoxy)methyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one ; | EMTRICITABINE N-ACETYL O-BENZOYL 5-EPIMER ; EMT77 : ((2R,5R)-5-(4-Acetamido-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl benzoate ; | EMTRICITABINE O-SS-D-GLUCURONIDE SODIUM SALT ; CAS:152128-78-4 EMT90N : (2R-cis)-[5-(4-Amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl] methyl ß-D-glucopyranosiduronic acid sodium salt ; | EMTRICITABINE SULFOXIDE ; CAS:152128-77-3 EMT50 : 4-Amino-5-fluoro-1-[(2R,5S)-2- (hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl]-2-(1H)-pyrimidone ; | EMTRICITABINE TENOFOVIR DISOPROXIL DIMER ; EMT79 : ((((((R)-1-(6-((((5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) Diisopropyl Dicarbonate ; | EMTRICITABINE TENOFOVIR MONOISOPROXIL DIMER ; EMT80 : ((((((R)-1-(6-((((5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)amino)methyl)amino)-9H-purin-9-yl)propan-2-yl)oxy)methyl)(hydroxy)phosphoryl)oxy)methyl Isopropyl Carbonate ; | EMTRICITABINE THIOACETATE ; EMT81 : S-(((2R,5S)-5-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolan-2-yl)methyl) Ethanethioate ; | ENALAPRIL ALANYL PROLINE IMPURITY ; CAS:13485-59-1 ENL14 : L-Alanyl-L-proline ; | ENALAPRIL EP IMPURITY A ; (R,S,S)-ENALAPRIL HCL ; ENALAPRIL HCL (1R)-ISOMER ; CAS:1356932-13-2 ENL01H : (2S)-1-[(2S)-2-[[(1R)-1-(Ethoxycarbonyl)-3- phenylpropyl] amino] propanoyl] pyrrolidine-2-carboxylic acid HCl ; | ENALAPRIL EP IMPURITY B ; RAMIPRIL EP IMPURITY F ; TRANDOLAPRIL ECPPA IMPURITY ; MOEXIPRIL USP RC F ; QUINAPRIL EP IMPURITY B ; QUINAPRIL ECPPA IMPURITY ; SPIRAPRIL EP IMPURITY C ; CAS:82717-96-2 ENL02 : N-[(S)-(+)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine ("ECPPA") ; | ENALAPRIL EP IMPURITY C ; ENALAPRIL DIACID ; ENALAPRILATE; ENALAPRILAT ; CAS:76420-72-9 ENL03 : N-[(1S)-1-(Carboxy)-3-phenylpropyl]-L-alanyl]-L-proline ; | ENALAPRIL EP IMPURITY D ; ENALAPRIL DIKETOPIPERAZINE ; CAS:115729-52-7 ENL04 : Ethyl (2S)-2-[(3S,8aS)-3-methyl-1,4-dioxooctahydropyrrolo [1,2-a]pyrazin-2-yl]-4-phenylbutanoate ; | ENALAPRIL EP IMPURITY E (HCL SALT) ; ENALAPRIL PHENYLETHYL ESTER ANALOG (HCL SALT) ; ENL05H : (2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2-phenylethoxy) carbonyl] propyl] amino] propanoyl] pyrrolidine-2-carboxylic acid hydrochloride ; | ENALAPRIL EP IMPURITY E (MALEATE SALT) ; ENALAPRIL PHENYLETHYL ESTER ANALOG ; ENL05M : (2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2-phenylethoxy) carbonyl] propyl] amino] propanoyl] pyrrolidine-2-carboxylic acid maleate salt ; | ENALAPRIL EP IMPURITY F ; ENALAPRIL BUTYL ESTER ANALOG ; CAS:76420-77-4 ENL06H : (2S)-1-[(2S)-2-[[(1S)-1-(Butoxycarbonyl)-3-phenylpropyl] amino] propanoyl] pyrrolidine-2-carboxylic acid hydrochloride ; | ENALAPRIL EP IMPURITY G ; CAS:460720-14-3 ENL07 : (2S)-2-[[(1S)-3-Cyclohexyl-1-(ethoxycarbonyl)propyl]-amino] propanoic acid ; | ENALAPRIL EP IMPURITY H ; ENALAPRIL CYCLOHEXYL ANALOG ; ENALAPRIL HEXAHYDRO ANALOG ; CAS:2055735-10-7 ENL08H : (2S)-1-[(2S)-2-[[(1S)-3-Cyclohexyl-1-(ethoxycarbonyl)propyl] amino] propanoyl]pyrrolidine-2-carboxylic acid HCl ; | ENALAPRIL HOMOPHENYLALANINE IMPURITY ; LISINOPRIL EP IMPURITY A ; CAS:1012-05-1 ENL15 : (2RS)-2-Amino-4-phenylbutanoic acid ; DL-Homophenylalanine ; | ENALAPRIL MALEATE ; (S,S,S)-ENALAPRIL MALEATE ; CAS:76095-16-4 ENL00M : (2S)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl] pyrrolidine-2-carboxylic acid (Z)-butenedioate ; | ENALAPRILAT ; ENALAPRIL EP IMPURITY C ; CAS:76420-72-9 EPX00 : (S)-1-((S)-2-((S)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carboxylic acid dihydrate ; | ENALAPRILAT 1-ACYL GLUCURONIDE ; EPX51 : (S)-1-((S)-2-((S)-1-((2S,3R,4S,5S)-6-Carboxy-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-yloxy)-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT ACYL GLUCURONIDE ; EPX52 : (3S,4S,5R,6S)-6-((S)-1-((S)-2-((S)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carbonyloxy)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-carboxylic acid ; | ENALAPRILAT BENZYL ESTER ; CAS:76391-33-8 EPX53 : (S)-1-((S)-2-((S)-1-(Benzyloxy)-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT BIALLYLOXY ACYL GLUCURONIDE ; EPX54 : (S)-((2S,3R,4S,5S)-6-(Allyloxycarbonyl)-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-yl) 1-((S)-2-((S)-1-(allyloxy)-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylate ; | ENALAPRILAT BUTYL T-BUTYL DIESTER ; EPX55 : (S)-tert-Butyl 1-((S)-2-((S)-1-butoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylate | ENALAPRILAT EP IMPURITY A ; CAS:84023-58-5 EPX01 : (SR)-2-((SR)-1-Carboxyethylamino)-4-phenylbutanoic acid ; | ENALAPRILAT EP IMPURITY B ; EPX02 : (SR)-1-((RS)-2-((RS)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT EP IMPURITY C ; EPX03 : (SR)-1-((SR)-2-((RS)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carboxylic acid | ENALAPRILAT EP IMPURITY D ; EPX04 : (SR)-1-((RS)-2-((SR)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carboxylic acid | ENALAPRILAT EP IMPURITY E ; EPX05 : (SR)-1-((SR)-1-((SR)-2-((SR)-1-Carboxy-3-phenylpropylamino)propanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT EP IMPURITY F ; ENALAPRIL EP IMPURITY B ; MOEXIPRIL USP RC F ; QUINAPRIL EP IMPURITY B ; QUINAPRIL ECPPA IMPURITY ; RAMIPRIL EP IMPURITY F ; TRANDOLAPRIL ECPPA IMPURITY ; SPIRAPRIL EP IMPURITY C ; CAS:82717-96-2 EPX06 : (SR)-2-((SR)-1-Ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoic acid ; | ENALAPRILAT EP IMPURITY G ; CAS:115623-21-7 EPX07 : (SR)-Ethyl 2-((3RS,8aSR)-3-methyl-1,4-dioxo-hexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-4-phenylbutanoate ; | ENALAPRILAT N-GLUCURONIDE ; EPX56 : (S)-1-((S)-2-(((2R,3R,4S,5S)-6-carboxy-3,4,5-trihydroxy-tetrahydro-2H-pyran-2-yl)((S)-1-carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT PHENYLETHYL ESTER ; EPX57 : (S)-1-((S)-2-((S)-1-Oxo-1-phenethoxy-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid ; | ENALAPRILAT T-BUTYL ESTER ; CAS:674796-29-3 EPX58 : (S)-2-((S)-1-((S)-2-(tert-Butoxycarbonyl)pyrrolidin-1-yl)-1-oxopropan-2-ylamino)-4-phenylbutanoic acid ; | ENILCONAZOLE ; IMAZALIL ; CAS:35554-44-0 ENX00 : 1-[(2RS)-2-(2,4-Dichlorophenyl)-2-(prop-2-enyloxy)ethyl]-1H-imidazole ; | ENILCONAZOLE EP IMPURITY A ; ENX01 : (2RS)-2-(2,4-Dichlorophenyl)-2-(prop-2-enyloxy)-ethanamine ; | ENILCONAZOLE EP IMPURITY B ; ENX02 : N-[(2RS)-2-(2,4-Dichlorophenyl)-2-(prop-2-enyloxy)-ethyl]prop-2-en-1-amine ; | ENILCONAZOLE EP IMPURITY C ; ENX03 : N-[(2RS)-2-(2,4-Dichlorophenyl)-2-(prop-2-enyloxy)-ethyl]formamide ; | ENILCONAZOLE EP IMPURITY D ; ENX04 : N-[(2RS)-2-(2,4-Dichlorophenyl)-2-(prop-2-enyloxy)-ethyl]-N-(prop-2-enyl)formamide ; | ENILCONAZOLE EP IMPURITY E ; ECONAZOLE EP IMPURITY A ; CAS:24155-42-8 ENX05 : (1RS)-1-(2,4-Dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol ; | ENILCONAZOLE EP IMPURITY F ; ENX06 : 1-[(2RS)-2-(3,4-Dichlorophenyl)-2-(prop-2-enyloxy)ethyl]-1H-imidazole ; | ENOXOLONE ; GLYCYRRHETIC ACID ; CAS:471-53-4 EXN00 : (20ß)-3ß-Hydroxy-11-oxo-olean-12-en-29-oic acid ; (2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-Hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid ; | ENOXOLONE EP IMPURITY A ; 18A-GLYCYRRHETINIC ACID ; CAS:1449-05-4 EXN01 : (20ß)-3ß-Hydroxy-11-oxo-18a-olean-12-en-29-oic acid ; | ENOXOLONE EP IMPURITY B ; EXN02 : (4ß,20ß)-3ß,23-Dihydroxy-11-oxo-olean-12-en-29-oic acid ; | ENROFLOXACIN ; CAS:93106-60-6 ERF00 : 1-Cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo -3-quinolinecarboxylic acid; | ENROFLOXACIN EP IMPURITY A ; CIPROFLOXACIN EP IMPURITY A ; CAS:86393-33-1 ERF01 : 7-Chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | ENROFLOXACIN EP IMPURITY B ; CIPROFLOXACIN HCL ; CAS:86393-32-0 ERF02H : 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid HCl ; | ENROFLOXACIN EP IMPURITY C ; DESFLUORO ENROFLOXACIN ; CAS:138892-82-7 ERF03 : 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | ENROFLOXACIN EP IMPURITY D ; ERF04 : Enrofloxacin EP Impurity D ; | ENROFLOXACIN EP IMPURITY E ; ENROFLOXACIN CHLORO ANALOG ; CAS:1369495-59-9 ERF05 : 6-Chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ; | ENROFLOXACIN EP IMPURITY F ; DECARBOXY ENROFLOXACIN ; CAS:131775-99-0 ERF06 : 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoroquinolin-4(1H)-one ; | ENROFLOXACIN EP IMPURITY G ; CIPROFLOXACIN EP IMPURITY C ; ENROFLOXACIN ETHYLENEDIAMINE ANALOG ; DESETHYLENE CIPROFLOXACIN HCL ; CAS:103222-12-4 ERF07H : 7-[(2-Aminoethyl)amino]-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride ; | ENTACAPONE ; CAS:130929-57-6 ETC00 : (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide ; | ENTACAPONE AMIDE IMPURITY ; CAS:158693-01-7 ETC51 : (2E)-2-Cyano-(3,4-dihydroxy-5-nitrophenyl)propenamide ; | ENTACAPONE BENZOIC ACID IMPURITY ; CAS:84211-30-3 ETC53 : 3,4-Dihydroxy-5-nitrobenzoic acid ; | ENTACAPONE EP IMPURITY A ; ENTACAPONE USP RC A ; ENTACAPONE CIS-ISOMER ; CAS:145195-63-7 ETC01 : (2Z)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide ; | ENTACAPONE EP IMPURITY B ; CAS:116314-52-4 ETC02 : Ethyl (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoate ; | ENTACAPONE EP IMPURITY C ; CAS:116313-85-0 ETC03 : 3,4-Dihydroxy-5-nitrobenzaldehyde ; | ENTACAPONE EP IMPURITY D ; CAS:857629-79-9 ETC04 : (2E)-2-Cyano-3-(3-ethoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide ; | ENTACAPONE EP IMPURITY E ; CAS:7659-29-2 ETC05 : 3,5-Dinitrobenzene-1,2-diol ; 1,2-Dihydroxy-3,5-dinitrobenzene ; | ENTACAPONE EP IMPURITY F ; CAS:160391-70-8 ETC06 : (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoic acid ; | ENTACAPONE EP IMPURITY G ; CAS:857629-78-8 ETC07 : (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N-methyl-prop-2-enamide ; | ENTACAPONE EP IMPURITY H ; CAS:1150310-15-8 ETC08 : (2E)-3-(3,4-Dihydroxy-5-nitrophenyl)-2-(piperidin-1-ylcarbonyl)prop-2-ennitrile ; | ENTACAPONE EP IMPURITY I ; CAS:1364322-42-8 ETC09 : Propyl (2E)-2-Cyano-3-(3,4-dihydroxy-5-nitrophenyl)prop-2-enoate ; | ENTACAPONE METHOXY IMPURITY ; (E)-3-O-METHYL ENTACAPONE ; CAS:857629-78-8 ETC52 : (2E)-2-Cyano-3-(3-methoxy-4-hydroxy-5-nitrophenyl)-N,N-diethyl-2-propenamide ; | ENTECAVIR (R,R,R)-ISOMER ; (1R,3R,4R)-ENTECAVIR ; CAS:1367369-76-3 ECV45 : 2-Amino-9-[(1R,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR (S,S,R)-ISOMER ; (1S,3S,4R)-ENTECAVIR ; CAS:1367369-79-6 ECV46 : 2-Amino-9-[(1S,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR ; (1S,3R,4S)-ENTECAVIR ; CAS:142217-69-4 ECV00 : 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR BOC (1R,2R)-ISOMER ; CAS:325480-40-8 ECV51 : (1R,2R)-2-(Benzyloxymethyl)-3-cyclopenten-1-ol ; | ENTECAVIR BOC (1R,2S)-ISOMER ; CAS:188399-48-6 ECV52 : (1R,2S)-2-(Benzyloxymethyl)-3-cyclopenten-1-ol ; | ENTECAVIR BOC (1S,2R)-ISOMER ; CAS:110567-21-0 ECV53 : (1S,2R)-2-(Benzyloxymethyl)-3-cyclopenten-1-ol ; | ENTECAVIR DIBENZYL IMPURITY ; 3’,5’-DI-O-BENZYL ENTECAVIR ; CAS:142217-81-0 ECV35 : 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6H-purin-6-one ; | ENTECAVIR ENANTIOMER ; (1R,3S,4R)-ENTECAVIR ; CAS:188399-46-4 ECV40 : 2-Amino-9-[(1R,3S,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR EP IMPURITY A ; ENTECAVIR 1-EPIMER (USP) ; (1R,3R,4S)-ENTECAVIR ; CAS:1367369-78-5 ECV01 : 2-Amino-9-[(1R,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR EP IMPURITY B ; ENTECAVIR 3-EPIMER (USP) ; (1S,3S,4S)-ENTECAVIR ; CAS:1367369-77-4 ECV02 : 2-Amino-9-[(1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR EP IMPURITY C ; 8-HYDROXY ENTECAVIR (USP) ; ENTECAVIR DIONE ; ECV03 : 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-7,9-dihydro-1H-purine-6,8-dione ; | ENTECAVIR EP IMPURITY D ; ENTECAVIR 4-EPIMER (USP) ; (1S,3R,4R)-ENTECAVIR ; CAS:1367369-80-9 ECV04 : 2-Amino-9-[(1S,3R,4R)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-6,9-dihydro-3H-purin-6-one ; | ENTECAVIR EP IMPURITY E ; 8-METHOXY ENTECAVIR (USP) ; ECV05 : 2-Amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidene cyclopentyl]-8-methoxy-1,9-dihydro-6H-purin-6-one ; | ENTECAVIR EP IMPURITY F ; ENTECAVIR USP RC A ; ENTECAVIR DIMETHYLSILYL IMPURITY ; CAS:649761-24-0 ECV06 : 2-Amino-9-[(1S,3R,4S)-3-[(benzyloxy)methyl]-4-[dimethyl(phenyl)silyl]-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one ; | ENTECAVIR FURAN IMPURITY ; FUROENTECAVIR (USP) ; ECV41 : 9-[(3aS ,4S ,6S ,6aR )-3a,6-Dihydroxyhexahydro-1H -cyclopenta[c]furan-4-yl] guanine ; | ENTECAVIR TRIBENZYL ALCOHOL ; CAS:142217-77-4 ECV43 : (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3- (benzyloxy)-2-(benzyloxymethyl)cyclopentanol ; | ENZALUTAMIDE ; CAS:915087-33-1 EZL00 : 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide ; | ENZALUTAMIDE EP IMPURITY A ; CAS:112704-79-7 EZL01 : 4-Bromo-2-fluorobenzoic Acid ; | ENZALUTAMIDE EP IMPURITY B ; CAS:749927-69-3 EZL02 : 4-Bromo-2-fluoro-N-methylbenzamide ; | ENZALUTAMIDE EP IMPURITY C ; CAS:179232-29-2 EZL03 : 4-Bromo-2-fluorobenzoic Acid Methyl Ester ; | ENZALUTAMIDE IMPURITY 1 ; CAS:915087-32-0 EZL61 : 4-((2-Cyanopropan-2-yl)amino)-2-fluoro-N-methylbenzamide ; | ENZALUTAMIDE IMPURITY 2 ; CAS:143782-23-4 EZL62 : 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile ; | ENZALUTAMIDE IMPURITY 3 ; CAS:915087-25-1 EZL63 : 4-Amino-2-fluoro-N-methylbenzamide ; | ENZALUTAMIDE IMPURITY 4 ; CAS:915087-24-0 EZL64 : 2-Fluoro-N-methyl-4-nitrobenzamide ; | ENZALUTAMIDE IMPURITY 5 ; EZL65 : (4-((2-Cyanopropan-2-yl)amino)-N-methylbenzamide) ; | ENZALUTAMIDE IMPURITY 6 ; CAS:1895865-11-8 EZL66 : 1,3-bis(4-Cyano-3-(trifluoromethyl)phenyl)urea ; | ENZALUTAMIDE IMPURITY 7 ; CAS:1839619-50-9 EZL67 : 1,3-bis(4-Cyano-3-(trifluoromethyl)phenyl)thiourea ; | ENZALUTAMIDE IMPURITY I ; ENZALUTAMIDE DESFLUORO IMPURITY ; CAS:915087-16-0 EZL69 : 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-N-methylbenzamide ; | ENZALUTAMIDE IMPURITY J ; ENZALUTAMIDE OXO IMPURITY ; CAS:1242137-18-3 EZL70 : 4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-2,4-dioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide ; | ENZALUTAMIDE M1 ; ENZALUTAMIDE CARBOXYLIC ACID IMPURITY ; CAS:1242137-15-0 EZL51 : 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-benzoic Acid ; | ENZALUTAMIDE N-DESMETHYL IMPURITY ; CAS:1242137-16-1 EZL52 : 4-?[3-?[4-?Cyano-?3-?(trifluoromethyl)?phenyl]?-?5,?5-?dimethyl-?4-?oxo-?2-?thioxo-?1-?imidazolidinyl]?-?2-?fluorobenzamide ; | EPINASTINE EP IMPURITY A ; 9,13B-DEHYDRO EPINASTINE ; CAS:706753-75-5 EPN01B : 9H-Dibenzo[c,f]imidazo[1,5-a]azepin-3-amine ; | EPINASTINE EP IMPURITY B ; 7-BROMO EPINASTINE ; CAS:1217052-16-8 EPN02B : (13bRS)-7-Bromo-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-amine ; 3-Amino-7-bromo-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine ; | EPINASTINE HCL ; CAS:108929-04-0 EPN00H : (13bRS)-9,13b-Dihydro-1H-dibenzo[c,f]imidazo[1,5a]azepin-3-amine hydrochloride ; | EPINASTINE USP RC A ; EPINASTINE AMINOMETHYL IMPURITY ; CAS:127785-96-0 EPN21F : 6-Aminomethyl-6,?11-?Dihydro-?5H-?dibenzo[b,?e]?azepine fumarate ; | EPLERENONE ; CAS:107724-20-9 ERN00 : (7a, 11a, 17a)-9,11-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid, ?-lactone, methyl ester ; | EPLERENONE 11-ALPHA-HYDROXY ANALOG ; 11A-HYDROXY MEXRENONE ; CAS:192704-56-6 ERN40 : (7a,11a,17a)-11,17-Dihydroxy-3-oxopregn-4-ene-7,21-dicarboxylic acid ?-lactone methyl ester ; | EPLERENONE 11-ALPHA-HYDROXY CANRENONE IMPURITY ; CAS:192569-17-8 ERN53 : 11,17-Dihydroxy-3-oxo-pregna-4,6-diene-21-carboxylic acid gama-lactone ; | EPLERENONE 11-ALPHA-HYDROXY NITROETHYL IMPURITY ; ERN44 : (7a,11a,17a)-11,17-Dihydroxy-7-nitroethyl-3-oxopregn-4-ene-21-carboxylic acid ?-lactone ; | EPLERENONE 6-BETA-HYDROXY ANALOG ; CAS:209253-80-5 ERN41 : (6ß,7a,11a,17a)-9,11-Epoxy-6,17-dihydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid ?-lactone methyl ester ; | EPLERENONE ANHYDRO CANRENONE IMPURITY ; EPLERENONE 9,11-DIDEHYDRO CANRENONE IMPURITY ; DELTA-9 CANRENONE ; CAS:95716-71-5 ERN52 : 17-Hydroxy-3-oxo-pregna-4,6,9(11)-trien-21-carboxylic acid gama-lactone ; | EPLERENONE CANRENONE IMPURITY ; CANRENONE ; CAS:976-71-6 ERN54 : 17-Hydroxy-3-oxo-pregna-4,6-dien-21-carboxylic acid gama-lactone ; | EPLERENONE EP IMPURITY A ; CAS:209253-67-8 ERN01 : (2'S)-3',4'-Dihydro-3,5'-dioxospiro[androst-4-ene-17,2'-furan]-7a,9a-carbolactone ; | EPLERENONE EP IMPURITY B ; CAS:192704-82-8 ERN02 : (2'S)-11a,12a-Epoxy-3',4'-dihydro-7a-methoxycarbonylspiro[androst-4-ene-17,2'-furan]-3,5'-dione ; | EPLERENONE EP IMPURITY C ; EPLERENONE DELTA-9,11-ANALOG ; CAS:95716-70-4 ERN03 : (7a,17a)-17-Hydroxy-3-oxo-pregna-4,9(11)-diene-7,21-dicarboxylic acid ?-lactone 7-methyl ester ; | EPLERENONE EP IMPURITY D ; EPLERENONE 7-CARBOXYLIC ACID ; CAS:209253-82-7 ERN04 : (2'R)-9a,11a-Epoxy-3',4'-dihydro-3,5'-dioxospiro[androst-4-ene-17,2'-furan]-7a-carboxylic acid ; | EPLERENONE EP IMPURITY E ; EPLERENONE 7-BETA-ISOMER ; CAS:209253-81-6 ERN05 : (7beta, 11a, 17a)-9,11-Epoxy-17-hydroxy-3-oxo-pregn-4-ene-7,21-dicarboxylic acid, ?-lactone, methyl ester ; | EPLERENONE EP IMPURITY F ; EPLERENONE OPEN-RING ACID POTASSIUM SALT ; CAS:95716-98-6 ERN06K : 9a,11a-Epoxy-7a-methoxycarbonyl-17ß-hydroxy-3-oxopregn-4-ene-21-carboxylic acid potassium salt ; | EPLERENONE EP IMPURITY G ; MEXRENONE ; CAS:41020-65-9 ERN07 : (2'R)-3',4'-Dihydro-7a-methoxycarbonylspiro[androst-4-ene-17,2'-furan]-3,5'-dione ; | EPOTHILONE A ; 12-DESMETHYL EPOTHILONE B ; CAS:152044-53-6 EPT01 : (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12-tetramethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0]heptadecane-5,9-dione ; | EPOTHILONE B ; PATUPILONE ; CAS:152044-54-7 EPT02 : (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-4,17-dioxabicyclo[14.1.0] heptadecane-5,9-dione ; | EPOTHILONE D ; 12,13-DESOXY EPOTHILONE B ; CAS:189453-10-9 EPT04 : (4S,7R,8S,9S,13Z,16S)-4,8-Dihydroxy-5,5,7,9,13-pentamethyl-16-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]oxacyclohexadec-13-ene-2,6-dione ; | EPROSARTAN ; CAS:133040-01-4 EPS00B : (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid ; | EPROSARTAN DIMETHYL DIESTER ; CAS:133040-06-9 EPS40 : (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid dimethyl diester ; | EPROSARTAN MESYLATE ; CAS:144143-96-4 EPS00M : (E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]-imidazol-5-yl]-2-(2-thienyl methyl)-2-propenoic acid monomethanesulfonate ; | EPROSARTAN USP RC A ; CAS:1169702-90-2 EPS21 : (E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-yl-methyl)acrylic acid ; | EPROSARTAN USP RC B ; CAS:5928-51-8 EPS22 : 3-(Thiophen-2-yl)propanoic acid ; | EPROSARTAN USP RC C ; CAS:4475-24-5 EPS23 : 2-(Thiophen-2-ylmethyl)malonic acid ; | EPROSARTAN USP RC D ; CAS:6232-88-8 EPS24 : 4-(Bromomethyl)benzoic acid ; | EPROSARTAN USP RC E ; CAS:3006-96-0 EPS25 : 4-(Hydroxymethyl)benzoic acid ; | EPROSARTAN USP RC F ; (Z)-EPROSARTAN ; CAS:148674-39-9 EPS26 : (Z)-4-({2-Butyl-5-[2-carboxy-3-(thiophen-2-yl)prop-1-enyl]-1H-imidazol-1-yl}methyl)benzoic acid ; | EQUILENIN ; CAS:517-09-9 EQL00 : 3-Hydroxy-1,3,5(10),6,8-estrapentaen-17-one ; | EQUILENIN 17A-DIHYDRO IMPURITY ; CAS:6639-99-2 EQL57 : 17a-Dihydroequilenin | EQUILENIN 17A-DIHYDRO SODIUM SULFATE ; CAS:56086-66-9 EQL67N : 17a-Dihydroequilenin sodium sulfate ; | EQUILENIN 17SS-DIHYDRO 17A-ETHINYL IMPURITY ; CAS:1357266-17-1 EQL51 : (17a)-19-Norpregna-1,3,5,7,9-pentaen-20-yne-3,17-diol ; | EQUILENIN 17SS-DIHYDRO IMPURITY ; 17SS-EQUILENOL ; CAS:1423-97-8 EQL58 : 17ß-Dihydroequilenin | EQUILENIN 17SS-DIHYDRO SODIUM SULFATE ; CAS:16680-50-5 EQL68N : 17ß-Dihydroequilenin sodium sulfate ; | EQUILENIN SODIUM SULFATE ; CAS:16680-48-1 EQL50N : 3-Hydroxy-1,3,5(10),6,8-estrapentaen-17-one sodium sulfate ; | EQUILIN ; 7,8-DEHYDROESTRONE ; CAS:474-86-2 EQU00 : 3-Hydroxy-1,3,5(10),7-estratetraen-17-one ; | EQUILIN 17A-DIHYDRO IMPURITY ; CAS:651-55-8 EQU57 : (17a)-Estra-1,3,5(10),7-tetraene-3,17-diol ; Estra-1,3,5(10),7-tetraene-3,17a-diol ; | EQUILIN 17A-DIHYDRO SULFATE SODIUM SALT ; CAS:56050-05-6 EQU67N : (17a)-Estra-1,3,5(10),7-tetraene-3,17-diol 3-(hydrogen sulfate) sodium salt ; | EQUILIN 17SS-DIHYDRO IMPURITY ; CAS:3563-27-7 EQU58 : (17ß)-Estra-1,3,5(10),7-tetraene-3,17-diol ; Estra-1,3,5(10),7-tetraene-3,17ß-diol ; | EQUILIN 17SS-DIHYDRO SULFATE SODIUM SALT ; CAS:16680-49-2 EQU68N : (17ß)-Estra-1,3,5(10),7-tetraene-3,17-diol 3-(hydrogen sulfate) sodium salt ; | EQUILIN 3-O-METHYL ETHER ; EQU53 : 3-Methoxy-1,3,5(10),7-estratetraen-17-one ; | EQUILIN SULFATE SODIUM SALT ; CAS:16680-47-0 EQU50N : 3-(Sulfooxy)estra-1,3,5(10),7-tetraen-17-one sodium salt ; | ERISMODEGIB ; CAS:956697-53-3 EMG00 : rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide ; | ERISMODEGIB IMPURITY 1 ; CAS:1221722-10-6 EMG51 : 2-Methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid ; | ERISMODEGIB IMPURITY 2 ; CAS:1282295-12-8 EMG52H : 6-((2R,6S)-2,6-Dimethylmorpholino)pyridin-3-amine hydrochloride ; | ERLOTINIB 3-BROMO IMPURITY ; CAS:2055840-41-8 ELT53H : N-(3-Bromophenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride ; | ERLOTINIB 3-ETHYL ANALOG ; CAS:299912-61-1 ELT63B : N-(3-Ethylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine ; | ERLOTINIB 3-VINYL ANALOG ; CAS:1624294-38-7 ELT73H : N-(3-Vinylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride ; | ERLOTINIB 4-HYDROXY METABOLITE (M16) ; CAS:882420-22-6 ELT27H : N-(3-Ethynyl-4-hydroxy-phenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl] amine hydrochloride ; | ERLOTINIB 4-METHYL ANALOG ; CAS:1346601-52-2 ELT54H : N-(3-Ethynyl-4-methylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl ; | ERLOTINIB 6-O-CHLOROETHYL ANALOG ; CAS:183320-04-9 ELT60H : 6-(2-Chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)-4-quinazolinamine hydrochloride ; | ERLOTINIB 6-O-DESMETHYL ACETATE ; CAS:183320-15-2 ELT66H : 6-(2-Acetoxy-ethoxy)-4-(3-ethynyl-phenylamino)-7-(2-methoxy-ethoxy)quinazoline ; | ERLOTINIB 6-O-DESMETHYL METABOLITE ; ERLOTINIB METABOLITE M14 ; 6-O-DESMETHYL ERLOTINIB FORMATE ; CAS:183321-86-0 ELT14F : 2-[[4-[(3-Ethynylphenyl)amino]-7-(2-methoxyethoxy)-6-quinazolinyl] oxy]ethanol formate ; | ERLOTINIB 7-O-CHLOROETHYL ANALOG ; CAS:183320-19-6 ELT70H : 7-(2-Chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)-4-quinazolinamine hydrochloride ; | ERLOTINIB 7-O-DESMETHYL METABOLITE ; ERLOTINIB METABOLITE M13 ; 7-O-DESMETHYL ERLOTINIB FORMATE ; CAS:183320-29-8 ELT13F : 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl] oxy]ethanol formate ; | ERLOTINIB CARBOXYLIC ACID ; ERLOTINIB METABOLITE M6 ; CAS:882420-21-5 ELT26 : N-(3-Carboxymethylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine ; | ERLOTINIB CHLORO IMPURITY ; CAS:183322-18-1 ELT29 : 4-Chloro-6,7-(2-methoxyethoxy)-quinazoline ; | ERLOTINIB DICHLOROETHYL IMPURITY ; CAS:183320-00-5 ELT52 : 6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)-4-quinazolinamine HCl ; | ERLOTINIB DIDESMETHYL IMPURITY ; ERLOTINIB METABOLITE M12 ; CAS:183321-84-8 ELT25 : 2,2’-[[4-[(3-Ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-ethanol ; | ERLOTINIB HCL ; CAS:183319-69-9 ELT00H : N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine hydrochloride ; | ERLOTINIB LACTAM IMPURITY ; CAS:179688-29-0 ELT28 : 6,7-bis (2-Methoxyethoxy)-quinazolin-4(3H)-one ; | ERTAPENEM 4-NITROBENZYL METHYL ESTER ; ETP51 : (4R,5S,6S)-4-Nitrobenzyl 3-((3S,5S)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM DIMER ?N-TERT-BUTYLOXYCARBONYL P-NITROBENZYL DIMETHYL ESTER ; ETP56 : (4R,5S,6S)-4-Nitrobenzyl 3-((3S,5S)-1-((4R,5S,6S)-3-((3S,5S)-1-(tert-butoxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-enecarbonyl)-5-((3-(methoxycarbonyl)phenyl)c | ERTAPENEM DIMER 3 ; CAS:1199797-42-6 ETP52 : (4R,5S,6S)-3-((3S,5S)-5-((3-((2S,3R)-4-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-5-carboxy-2-((1S,2R)-1-carboxy-2-hydroxypropyl)-3-methyl-2,3-dihydro-1H-pyrrole-1-carbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-me | ERTAPENEM DIMER ESTER ; CAS:402955-38-8 ETP53 : (4R,5S,6S)-3-((3S,5S)-5-((3-(((1S,2R)-1-((2S,3R)-4-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-5-carboxy-3-methyl-3,4-dihydro-2H-pyrrol-2-yl)-1-carboxypropan-2-yloxy)carbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-m | ERTAPENEM DIMER FORM D IMPURITY ; CAS:1199797-41-5 ETP54 : (4R,5S,6S)-3-((3S,5S)-1-((3R)-2-((3R)-4-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-5-carboxy-3-methyl-3,4-dihydro-2H-pyrrol-2-yl)-3-hydroxybutanoyl)-5-((3-carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo- | ERTAPENEM DIMER N-CARBOXYBENZYL P-NITROBENZYL METHYL ESTER ; ETP55 : (4R,5S,6S)-4-Nitrobenzyl 3-((3S,5S)-1-((4R,5S,6S)-3-((3S,5S)-1-(benzyloxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-enecarbonyl)-5-((3-(methoxycarbonyl)phenyl)car | ERTAPENEM DISODIUM ; CAS:153832-38-3 ETP50N : [4R-[3(3S*,5S*),4a,5ß,6ß(R*)]]-3-[[5-[[(3Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-1azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid disodium salt ; | ERTAPENEM METHYL ESTER SODIUM SALT ; CAS:1632985-10-4 ETP57N : Sodium (4R,5S,6S)-3-((3S,5S)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM MONOSODIUM ; ERTAPENEM SODIUM ; CAS:153773-82-1 ETP00N : [4R-[3(3S*,5S*),4a,5ß,6ß(R*)]]-3-[[5-[[(3Carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-(1-hydroxyethyl)-4-methyl-7-oxo-1azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monosodium salt ; | ERTAPENEM N-CARBOXYBENZYL METHYL ESTER ; ETP58 : Sodium (4R,5S,6S)-3-((3S,5S)-1-(benzyloxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM N-ISOBUTOXYCARBONYL O-(4-NITROBENZYL) ; ETP59 : (4R,5S,6S)-4-Nitrobenzyl 6-((R)-1-hydroxyethyl)-3-((3S,5S)-1-(isobutoxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM N-TERT-BUTYLOXYCARBONYL 4-NITROPHENYL METHYL ESTER ; ETP61 : (4R,5S,6S)-4-Nitrobenzyl 3-((3S,5S)-1-(tert-butoxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM N-TERT-BUTYLOXYCARBONYL METHYL ESTER ; ETP62 : Sodium (4R,5S,6S)-3-((3S,5S)-1-(tert-butoxycarbonyl)-5-((3-(methoxycarbonyl)phenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate ; | ERTAPENEM OPEN-RING TRIACID ; CAS:357154-27-9 ETP63 : (4R,5S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-5-((1S,2R)-1-carboxy-2-hydroxypropyl)-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid ; | ERTAPENEM SIDE CHAIN ACID HCL ; CAS:791582-43-9 ETP60H : 3-[(2S,4S)-4-Mercaptopyrrolidine-2-carboxamido]benzoic acid HCl ; | ERYTHROMYCIN ; ERYTHROMYCIN A ; CAS:114-07-8 ETM00 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-ß-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN 12-DESHYDROXY IMPURITY ; ERYTHROMYCIN B ; 12-DEOXY ERYTHROMYCIN ; CAS:527-75-3 ETM62 : (3R,4S,5S,6R,7R,9R,11R,12S,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,13-dihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-ß-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN A IMINO ETHER ; CAS:161193-44-8 ETM51 : (3R,4R,5S,6R,9R,10S,11S,12R,13S,15R,Z)-12-[[3,4,6-Trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6-ethyl-4,5-dihydroxy-10-[(2,6-dideoxy-3-C-methyl-3-O-methyl-a-L-ribohexopyranosyl)oxy]-3,5,9,11,13,15-hexamethyl-7,16-dioxa-2-azabicyclo[11.2.1]hexad | ERYTHROMYCIN A N-OXIDE ; CAS:992-65-4 ETM52 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-ß-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione N-Oxid | ERYTHROMYCIN C ; 3-O-DESMETHYL ERYTHROMYCIN ; CAS:1675-02-1 ETM53 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-hydroxy-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[(3,4,6-trideoxy-3-dimethylamino-ß-D-xylo-hexopyranosyl)-oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN EP IMPURITY A ; ERYTHROMYCIN F ; ERYTHROMYCIN A 2-HYDROXYMETHYL ANALOG ; CAS:82230-93-1 ETM01 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3-(hydroxymethyl)-5,7,9,11,13-pentamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy] oxacyclotetradecane | ERYTHROMYCIN EP IMPURITY B ; ERYTHROMYCIN USP RC N ; N-DESMETHYLERYTHROMYCIN A ; CLARITHROMYCIN EP IMPURITY R ; CAS:992-62-1 ETM02 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(methylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN EP IMPURITY C ; ERYTHROMYCIN E ; CAS:41451-91-6 ETM03 : (2S,4aR,4'R,5'S,6'S,7R,8S,9R,10R,12R,14R,15R,16S)7-Ethyl-5',8,9,14-tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16-heptamethyl-15-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]hexadecahydrospiro[5H,11H-1,3-dioxino[5,4c]oxacyclotetradecin-2,2'- | ERYTHROMYCIN EP IMPURITY D ; ANHYDRO ERYTHROMYCIN A ; CAS:23893-13-2 ETM04 : (1S,2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-9[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-Lribo-hexopyranosyl)oxy]-5-ethyl-3-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec | ERYTHROMYCIN EP IMPURITY E ; ERYTHROMYCIN A ENOL ETHER ; CAS:33396-29-1 ETM05 : (2R,3R,4S,5R,8R,9S,10S,11R,12R)-9-[(2,6-Dideoxy-3C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-5-ethyl-3,4-dihydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylohexopyranosyl]oxy]-6,15-dioxabicyclo[10.2.1]pentadec1(14)-en-7-o | ERYTHROMYCIN EP IMPURITY F ; PSEUDOERYTHROMYCIN A ENOL ETHER ; CAS:105882-69-7 ETM06 : (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl3-O-methyl-a-L-ribo-hexopyranosyl) oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylohexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1 ]tridec-1(12) | ERYTHROMYCIN EP IMPURITY H ; ERYTHROMYCIN A N-OXIDE ; CAS:992-65-4 ETM08 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2,10-dione N-oxid | ERYTHROMYCIN EP IMPURITY I ; ERYTHRALOSAMINE ; CAS:546-57-6 ETM09 : (1S,4S,5R,8R,9S,10S,11R,12R,14R)-5-Ethyl-9-hydroxy-2,4,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-6,15,16-trioxatricyclo[10.2.1.11,4]hexadec-2-en-7-one ; | ERYTHROMYCIN EP IMPURITY J ; PSEUDOERYTHROMYCIN A HEMIKETAL ; CAS:105900-46-7 ETM10 : (1RS,2R,3R,6R,7S,8S,9R,10R,12R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-1-hydroxy-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[ | ERYTHROMYCIN EP IMPURITY K ; ERYTHROMYCIN D ; CAS:33442-56-7 ETM11 : (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-[(2,6-Dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12-dihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN EP IMPURITY L ; N-DEMETHYL-N-FORMYL ERYTHROMYCIN A ; CAS:127955-44-6 ETM12 : (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(formylmethylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2,10-dione ; | ERYTHROMYCIN EP IMPURITY M ; ERYTHROMYCIN G ; 12-DEOXY ERYTHROMYCIN 2-HYDROXYMETHYL ANALOG ; ETM13 : (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12-dihydroxy-3-(hydroxymethyl)-5,7,9,11,13-pentamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylohexopyranosyl]oxy]oxacyclotetradecane-2,10 | ERYTHROMYCIN EP IMPURITY N ; ERYTHRONOLIDE B ; CAS:3225-82-9 ETM14 : (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-14-Ethyl-4,6,7,12-tetrahydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione ; | ESCITALOPRAM EP IMPURITY A ; CITALOPRAM EP IMPURITY A ; CITALOPRAM AMIDE ; CAS:64372-56-1 ECT01 : 1-(3-(Dimethylamino)propyl)-1-(4'-fluorophenyl)-1,3-dihydro isobenzo furan-5-carboxamide ; | ESCITALOPRAM EP IMPURITY B ; CITALOPRAM EP IMPURITY B ; CITALOPRAM USP RC B ; 3-HYDROXY CITALOPRAM ; CAS:1332724-03-4 ECT02 : 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihydro isobenzofuran-5-carbonitrile ; | ESCITALOPRAM EP IMPURITY C ; CITALOPRAM EP IMPURITY C ; CITALOPRAM USP RC C ; 3-OXO CITALOPRAM ; CAS:372941-54-3 ECT03B : 3-[3-(Dimethylamino)-1-propyl](4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone ; | ESCITALOPRAM EP IMPURITY D (= USP RC D) ; CITALOPRAM EP IMPURITY D ; N-DESMETHYL CITALOPRAM HCL ; CAS:62498-67-3 ECT04H : 1-(4'-Fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzo furan-5-carbonitrile hydrochloride ; | ESCITALOPRAM EP IMPURITY E ; ESCITALOPRAM USP RC A ; CITADIOL HBR ; CITALOPRAM DIHYDROXY IMPURITY ; CAS:103146-26-5 ECT05H : 4-{4-(Dimethylamino)-[1-(4-fluorophenyl)-1-hydroxybutyl]}-3-(hydroxymethyl) benzonitrile HBr ; | ESCITALOPRAM EP IMPURITY F ; CAS:2102609-59-4 ECT06 : (1RS)-1-[3-(Dimethylamino)propyl]-1-hydroxy-1,3-dihydroisobenzofuran-5-carbonitrile ; | ESCITALOPRAM EP IMPURITY G ; CITALOPRAM EP IMPURITY G ; CAS:1329745-98-3 ECT07X : 4-(Dimethylamino)-1-[(1RS)-1-[3- (dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2- benzofuran-5-yl]butan-1-one oxalate ; | ESCITALOPRAM EP IMPURITY H ; CITALOPRAM USP RC E ; CITALOPRAM N-OXIDE ; CAS:63284-72-0 ECT08 : 1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzo furan-5-carbonitrile N-oxide ; | ESCITALOPRAM EP IMPURITY I ; CAS:1370643-22-3 ECT09X : 4-[(1Z)-4-(Dimethylamino)-1-(4-fluorophenyl)but-1-en-1-yl]-3-(hydroxy methyl)benzonitrile oxalate ; | ESCITALOPRAM EP IMPURITY J ; ECT10 : 4-Methylbenzenesulfonic acid ; p-Toluenesulfonic acid ; | ESCITALOPRAM EP IMPURITY K ; CITALOPRAM R-ISOMER ; CAS:219861-53-7 ECT11X : (R)-(-)-1-(3-Dimethylaminopropyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile oxalate ; | ESCITALOPRAM EP IMPURITY L ; CITALOPRAM DESFLUORO IMPURITY ; ESCITALOPRAM DESFLUORO IMPURITY ; CAS:1346617-30-8 ECT12X : (1RS)-1-[3-(Dimethylamino)propyl]-1-phenyl-1,3-dihydroisobenzofuran-5-carbonitrile oxalate ; | ESCITALOPRAM EP IMPURITY M ; CITALOPRAM CARBOXYLIC ACID IMPURITY ; CAS:440121-09-5 ECT13 : (1RS)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzo furan-5-carboxylic acid ; | ESCITALOPRAM N-DESMETHYL HCL ; N-DESMETHYL (S)-CITALOPRAM HCL ; CAS:144025-14-9 ECT54H : (S)-1-(4'-Fluorophenyl)-1-(3-(methylamino)propyl)-1,3-dihydroisobenzo furan-5-carbonitrile hydrochloride ; | ESCITALOPRAM N-OXIDE ; CAS:917482-45-2 ECT58 : (S)-1-(3-Dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzo furan-5-carbonitrile N-oxide ; | ESCITALOPRAM OXALATE ; CITALOPRAM S-ISOMER OXALATE ; CAS:219861-08-2 ECT00X : S-(+)-1-[3-(Dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalan carbonitrile oxalate; | ESOMEPRAZOLE ; CAS:119141-88-7 EOM00 : 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole ; | ESOMEPRAZOLE DESMETHYLSULFINYL IMPURITY ; OMEPRAZOLE DESMETHYLSULFINYL IMPURITY ; EOM50 : 5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-yl)-1H-benzimidazole ; | ESOMEPRAZOLE EP IMPURITY A ; OMEPRAZOLE EP IMP. A ; CAS:37052-78-1 EOM01 : 5-Methoxy-1H-benzimidazole-2-thiol ; | ESOMEPRAZOLE EP IMPURITY B ; OMEPRAZOLE EP IMP. B ; 4-DESMETHOXY OMEPRAZOLE ; CAS:110374-16-8 EOM02 : 5-Methoxy-2-[[(3,5-dimethylpyridin-2-yl) methyl] sulfinyl]-1H-benzimidazole ; | ESOMEPRAZOLE EP IMPURITY C ; OMEPRAZOLE EP IMP. C ; CAS:73590-85-9 EOM03 : 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole ; | ESOMEPRAZOLE EP IMPURITY D ; OMEPRAZOLE EP IMP. D ; ESOMEPRAZOLE USP RC A ; CAS:88546-55-8 EOM04 : 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl) methyl]sulfonyl]-1H-benzimidazole ; | ESOMEPRAZOLE EP IMPURITY E ; OMEPRAZOLE EP IMP. E ; CAS:176219-04-8 EOM05 : 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-1H-benzimidazole N-Oxide ; | ESOMEPRAZOLE EP IMPURITY F ; OMEPRAZOLE R-ISOMER POTASSIUM ; CAS:161796-77-6 EOM06K : 6-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole potassium salt ; | ESOMEPRAZOLE IMPURITY H ; OMEPRAZOLE PYRIDONE ACID SODIUM SALT ; CAS:1227380-90-6 EOM40N : 1-(5-Methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid sodium salt ; | ESOMEPRAZOLE MAGNESIUM TRIHYDRATE ; CAS:161973-10-0 EOM00M : 5-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl] benzimidazole magnesium salt (2:1), triydrate ; | ESOMEPRAZOLE POTASSIUM ; CAS:161796-84-5 EOM00K : 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole potassium salt ; | ESOMEPRAZOLE PYRIDONE ACID DIMER ; ESOMEPRAZOLE IMPURITY 2 ; EOM55 : 1-(5-Methoxy-1-(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carbonyl)-1H-benzo[d]imidazol-2-yl)-3,5-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid ; | ESOMEPRAZOLE SODIUM ; CAS:161796-78-7 EOM00N : 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sodium salt ; | ESOMEPRAZOLE TRIMETHYL-4-PYRIDONE IMPURITY ; ESOMEPRAZOLE IMPURITY 1 ; EOM54 : 1-(5-Methoxy-1H-benzo[d]imidazol-2-yl)-2,3,5-trimethylpyridin-4(1H)-one ; | ESTRADIOL ; 17SS-ESTRADIOL ; 16-DESHYDROXY ESTRIOL ; CAS:35380-71-3 ETL00 : Estra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL 16-KETO IMPURITY ; CAS:566-75-6 ETL66 : (17ß)-3,17-Dihydroxyestra-1,3,5(10)-trien-16-one ; 1,3,5(10)-Estratriene-3,17ß-diol-16-one ; | ESTRADIOL 17-DESOXY IMPURITY ; CAS:53-63-4 ETL50 : (8S,9S,13S,14S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol ; | ESTRADIOL 17A-HYDROXY IMPURITY ; CAS:57-91-0 ETL57 : 13ß-Methyl-1,3,5(10)-gonatriene-3,17a-diol ; | ESTRADIOL 17A-HYDROXY SULFATE SODIUM SALT ; CAS:56050-04-5 ETL58 : (17a)-Estra-1,3,5(10)-triene-3,17-diol 3-(hydrogen sulfate) sodium salt ; 17a-Acetoxy-3-sulfatoxy-estra-1,3,5(10)-triene sodium salt ; | ESTRADIOL 17SS-HYDROXY SULFATE SODIUM SALT ; CAS:4999-79-5 ETL59 : (17ß)-Estra-1,3,5(10)-triene-3,17-diol 3-(hydrogen sulfate) sodium salt ; | ESTRADIOL 2-METHYL IMPURITY ; CAS:1818-12-8 ETL52 : (17ß)-2-Methylestra-1,3,5(10)-triene-3,17-diol ; 2-Methyl-17ß-estradiol ; 2-Methylestra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL 4-METHOXY IMPURITY ; CAS:26788-23-8 ETL64 : (17ß)-4-Methoxy-estra-1,3,5(10)-triene-3,17-diol ; 4-Methoxyestra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL 6A-HYDROXY IMPURITY ; CAS:1229-24-9 ETL61 : 3,6a,17ß-Estratriol ; | ESTRADIOL 6SS-HYDROXY IMPURITY ; CAS:3/7/3583 ETL62 : 3,6ß,17ß-Estratrienetriol ; | ESTRADIOL BENZOATE ; CAS:50-50-0 EDB00 : 17ß-Hydroxyestra-1,3,5(10)-trien-3-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY A ; 17SS-ESTRADIOL ; ESTRADIOL ; CAS:50-28-2 EDB01 : Estra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL BENZOATE EP IMPURITY B ; EDB02 : 17ß-Hydroxy-4-methylestra-1,3,5(10)-trien-3-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY C ; 17B-ESTRADIOL DIBENZOATE ; CAS:4147-13-1 EDB03 : Estra-1,3,5(10)-triene-3,17ß-diyl dibenzoate ; | ESTRADIOL BENZOATE EP IMPURITY D ; CAS:983-30-2 EDB04 : 3-Hydroxyestra-1,3,5(10)-trien-17ß-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY E ; CAS:6045-53-0 EDB05 : 17a-Hydroxyestra-1,3,5(10)-trien-3-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY F ; EDB06 : 17ß-Hydroxyestra-1,3,5(10),9(11)-tetraen-3-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY G ; ESTRONE BENZOATE ; CAS:2393-53-5 EDB07 : 17-Oxoestra-1,3,5(10)-trien-3-yl benzoate ; | ESTRADIOL BENZOATE EP IMPURITY H ; CAS:4954-17-0 EDB08 : Estra-1,3,5(10)-triene-3,17ß-diyl-17-acetate-3-benzoate ; | ESTRADIOL DIVALERATE ; ESTRADIOL 3,17SS-DIVALERATE ; CAS:63042-28-4 EDV55 : (17ß)-Estra-1,3,5(10)-triene-3,17-diol 3,17-Dipentanoate ; | ESTRADIOL DIVALERATE 6-KETO IMPURITY ; CAS:1350468-78-8 EDV57 : (17ß)-3,17-Bis[(1-Oxopentyl)oxy]-estra-1,3,5(10)-trien-6-one ; | ESTRADIOL DIVALERATE 6A-HYDROXY IMPURITY ; CAS:1350468-75-5 EDV56 : (6a,17ß)-Estratriol 3,17-Dipentanoate ; (6a,17ß)-Estra-1,3,5(10)-triene-3,6,17-triol 3,17-Dipentanoate ; | ESTRADIOL EP IMPURITY A ; ESTRIOL EP IMPURITY B ; ETHINYLESTRADIOL EP IMPURITY C ; ESTRONE ; CAS:53-16-7 ETL01 : 3-Hydroxyestra-1,3,5(10)-trien-17-one ; | ESTRADIOL EP IMPURITY B ; ETHINYLESTRADIOL EP IMPURITY L ; 17A-ESTRADIOL ; ESTRADIOL 17A-HYDROXY IMPURITY ; CAS:57-91-0 ETL02 : Estra-1,3,5(10)-triene-3,17a-diol ; | ESTRADIOL EP IMPURITY C ; 4-METHYL ESTRADIOL ; CAS:6171-48-8 ETL03 : 4-Methylestra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL EP IMPURITY D ; ?9(11)-ESTRADIOL ; CAS:791-69-5 ETL04 : Estra-1,3,5(10),9(11)-tetraene-3,17ß-diol ; | ESTRADIOL USP RC B ; 6,7-DEHYDRO ESTRADIOL ; CAS:7291-41-0 ETL22 : (17ß)-Estra-1,3,5(10),6-tetraene-3,17-diol ; Estra-1,3,5(10),6-tetraene-3,17ß-diol ; | ESTRADIOL USP RC C ; 6-KETO ESTRADIOL ; CAS:571-92-6 ETL23 : 3,17ß-Dihydroxyestra-1,3,5(10)-trien-6-one ; | ESTRADIOL VALERATE ; CAS:979-32-8 EDV00 : 3-Hydroxyestra-1,3,5(10)-trien-17ß-yl pentanoate ; | ESTRADIOL VALERATE 17A-ISOMER ; CAS:182624-54-0 EDV67 : (17a)-Estra-1,3,5(10)-triene-3,17-diol 17-pentanoate ; | ESTRADIOL VALERATE 2-VALERYL IMPURITY ; 2-VALERYL-17SS-ESTRADIOL 17-VALERATE ; CAS:1421283-56-8 EDV50 : (17ß)-2-Valerylestra-1,3,5(10)-triene-1,17-diol 17-pentanoate ; | ESTRADIOL VALERATE 6-DEHYDRO IMPURITY ; 6-DEHYDRO ESTRADIOL 17-VALERATE ; CAS:1313382-25-0 EDV59 : (17ß)-Estra-1,3,5(10),6-tetraene-3,17-diol 17-pentanoate ; | ESTRADIOL VALERATE 6-KETO IMPURITY ; CAS:1313382-51-2 EDV60 : 6-Oxo-17ß-estradiol 17-valerate ; | ESTRADIOL VALERATE 6A-HYDROXY IMPURITY ; CAS:1313382-26-1 EDV61 : (6a,17ß)-Estra-1,3,5(10)-triene-3,6-17-triol 17-pentanoate ; | ESTRADIOL VALERATE 6SS-HYDROXY IMPURITY ; CAS:1313382-32-9 EDV62 : (6ß,17ß)-Estra-1,3,5(10)-triene-3,6,17-triol 17-Pentanoate ; 6ß-Hydroxy-17ß-estradiol 17-Valerate ; | ESTRADIOL VALERATE EP IMPURITY A ; ESTRADIOL ; 17SS-ESTRADIOL ; 16-DESHYDROXY ESTRIOL ; CAS:50-28-2 EDV01 : Estra-1,3,5(10)-triene-3,17ß-diol ; | ESTRADIOL VALERATE EP IMPURITY B ; ESTRADIOL 3-VALERATE ; CAS:21881-45-8 EDV02 : 17ß-Hydroxyestra-1,3,5(10)-trien-3-yl pentanoate ; | ESTRADIOL VALERATE EP IMPURITY C ; CAS:95959-20-9 EDV03 : 3-Hydroxyestra-1,3,5(10),9(11)-tetraen-17ß-yl pentanoate ; | ESTRADIOL VALERATE EP IMPURITY D ; CAS:1359847-37-2 EDV04 : 3-Hydroxy-4-methylestra-1,3,5(10)-trien-17ß-yl pentanoate ; | ESTRADIOL VALERATE EP IMPURITY E ; ESTRADIOL 3,17-DIVALERATE ; CAS:63042-28-4 EDV05 : Estra-1,3,5(10)-trien-3,17ß-diyl dipentanoate ; | ESTRADIOL VALERATE EP IMPURITY F ; ESTRADIOL 17-BUTYRATE ; CAS:18069-79-9 EDV06 : 3-Hydroxyestra-1,3,5(10)-trien-17ß-yl butanoate ; | ESTRATETRAENOL ; CAS:1150-90-9 PRM09 : Estra-1,3,5(10),16-tetraen-3-ol ; | ESTRATETRAENOL METHYL ETHER ; CAS:28336-31-4 PRM10 : 3-Methoxy-estra-1,3,5(10),16-tetraene ; | ESTRATETRAENONE ; ?8,9-DEHYDRO ESTRONE ; CAS:474-87-3 PRM11 : Estra-1,3,5(10),8-tetraen-3-ol-17-one ; | ESTRATETRAENONE METHYL ETHER ; CAS:6030-83-7 PRM12 : 3-Methoxy-estra-1,3,5(10),8-tetraen-17-one ; | ESTRATETRAENYL ACETATE ; ESTRATETRAENOL ACETATE ; PRM19 : Estra-1,3,5(10),16-tetraen-3-yl acetate ; | ESTRIOL ; CAS:50-27-1 EST00 : Estra-1,3,5(10)-triene-3,16a,17ß-triol ; | ESTRIOL EP IMPURITY A ; ESTRIOL USP RC A ; 9,11-DIDEHYDROESTRIOL ; CAS:246021-20-5 EST01 : Estra-1,3,5(10),9(11)-tetraene-3,16a,17ß-triol ; | ESTRIOL EP IMPURITY B ; ESTRONE ; ETHINYLESTRADIOL EP IMPURITY C ; CAS:53-16-7 EST02 : 3-Hydroxyestra-1,3,5(10)-trien-17-one ; | ESTRIOL EP IMPURITY C ; ESTRIOL 3-METHYL ETHER ; CAS:1474-53-9 EST03 : 3-Methoxyestra-1,3,5(10)-triene-16a,17ß-diol ; | ESTRIOL EP IMPURITY D ; ESTRADIOL ; 17SS-ESTRADIOL ; 16-DESHYDROXY ESTRIOL ; CAS:50-28-2 EST04 : Estra-1,3,5(10)-triene-3,17ß-diol ; | ESTRIOL EP IMPURITY E ; 17-EPI-ESTRIOL ; CAS:1228-72-4 EST05 : Estra-1,3,5(10)-triene-3,16a,17a-triol ; | ESTRIOL EP IMPURITY F ; 16-EPI-ESTRIOL ; CAS:547-81-9 EST06 : Estra-1,3,5(10)-triene-3,16ß,17ß-triol ; | ESTRIOL EP IMPURITY G ; 16,17-EPI-ESTRIOL ; CAS:793-89-5 EST07 : Estra-1,3,5(10)-triene-3,16ß,17a-triol ; | ESTRIOL EP IMPURITY H ; 16A-HYDROXY ESTRONE ; CAS:566-76-7 EST08 : 3,16a-Dihydroxyestra-1,3,5(10)-trien-17-one ; | ESTRIOL EP IMPURITY I ; CAS:15370-49-7 EST09 : (4aS,4bR,10bS,12aS)-8-Hydroxy-12a-methyl-4,4a,5,6,10b,11,12,12a-octahydro-3H-naphtho[2,1-f]isochromen-1(4bH)-one ; | ESTRONE ; (+)-ESTRONE; ESTRADIOL EP IMPURITY A ; ESTRIOL EP IMPURITY B ; ETHINYLESTRADIOL EP IMPURITY C ; CAS:53-16-7 ETN00 : 1,3,5(10)-Estratrien-3-ol-17-one ; | ESTRONE 1-METHYL IMPURITY ; CAS:4011-48-7 ETN71 : 3-Hydroxy-1-methyl-estra-1,3,5(10)-trien-17-one ; | ESTRONE 13-ETHYL 3-METHOXY IMPURITY ; CAS:848-04-4 ETN73 : 13-Ethyl-3-methoxy-gona-1,3,5(10)-trien-17-one ; | ESTRONE 2-METHOXY IMPURITY ; 2-HYDROXYESTRONE 2-METHYL ETHER ; CAS:362-08-3 ETN50 : 3-Hydroxy-2-methoxyestra-1,3,5(10)-trien-17-one ; | ESTRONE 3-ACETATE 1-METHYL IMPURITY ; CAS:30903-07-2 ETN51 : 3-(Acetyloxy)-1-methylestra-1,3,5(10)-trien-17-one ; 3-Hydroxy-1-methylestra-1,3,5(10)-trien-17-one ; | ESTRONE 3-O-METHYL HYDRAZONE IMPURITY ; CAS:105663-60-3 ETN52 : 3-Methoxy-estra-1,3,5(10)-trien-17-one hydrazone ; | ESTRONE 3-O-METHYL IMPURITY ; (+)-ESTRONE 3-METHYL ETHER; ; CAS:1624-62-0 ETN53 : 3-Methoxy-estra-1,3,5(10)-trien-17-one ; | ESTRONE 3-SULFATE SODIUM SALT ; CAS:438-67-5 ETN54 : Estra-1,3,5(10)-trien-17-one 3-(sulfooxy) sodium salt ; | ESTRONE 4-HYDROXY IMPURITY ; CAS:3131-23-5 ETN55 : 3,4-Dihydroxyestra-1,3,5(10)-trien-17-one ; 3,4-Dihydroxy-1,3,5(10)-estratrien-17-one ; | ESTRONE 4-METHOXY IMPURITY ; CAS:58562-33-7 ETN56 : 3-Hydroxy-4-methoxyestra-1,3,5(10)-trien-17-one ; | ESTRONE 4-METHYL IMPURITY ; ETN57 : 3-Hydroxy-4-methylestra-1,3,5(10)-trien-17-one ; | ESTRONE 6-DEHYDRO IMPURITY ; CAS:2208-12-0 ETN58 : 6,7-Dehydroestrone ; | ESTRONE 6-KETO IMPURITY ; 6-OXO ESTRONE ; CAS:1476-34-2 ETN59 : 3-Hydroxyestra-1,3,5(10)-triene-6,17-dione ; | ESTRONE 6A-HYDROXY IMPURITY ; CAS:1476-78-4 ETN60 : (6a)-3,6-Dihydroxyestra-1,3,5(10)-trien-17-one ; 3,6a-Dihydroxyestra-1,3,5(10)-trien-17-one ; | ESTRONE 8(9)-DEHYDRO IMPURITY ; ESTRATETRAENONE ; CAS:474-87-3 ETN61 : 3-Hydroxyestra-1,3,5(10),8-tetraen-17-one ; | ESTRONE 9(11)-DEHYDRO IMPURITY ; CAS:1089-80-1 ETN62 : 3-Hydroxy-estra-1,3,5(10),9(11) -tetraen-17-one ; | ESTRONE DIMER ; ETN33 : Estrone 3,3'-Dimer ; | ETACRYNIC ACID ; CAS:58-54-8 ECN00 : [2,3-Dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid ; | ETACRYNIC ACID EP IMPURITY A ; CAS:1217-67-0 ECN01 : (4-Butanoyl-2,3-dichlorophenoxy)acetic acid ; (2,3-Dichloro-4-butyrylphenoxy)acetic acid ; | ETACRYNIC ACID EP IMPURITY B ; 2-DESMETHYLENE 2-CHLOROMETHYL ETHACRYNIC ACID ; CAS:27929-18-6 ECN02 : [2,3-Dichloro-4-[2-(chloromethyl)butanoyl]-phenoxy]acetic acid ; | ETACRYNIC ACID EP IMPURITY C ; ETACRYNIC ACID USP RC C ; CAS:25355-92-4 ECN03 : [4-[2-[4-(Carboxymethoxy)-2,3-dichlorobenzoyl]-2,5-diethyl-3,4-dihydro-2H-pyran-6-yl]-2,3-dichlorophenoxy]acetic acid ; | ETHAMBUTOL DIHYDROCHLORIDE ; CAS:1070-11-7 ETB00H : (2S,2'S)-2,2'-(Ethylenediimino)dibutan-1-ol dihydrochloride ; | ETHAMBUTOL EP IMPURITY A ; CAS:96-20-8 ETB01 : 2-Aminobutan-1-ol ; | ETHAMBUTOL EP IMPURITY B ; ETHAMBUTOL USP RC A ; MESO-ETHAMBUTOL ; (R,S)-ETHAMBUTOL DIHYDROCHLORIDE ; CAS:32454-69-6 ETB02H : (2R,2'S)-2,2'-(Ethylenediimino)dibutan-1-ol dihydrochloride ; | ETHAMBUTOL EP IMPURITY C ; ETHAMBUTOL USP RC B ; (R,R)-ETHAMBUTOL DIHYDROCHLORIDE ; CAS:134566-79-3 ETB03H : (2R,2'R)-2,2'-(Ethylenediimino)dibutan-1-ol dihydrochloride ; | ETHINYLESTRADIOL ; CAS:57-63-6 ETE00 : 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,17-diol ; | ETHINYLESTRADIOL 1-HYDROXY 4-METHYL IMPURITY ; CAS:1034298-00-4 ETE51 : (8S,9S,13S,14S,17R)-17-Ethynyl-4,13-dimethyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-1,17-diol ; | ETHINYLESTRADIOL 13-ETHYL IMPURITY ; CAS:14012-72-7 ETE63 : 13-Ethyl-17a-ethynylgona-1,3,5(10)-triene-3,17ß-diol ; | ETHINYLESTRADIOL 2-HYDROXY IMPURITY ; CAS:50394-89-3 ETE52 ; (8R,9S,13S,14S,17S)-17-Ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-2,3,17-triol ; | ETHINYLESTRADIOL 2-OXY DIMER ; CAS:303014-91-7 ETE62 ; 2-[[17a-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl]oxy]-19-norpregna-1,3,5(10)-trien-20-yne-3,17a-diol ; | ETHINYLESTRADIOL 3-SULFATE SODIUM SALT ; CAS:724762-79-2 ETE53 : (17a)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol 3-(hydrogen sulfate) sodium salt ; | ETHINYLESTRADIOL 4-HYDROXY IMPURITY ; CAS:50394-90-6 ETE54 ; (8R,9S,13S,14S,17S)-17-Ethynyl-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,4,17-triol ; | ETHINYLESTRADIOL 4-OXY DIMER ; CAS:303014-90-6 ETE64 ; 4-[[17a-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl]oxy]-19-norpregna-1,3,5(10)-trien-20-yne-3,17a-diol ; | ETHINYLESTRADIOL DELTA-8(9) IMPURITY ; CAS:100019-04-3 ETE89 : delta-8(9)-Ethynylestradiol ; | ETHINYLESTRADIOL EP IMPURITY A ; 17SS-ETHINYLESTRADIOL ; 17-EPI-ETHYNYL ESTRADIOL ; 17SS-ETHYNYL-3,17A-ESTRADIOL ; CAS:4717-38-8 ETE01 : 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol ; | ETHINYLESTRADIOL EP IMPURITY B ; ETHINYLESTRADIOL USP RC B ; 9,11-DEHYDRO ETHYNYL ESTRADIOL ; CAS:1231-96-5 ETE02 : 19-Nor-17a-pregna-1,3,5(10),9(11)-tetraen-20-yne-3,17-diol ; | ETHINYLESTRADIOL EP IMPURITY C ; ESTRADIOL EP IMPURITY A ; ESTRIOL EP IMPURITY B ; ESTRONE ; CAS:53-16-7 ETE03 : 3-Hydroxyestra-1,3,5(10)-trien-17-one ; | ETHINYLESTRADIOL EP IMPURITY D ; ESTRADIOL ; 17SS-ESTRADIOL ; 16-DESHYDROXY ESTRIOL ; CAS:50-28-2 ETE04 : Estra-1,3,5(10)-triene-3,17ß-diol ; | ETHINYLESTRADIOL EP IMPURITY E ; 6A-HYDROXY-ETHINYLESTRADIOL ; CAS:27521-34-2 ETE05 : 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,6a,17-triol ; | ETHINYLESTRADIOL EP IMPURITY F ; 6SS-HYDROXY-ETHINYLESTRADIOL ; CAS:56324-28-8 ETE06 : 19-Nor-17a-pregna-1,3,5(10)-trien-20-yne-3,6ß,17-triol ; | ETHINYLESTRADIOL EP IMPURITY G ; ETHINYLESTRADIOL USP RC A ; 6-OXO-ETHINYLESTRADIOL ; CAS:38002-18-5 ETE07 : 3,17-Dihydroxy-19-nor-17a-pregna-1,3,5(10)-trien-20-yn-6-one ; | ETHINYLESTRADIOL EP IMPURITY H ; 16-OXO-ETHINYLESTRADIOL ; 16-KETO-ETHYNYLESTRADIOL ; CAS:1350468-76-6 ETE08 : 3,17-Dihydroxy-19-nor-17a-pregna-1,3,5(10)-trien-20-yn-16-one ; | ETHINYLESTRADIOL EP IMPURITY I ; 6,7-DEHYDRO ETHYNYL ESTRADIOL ; CAS:67703-68-8 ETE09 : 19-Nor-17a-pregna-1,3,5(10),6-tetraen-20-yne-3,17-diol ; | ETHINYLESTRADIOL EP IMPURITY J ; 1-METHYL ETHYNYL ESTRADIOL ; CAS:15071-66-6 ETE10 : (17a)-1-Methyl-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol ; | ETHINYLESTRADIOL EP IMPURITY K ; 4-METHYL ETHYNYL ESTRADIOL ; CAS:155683-61-7 ETE11 : (17a)-4-Methyl-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol ; | ETHINYLESTRADIOL EP IMPURITY L ; ESTRADIOL EP IMPURITY B ; 17A-ESTRADIOL ; ESTRADIOL 17A-HYDROXY IMPURITY ; CAS:57-91-0 ETE12 : Estra-1,3,5(10)-triene-3,17a-diol ; | ETHINYLESTRADIOL EP IMPURITY M ; 2-METHYL ETHYNYL ESTRADIOL ; CAS:3240-39-9 ETE13 : (17a)-2-Methyl-19-norpregna-1,3,5(10)-trien-20-yne-3,17-diol ; | ETHIONAMIDE ; CAS:536-33-4 EHA00 : 2-Ethylpyridine-4-carbothioamide ; | ETHIONAMIDE EP IMPURITY A ; CAS:2196-13-6 EHA01 : Pyridine-4-carbothioamide ; | ETHIONAMIDE EP IMPURITY B ; 4-CYANOPYRIDINE ; CAS:100-48-1 EHA02 : Pyridine-4-carbonitrile ; | ETHIONAMIDE EP IMPURITY C ; PROTHIONAMIDE ; CAS:14222-60-7 EHA03 : 2-Propylpyridine-4-carbothioamide ; | ETHIONAMIDE EP IMPURITY D ; CAS:1531-18-6 EHA04 : 2-Ethylpyridine-4-carbonitrile ; 2-Ethylisonicotinonitrile ; | ETHIONAMIDE EP IMPURITY E ; CAS:1391052-80-4 EHA05 : 2,6-Diethylpyridine-4-carbothioamide ; | ETHIONAMIDE EP IMPURITY F ; CAS:37581-44-5 EHA06 : 2,6-Diethylpyridine-4-carbonitrile ; 4-Cyano-2,6-diethylpyridine ; | ETHIONAMIDE SULFOXIDE ; CAS:536-28-7 EHA50 : 2-Ethyl-4-pyridinecarbothioamide S-Oxide ; | ETHOSUXIMIDE ; CAS:77-67-8 ETS00 : (RS)-3-Ethyl-3-methylpyrrolidine-2,5-dione ; | ETHOSUXIMIDE EP IMPURITY A ; ETHOSUXIMIDE USP RC A ; CAS:631-31-2 ETS01 : (2RS)-2-Ethyl-2-methylbutanedioic acid ; | ETHYLVANILLIN ; CAS:121-32-4 EVN00 : 3-Ethoxy-4-hydroxybenzaldehyde ; | ETHYLVANILLIN DESFORMYL IMPURITY ; CAS:94-71-3 EVN01 : 2-Ethoxyphenol ; | ETILEFRINE EP IMPURITY A ; ETILEFRONE ; CAS:22510-12-9 EFR01 : 2-(Ethylamino)-1-(3-hydroxyphenyl)ethanone ; | ETILEFRINE EP IMPURITY B ; CAS:154-86-9 EFR02H : (1RS)-1-(3-Hydroxyphenyl)-2-(methylamino)ethanol hydrochloride ; | ETILEFRINE EP IMPURITY C ; RAC NORPHENYLEPHRINE HCL ; NORFENEFRINE HCL ; CAS:4779-94-6 EFR03H : (1RS)-2-Amino-1-(3-hydroxyphenyl)ethanol hydrochloride ; | ETILEFRINE EP IMPURITY D ; BENZYLETILEFRONE ; CAS:42146-10-1 EFR04 : 2-(Benzylethylamino)-1-(3-hydroxyphenyl)ethanone ; | ETILEFRINE EP IMPURITY E ; 3-HYDROXYACETOPHENONE ; CAS:121-71-1 EFR05 : 1-(3-Hydroxyphenyl)ethanone ; | ETILEFRINE EP IMPURITY F ; BENZYLETHYLAMINE ; CAS:14321-27-8 EFR06 : N-Benzylethanamine ; | ETILEFRINE HCL ; CAS:943-17-9 EFR00H : (1RS)-2-(Ethylamino)-1-(3-hydroxyphenyl)ethanol hydrochloride ; | ETODOLAC ; CAS:41340-25-4 ETD00 : 2-[(1RS)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY A ; 8-DESETHYL ETODOLAC ; CAS:41339-67-7 ETD01 : 2-[(1RS)-1-Ethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY B ; 8-METHYL ETODOLAC ; CAS:41340-19-6 ETD02 : 2-[(1RS)-1-Ethyl-8-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY C ; ETODOLAC USP RC A ; 1-METHYL ETODOLAC ; CAS:109518-47-0 ETD03 : 2-[(1RS)-8-Ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY D ; 8-ISOPROPYL ETODOLAC ; CAS:57917-63-2 ETD04 : 2-[(1RS)-1-Ethyl-8-(1-methylethyl)-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY E ; 8-PROPYL ETODOLAC ; CAS:57817-27-3 ETD05 : 2-[(1RS)-1-Ethyl-8-propyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY F ; 1-ISOPROPYL ETODOLAC ; CAS:849630-65-5 ETD06 : 2-[(1RS)-8-Ethyl-1-(1-methylethyl)-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY G ; 1-PROPYL ETODOLAC ; CAS:57816-83-8 ETD07 : 2-[(1RS)-8-Ethyl-1-propyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid ; | ETODOLAC EP IMPURITY H ; 7-ETHYLTRYPTOPHOL ; CAS:41340-36-7 ETD08 : 2-(7-Ethyl-1H-indol-3-yl)ethanol ; | ETODOLAC EP IMPURITY I ; ETODOLAC DIMER ; ETD09 : (3RS)-3-[7-Ethyl-3-(2-hydroxyethyl)-1H-indol-2-yl]-3-(7-ethyl-1H-indol-3-yl)pentanoic acid ; | ETODOLAC EP IMPURITY J ; DECARBOXY ETODOLAC ; CAS:115066-03-0 ETD10 : (1RS)-1,8-Diethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indole ; | ETODOLAC EP IMPURITY K ; ETODOLAC METHYL ESTER ; CAS:122188-02-7 ETD11 : Methyl 2-[(1RS)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetate ; | ETODOLAC EP IMPURITY L ; ETD12 : (EZ)-3-[7-Ethyl-3-(2-hydroxyethyl)-1H-indol-2-yl]pent-3-enoic acid ; | ETOFENAMATE ; CAS:30544-47-9 EFN00 : 2-(2-Hydroxyethoxy)ethyl 2-[[3-(trifluoromethyl)phenyl]amino]benzoate ; | ETOFENAMATE EP IMPURITY A ; FLUFENAMIC ACID ; CAS:530-78-9 EFN01 : 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid ; | ETOFENAMATE EP IMPURITY B ; BUTYL FLUFENAMATE ; CAS:67330-25-0 EFN02 : Butyl 2-[[3-(trifluoromethyl)phenyl]amino]benzoate ; | ETOFENAMATE EP IMPURITY C ; CAS:101-23-5 EFN03 : N-Phenyl-3-(trifluoromethyl)aniline ; | ETOFENAMATE EP IMPURITY D ; CAS:64352-84-7 EFN04 : 2,2'-Oxybis(ethylene) bis[2-[[3-(trifluoromethyl)phenyl]amino]benzoate] ; | ETOFENAMATE EP IMPURITY E ; EFN05 : 2-(2-Butoxyethoxy)ethyl 2-[[3-(trifluoromethyl)phenyl]amino]benzoate ; | ETOFENAMATE EP IMPURITY F ; CAS:111-46-6 EFN06 : Diethylene Glycol ; 2-Hydroxyethoxyethanol ; | ETOFENAMATE EP IMPURITY G ; CAS:32508-98-8 EFN07 : 2-Hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]benzoate ; | ETOFENAMATE MYRISTATE ; CAS:81427-99-8 EFN51 : 2-(2-(Tetradecanoyloxy)ethoxy)ethyl 2-(3-(trifluoromethyl)phenylamino)benzoate ; | ETOFENAMATE PALMITATE ; CAS:81427-95-4 EFN52 : 2-(2-(Palmitoyloxy)ethoxy)ethyl 2-(3-(trifluoromethyl)phenylamino)benzoate ; | ETOFENAMATE STEARATE ; CAS:81427-97-6 EFN53 : 2-(2-(Stearoyloxy)ethoxy)ethyl 2-(3-(trifluoromethyl)phenylamino)benzoate ; | ETOMIDATE ; ETOMIDATE R-ISOMER ; CAS:33125-97-2 EDT00 : (R)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate ; | ETOMIDATE ACID R-ISOMER ; ETOMIDATE ACID ; CAS:56649-48-0 EDT50 : (R)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ; | ETOMIDATE ACID S-ISOMER ; ETOMIDATE S-ISOMER O-DESETHYL IMPURITY ; CAS:56649-49-1 EDT62 : (S)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ; | ETOMIDATE DESPHENYLETHYL 1-CARBOXYLATE IMPURITY ; CAS:19213-72-0 EDT63 : Ethyl 1H-Imidazole-1-carboxylate ; | ETOMIDATE DESPHENYLETHYL IMPURITY ; CAS:23785-21-9 EDT64 : Ethyl 1H-Imidazole-5-carboxylate ; | ETOMIDATE EP IMPURITY A ; ETOMIDATE ACID RACEMATE ; CAS:7036-56-8 EDT01 : 1-[(1RS)-1-Phenylethyl]-1H-imidazole-5-carboxylic acid ; | ETOMIDATE EP IMPURITY B ; METOMIDATE ; CAS:5377-20-8 EDT02 : Methyl 1-[(1RS)-1-Phenylethyl]-1H-imidazole-5-carboxylate ; | ETOMIDATE EP IMPURITY C ; CAS:792842-51-4 EDT03 : 1-Methylethyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate ; | ETOMIDATE R-ISOMER METHYL ESTER ; (R)-METOMIDATE ; CAS:61045-91-8 EDT51 : (R)-Methyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate ; | ETOMIDATE S-ISOMER ; (S)-ETOMIDATE ; CAS:56649-47-9 EDT60 : (S)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate ; | ETORICOXIB ; CAS:202409-33-4 ECX00 : 5-Chloro-6’-methyl-3-[4-(methylsulfonyl)phenyl]-2,3’-bipyridine ; | ETORICOXIB 6-CARBOXY IMPURITY ; CAS:349536-39-6 ECX51 : 5-Chloro-3-[4-(methylsulfonyl)phenyl]-[2,3'-bipyridine]-6'-carboxylic acid ; | ETORICOXIB 6-HYDROXYMETHYL IMPURITY ; CAS:349536-41-0 ECX52 : 5-Chloro-3-[4-(methylsulfonyl)phenyl]-[2,3'-bipyridine]-6'-methanol ; | ETORICOXIB 6-HYDROXYMETHYL N1-OXIDE ; CAS:570394-08-0 ECX54 : 5-Chloro-6'-(hydroxymethyl)-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridine] 1'-oxide ; | ETORICOXIB 6-HYDROXYMETHYL SS-GLUCURONIDE ; CAS:349536-40-9 ECX53 : (2S,3S,4S,5R,6R)-6-((5-Chloro-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-6'-yl)methoxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid ; | ETORICOXIB DESMETHYL IMPURITY ; CAS:202409-31-2 ECX50 : 5-Chloro-3-[4-(methylsulfonyl)phenyl]-2,3’-bipyridine ; | ETORICOXIB N,N-DIOXIDE ; ECX55 : 5-Chloro-6’-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3’-bipyridine] 1-1’-dioxide ; | ETORICOXIB N1-OXIDE ; CAS:325855-74-1 ECX56 : 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine 1'-oxide ; 5-{5-Chloro-3-[4-(methylsulfonyl)phenyl]pyridine-2-yl}-2-methylpyridine-1-oxide ; | ETORICOXIB USP RC A ; CAS:10297-73-1 ECX21 : 4-(Methylsulfonyl)acetophenone ; | ETORICOXIB USP RC B ; CAS:90536-66-6 ECX22 : 4-(Methylsulfonyl)-phenyl acetic acid ; | ETORICOXIB USP RC C ; CAS:249561-98-6 ECX23 : 2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate ; | ETRAVIRINE ; CAS:269055-15-4 ETV00 : 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; | ETRAVIRINE 5-DESBROMO 6-CHLORO IMPURITY ; CAS:1070377-34-2 ETV56 : 4-[[6-Chloro-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; | ETRAVIRINE 6-DESAMINO 5-CHLORO IMPURITY ; CAS:269055-05-2 ETV65 : 4-[[5-Bromo-5-chloro-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; | ETRAVIRINE 6-DESAMINO 6-CHLORO IMPURITY ; CAS:269055-76-7 ETV66 : 4-[[5-Bromo-6-chloro-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile ; | ETRAVIRINE DIHYDROXY IMPURITY ; CAS:1246818-67-6 ETV52 : 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-bis(hydroxymethyl)benzonitrile ; | ETRAVIRINE MONOHYDROXY IMPURITY ; CAS:1246815-68-8 ETV51 : 4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3-hydroxymethylbenzonitrile ; | EVEROLIMUS ; CAS:159351-69-6 EVR00 : (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,2 | EVEROLIMUS 18-OXO IMPURITY ; 31-OXO EVEROLIMUS ; EVR18 : (1R,9S,12S,15R,16E,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1-Hydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,26,28-tetr | EVEROLIMUS 30-O-DESMETHYL IMPURITY ; CAS:745779-75-3 EVR60 : (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18,30-trihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-19-methoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,26 | EVEROLIMUS EP IMPURITY A ; SIROLIMUS ; RAPAMYCIN ; CAS:53123-88-9 EVR01 : (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-[(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,?]hexatriaconta-16,24,26,28-tetra | EVEROLIMUS EP IMPURITY B ; EVEROLIMUS 19-ENE OPEN-RING IMPURITY (EP) ; SECO EVEROLIMUS ; CAS:1062122-63-7 EVR02 : (2S)-1-[[(2R,3R,6S)-2-Hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19Z,21R)-14- hydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11, 15,17,21-hexamethyl-12,18-dioxodocosa-3,5,7,15,19-pentaen-1-yl]-3-methyltetrahydro-2H- | EVEROLIMUS EP IMPURITY C ; 10-DESMETHYL EVEROLIMUS (EP) ; 19-DESMETHYL EVEROLIMUS ; EVR03 : (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18,19-Trihydroxy-12- [(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl]-30-methoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo [30.3.1.04,9]hexatriaconta-16,24, | | |